<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":4.136413,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpFDhsSD1wPC1dKF1MXQQ8BDQNATE4fVUhaHEZIUFFUB01VBAQNA1AHSQQUCl8=","queueTime":0,"ttGuid":"501822152bc8e5b9"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full">
<meta property="description" name="description" content="Ion channels and cytoskeletal proteins in the cardiac dyad play a critical role in maintaining excitation-contraction (E-C) coupling and in providing cardiac...">
<meta property="og:title" name="title" content="Frontiers | Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions">
<meta property="og:description" name="description" content="Ion channels and cytoskeletal proteins in the cardiac dyad play a critical role in maintaining excitation-contraction (E-C) coupling and in providing cardiac...">
<meta name="keywords" content="iPSCs,patient-specific iPSC-CMs,in vitro arrhythmia models,Ion Channels,personalized medicine,CRISPR,gene editing,optogenetics Font: Italic Formatted: Font: Italic Formatted: Normal">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="15">
<meta name="citation_journal_title" content="Frontiers in Physiology">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Physiol.">
<meta name="citation_issn" content="1664-042X">
<meta name="citation_doi" content="10.3389/fphys.2024.1475152">
<meta name="citation_firstpage" content="1475152">
<meta name="citation_language" content="English">
<meta name="citation_title" content="Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions">
<meta name="citation_keywords" content="iPSCs; patient-specific iPSC-CMs; in vitro arrhythmia models; Ion Channels; personalized medicine; CRISPR; gene editing; optogenetics Font: Italic Formatted: Font: Italic Formatted: Normal">
<meta name="citation_abstract" content="Ion channels and cytoskeletal proteins in the cardiac dyad play a critical role in maintaining excitation-contraction (E-C) coupling and in providing cardiac homeostasis. However, functional changes in these dyad proteins, whether induced by genetic, epigenetic, metabolic, therapeutic, or environmental factors disrupt normal cardiac electrophysiology, leading to abnormal E-C coupling and arrhythmias. Animal models and heterologous cell cultures provide platforms to elucidate the pathogenesis of arrhythmias for basic cardiac research; however, these traditional systems do not truly reflect human cardiac electro-pathophysiology. Notably, patients with the same genetic variants of inherited channelopathies (ICC) often exhibit incomplete penetrance and variable expressivity which underscores the need to establish patient-specific disease models to comprehend the mechanistic pathways of arrhythmias and determine personalized therapies. Patient-specific induced pluripotent stem cells-derived cardiomyocytes (iPSC-CMs) inherit the genetic background of the patient and reflect the electrophysiological characteristics of the native cardiomyocytes. Thus, iPSC-CMs provide an innovative and translational platform in cardiac disease modeling and therapeutic screening. In this review, we will examine how patient-specific iPSC-CMs historically evolved to model arrhythmia syndromes in a dish, and their utility in understanding the role of specific ion channels and their functional characteristics in causing arrhythmias. We will also examine utility of CRISPR/Cas9 to establish patient-independent, variant-induced arrhythmia models. Next, we will examine the limitations of using human iPSC-CMs with respect to in vitro arrhythmia modeling that stems from variations in iPSCs or toxicity due to gene editing on iPSC or iPSC-CMs and explore how such hurdles are being addressed. Importantly, we will also discuss how novel 3D iPSC-CM models better capture in vivo characteristics and how all-optical platforms provide non-invasive and high-throughput electrophysiological data that is useful for stratification of emerging arrhythmogenic variants and drug discovery. Finally, we will examine strategies to improve iPSC-CM maturity, including powerful gene editing and optogenetic tools that can introduce/modify specific ion channels in the iPSC-CMs and tailor cellular and functional characteristics. We anticipate that an elegant synergy of iPSCs, novel gene editing, 3D-culture models, and all-optical platforms will offer a high-throughput template to faithfully recapitulate in  vivo arrhythmogenic events necessary for personalized arrhythmia monitoring and drug screening.">
<meta name="citation_article_type" content="Review">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2024/08/28">
<meta name="citation_publication_date" content="2024/09/12">
<meta name="citation_author" content="Joshi, Jyotsna ">
<meta name="citation_author_institution" content="Department of Internal Medicine, United States">
<meta name="citation_author" content="Albers, Cora ">
<meta name="citation_author_institution" content="Department of Internal Medicine, United States">
<meta name="citation_author" content="Smole, Nathan ">
<meta name="citation_author_institution" content="Department of Internal Medicine, United States">
<meta name="citation_author" content="Guo, Shuliang ">
<meta name="citation_author_institution" content="Department of Internal Medicine, United States">
<meta name="citation_author" content="Smith, Sakima A. ">
<meta name="citation_author_institution" content="Department of Internal Medicine, United States">
<meta name="dc.identifier" content="doi:10.3389/fphys.2024.1475152">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions","author":[{"@type":"Person","name":"Jyotsna Joshi","affiliation":["Department of Internal Medicine, United States"]},{"@type":"Person","name":"Cora Albers","affiliation":["Department of Internal Medicine, United States"]},{"@type":"Person","name":"Nathan Smole","affiliation":["Department of Internal Medicine, United States"]},{"@type":"Person","name":"Shuliang Guo","affiliation":["Department of Internal Medicine, United States"]},{"@type":"Person","name":"Sakima A. Smith","affiliation":["Department of Internal Medicine, United States"]}],"datePublished":"2024-09-12","dateModified":"2025-11-26","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2024","isPartOf":{"@type":"PublicationVolume","volumeNumber":"15","isPartOf":{"@type":"Periodical","name":"Frontiers in Physiology"}}},"citation":["https://doi.org/10.3389/fphys.2024.1475152"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="red"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/physiology" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Physiology</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=65&amp;specialtyid=0&amp;entitytype=2&amp;entityid=210" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/physiology" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Physiology</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/aquatic-physiology" data-event="iBarJournal-sections-a_id_230">Aquatic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/autonomic-neuroscience" data-event="iBarJournal-sections-a_id_157">Autonomic Neuroscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/avian-physiology" data-event="iBarJournal-sections-a_id_1328">Avian Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/biophysics" data-event="iBarJournal-sections-a_id_667">Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cardiac-electrophysiology" data-event="iBarJournal-sections-a_id_211">Cardiac Electrophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cell-physiology" data-event="iBarJournal-sections-a_id_2468">Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/chronobiology" data-event="iBarJournal-sections-a_id_1393">Chronobiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/clinical-and-translational-physiology" data-event="iBarJournal-sections-a_id_579">Clinical and Translational Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/computational-physiology-and-medicine" data-event="iBarJournal-sections-a_id_212">Computational Physiology and Medicine</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/craniofacial-biology-and-dental-research" data-event="iBarJournal-sections-a_id_214">Craniofacial Biology and Dental Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/developmental-physiology" data-event="iBarJournal-sections-a_id_1346">Developmental Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/environmental-aviation-and-space-physiology" data-event="iBarJournal-sections-a_id_1331">Environmental, Aviation and Space Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/exercise-physiology" data-event="iBarJournal-sections-a_id_215">Exercise Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/gastrointestinal-sciences" data-event="iBarJournal-sections-a_id_216">Gastrointestinal Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/integrative-physiology" data-event="iBarJournal-sections-a_id_218">Integrative Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/invertebrate-physiology" data-event="iBarJournal-sections-a_id_229">Invertebrate Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/lipid-and-fatty-acid-research" data-event="iBarJournal-sections-a_id_444">Lipid and Fatty Acid Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/medical-physics-and-imaging" data-event="iBarJournal-sections-a_id_670">Medical Physics and Imaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/membrane-physiology-and-membrane-biophysics" data-event="iBarJournal-sections-a_id_213">Membrane Physiology and Membrane Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/metabolic-physiology" data-event="iBarJournal-sections-a_id_2071">Metabolic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/mitochondrial-research" data-event="iBarJournal-sections-a_id_232">Mitochondrial Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/physio-logging" data-event="iBarJournal-sections-a_id_1496">Physio-logging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/red-blood-cell-physiology" data-event="iBarJournal-sections-a_id_1386">Red Blood Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/redox-physiology" data-event="iBarJournal-sections-a_id_219">Redox Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/renal-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_222">Renal Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/reproductive-and-mating-physiology" data-event="iBarJournal-sections-a_id_2527">Reproductive and Mating Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/respiratory-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_224">Respiratory Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skeletal-physiology" data-event="iBarJournal-sections-a_id_2275">Skeletal Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skin-physiology" data-event="iBarJournal-sections-a_id_2965">Skin Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/striated-muscle-physiology" data-event="iBarJournal-sections-a_id_221">Striated Muscle Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/vascular-physiology" data-event="iBarJournal-sections-a_id_225">Vascular Physiology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=65&amp;specialtyid=0&amp;entitytype=2&amp;entityid=210" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/physiology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Physiology</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/aquatic-physiology" data-event="iBarJournal-sections-a_id_230">Aquatic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/autonomic-neuroscience" data-event="iBarJournal-sections-a_id_157">Autonomic Neuroscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/avian-physiology" data-event="iBarJournal-sections-a_id_1328">Avian Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/biophysics" data-event="iBarJournal-sections-a_id_667">Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cardiac-electrophysiology" data-event="iBarJournal-sections-a_id_211">Cardiac Electrophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cell-physiology" data-event="iBarJournal-sections-a_id_2468">Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/chronobiology" data-event="iBarJournal-sections-a_id_1393">Chronobiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/clinical-and-translational-physiology" data-event="iBarJournal-sections-a_id_579">Clinical and Translational Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/computational-physiology-and-medicine" data-event="iBarJournal-sections-a_id_212">Computational Physiology and Medicine</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/craniofacial-biology-and-dental-research" data-event="iBarJournal-sections-a_id_214">Craniofacial Biology and Dental Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/developmental-physiology" data-event="iBarJournal-sections-a_id_1346">Developmental Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/environmental-aviation-and-space-physiology" data-event="iBarJournal-sections-a_id_1331">Environmental, Aviation and Space Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/exercise-physiology" data-event="iBarJournal-sections-a_id_215">Exercise Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/gastrointestinal-sciences" data-event="iBarJournal-sections-a_id_216">Gastrointestinal Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/integrative-physiology" data-event="iBarJournal-sections-a_id_218">Integrative Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/invertebrate-physiology" data-event="iBarJournal-sections-a_id_229">Invertebrate Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/lipid-and-fatty-acid-research" data-event="iBarJournal-sections-a_id_444">Lipid and Fatty Acid Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/medical-physics-and-imaging" data-event="iBarJournal-sections-a_id_670">Medical Physics and Imaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/membrane-physiology-and-membrane-biophysics" data-event="iBarJournal-sections-a_id_213">Membrane Physiology and Membrane Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/metabolic-physiology" data-event="iBarJournal-sections-a_id_2071">Metabolic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/mitochondrial-research" data-event="iBarJournal-sections-a_id_232">Mitochondrial Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/physio-logging" data-event="iBarJournal-sections-a_id_1496">Physio-logging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/red-blood-cell-physiology" data-event="iBarJournal-sections-a_id_1386">Red Blood Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/redox-physiology" data-event="iBarJournal-sections-a_id_219">Redox Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/renal-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_222">Renal Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/reproductive-and-mating-physiology" data-event="iBarJournal-sections-a_id_2527">Reproductive and Mating Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/respiratory-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_224">Respiratory Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skeletal-physiology" data-event="iBarJournal-sections-a_id_2275">Skeletal Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skin-physiology" data-event="iBarJournal-sections-a_id_2965">Skin Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/striated-muscle-physiology" data-event="iBarJournal-sections-a_id_221">Striated Muscle Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/vascular-physiology" data-event="iBarJournal-sections-a_id_225">Vascular Physiology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/physiology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Physiology</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/aquatic-physiology" data-event="iBarJournal-sections-a_id_230">Aquatic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/autonomic-neuroscience" data-event="iBarJournal-sections-a_id_157">Autonomic Neuroscience</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/avian-physiology" data-event="iBarJournal-sections-a_id_1328">Avian Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/biophysics" data-event="iBarJournal-sections-a_id_667">Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cardiac-electrophysiology" data-event="iBarJournal-sections-a_id_211">Cardiac Electrophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/cell-physiology" data-event="iBarJournal-sections-a_id_2468">Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/chronobiology" data-event="iBarJournal-sections-a_id_1393">Chronobiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/clinical-and-translational-physiology" data-event="iBarJournal-sections-a_id_579">Clinical and Translational Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/computational-physiology-and-medicine" data-event="iBarJournal-sections-a_id_212">Computational Physiology and Medicine</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/craniofacial-biology-and-dental-research" data-event="iBarJournal-sections-a_id_214">Craniofacial Biology and Dental Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/developmental-physiology" data-event="iBarJournal-sections-a_id_1346">Developmental Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/environmental-aviation-and-space-physiology" data-event="iBarJournal-sections-a_id_1331">Environmental, Aviation and Space Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/exercise-physiology" data-event="iBarJournal-sections-a_id_215">Exercise Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/gastrointestinal-sciences" data-event="iBarJournal-sections-a_id_216">Gastrointestinal Sciences</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/integrative-physiology" data-event="iBarJournal-sections-a_id_218">Integrative Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/invertebrate-physiology" data-event="iBarJournal-sections-a_id_229">Invertebrate Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/lipid-and-fatty-acid-research" data-event="iBarJournal-sections-a_id_444">Lipid and Fatty Acid Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/medical-physics-and-imaging" data-event="iBarJournal-sections-a_id_670">Medical Physics and Imaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/membrane-physiology-and-membrane-biophysics" data-event="iBarJournal-sections-a_id_213">Membrane Physiology and Membrane Biophysics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/metabolic-physiology" data-event="iBarJournal-sections-a_id_2071">Metabolic Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/mitochondrial-research" data-event="iBarJournal-sections-a_id_232">Mitochondrial Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/physio-logging" data-event="iBarJournal-sections-a_id_1496">Physio-logging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/red-blood-cell-physiology" data-event="iBarJournal-sections-a_id_1386">Red Blood Cell Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/redox-physiology" data-event="iBarJournal-sections-a_id_219">Redox Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/renal-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_222">Renal Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/reproductive-and-mating-physiology" data-event="iBarJournal-sections-a_id_2527">Reproductive and Mating Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/respiratory-physiology-and-pathophysiology" data-event="iBarJournal-sections-a_id_224">Respiratory Physiology and Pathophysiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skeletal-physiology" data-event="iBarJournal-sections-a_id_2275">Skeletal Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/skin-physiology" data-event="iBarJournal-sections-a_id_2965">Skin Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/striated-muscle-physiology" data-event="iBarJournal-sections-a_id_221">Striated Muscle Physiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/physiology/sections/vascular-physiology" data-event="iBarJournal-sections-a_id_225">Vascular Physiology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/physiology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/physiology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=65&amp;specialtyid=0&amp;entitytype=2&amp;entityid=210" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">REVIEW article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Physiol.</span><span>, 12 September 2024</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Cardiac Electrophysiology</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 15 - 2024 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fphys.2024.1475152">https://doi.org/10.3389/fphys.2024.1475152</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Functional Modifications of Ion Channels in Arrhythmogenesis</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 6 articles" href="https://www.frontiersin.org/research-topics/25491/functional-modifications-of-ion-channels-in-arrhythmogenesis/magazine" target="_self" data-event="customLink-linkType-a_viewAll6Articles"><span>View all 6 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract"><a id="h1" name="h1"></a><div class="authors"><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2069611" class="user-id-2069611"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2069611/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Jyotsna Joshi">Jyotsna Joshi</a></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2808208" class="user-id-2808208"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2808208/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Cora Albers">Cora Albers</a></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Nathan Smole" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Nathan Smole</span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Shuliang Guo" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Shuliang Guo</span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/49757" class="user-id-49757"><img class="pr5" src="https://loop.frontiersin.org/images/profile/49757/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Sakima A. Smith&#xa;">Sakima A. Smith</a>&#x0002a;</span></div><ul class="notes"><li>Department of Internal Medicine, Division of Cardiology, College of Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH, United States</li></ul><p class="mb15">Ion channels and cytoskeletal proteins in the cardiac dyad play a critical role in maintaining excitation-contraction (E-C) coupling and provide cardiac homeostasis. Functional changes in these dyad proteins, whether induced by genetic, epigenetic, metabolic, therapeutic, or environmental factors, can disrupt normal cardiac electrophysiology, leading to abnormal E-C coupling and arrhythmias. Animal models and heterologous cell cultures provide platforms to elucidate the pathogenesis of arrhythmias for basic cardiac research; however, these traditional systems do not truly reflect human cardiac electro-pathophysiology. Notably, patients with the same genetic variants of inherited channelopathies (ICC) often exhibit incomplete penetrance and variable expressivity which underscores the need to establish patient-specific disease models to comprehend the mechanistic pathways of arrhythmias and determine personalized therapies. Patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) inherit the genetic background of the patient and reflect the electrophysiological characteristics of the native cardiomyocytes. Thus, iPSC-CMs provide an innovative and translational pivotal platform in cardiac disease modeling and therapeutic screening. In this review, we will examine how patient-specific iPSC-CMs historically evolved to model arrhythmia syndromes in a dish, and their utility in understanding the role of specific ion channels and their functional characteristics in causing arrhythmias. We will also examine how CRISPR/Cas9 have enabled the establishment of patient-independent and variant-induced iPSC-CMs-based arrhythmia models. Next, we will examine the limitations of using human iPSC-CMs with respect to <em>in vitro</em> arrhythmia modeling that stems from variations in iPSCs or toxicity due to gene editing on iPSC or iPSC-CMs and explore how such hurdles are being addressed. Importantly, we will also discuss how novel 3D iPSC-CM models can better capture <em>in vitro</em> characteristics and how all-optical platforms provide non-invasive and high- throughput electrophysiological data that is useful for stratification of emerging arrhythmogenic variants and drug discovery. Finally, we will examine strategies to improve iPSC-CM maturity, including powerful gene editing and optogenetic tools that can introduce/modify specific ion channels in iPSC-CMs and tailor cellular and functional characteristics. We anticipate that an elegant synergy of iPSCs, novel gene editing, 3D- culture models, and all-optical platforms will offer a high-throughput template to faithfully recapitulate <em>in vitro</em> arrhythmogenic events necessary for personalized arrhythmia monitoring and drug screening process.</p><div class="clear"></div></div><div class="JournalFullText"><a id="h2" name="h2"></a><h2>1 Introduction</h2><p class="mb15">The human cardiac junctional dyad is a highly evolved signal amplification and transduction system with an intricate assembly of ion channels and membrane proteins. In concert, the sarcoplasmic reticulum (SR) and transverse tubule (TT) translates the wave of sarcolemmal depolarization to the TT to induce calcium-induced calcium release (CICR) from internal SR stores leading to excitation-contraction (E-C) coupling (<a href="#B73">Scoote et al., 2003</a>; <a href="#B50">Manfra et al., 2017</a>; <a href="#B47">Lu and Pu, 2020</a>). Ion channels and membrane proteins play fundamental roles in maintaining E-C coupling, and cardiac membrane cytoskeletal proteins and adapter proteins, such as spectrins and ankyrins, play a critical role in the post-translational targeting and localization of key proteins, such as the sodium/calcium exchanger (NCX), sodium/potassium ATPase (Na/K-ATPase), inositol triphosphate receptor (InsP3R), and ryanodine receptor 2 (RyR2) (<a href="#B80">Smith et al., 2015</a>; <a href="#B13">El Refaey and Mohler, 2017</a>; <a href="#B12">Derbala et al., 2018</a>). However, mutations in the genes encoding ion channels and myocyte structural components (e.g., Ankyrins, &#x003b2;II spectrin, Connexin 43, COL12A1 and ANGPTL2), disturbs cardiac electromechanical homeostasis and contribute to cardiac channelopathies and inherited arrhythmias (<a href="#B20">Giudicessi and Ackerman, 2013</a>; <a href="#B57">Musa et al., 2016</a>; <a href="#B46">Lozano-Velasco et al., 2020</a>; <a href="#B96">Wang and Tu, 2022</a>). An important example is Brugada syndrome (BrS), an inherited channelopathy caused by mutations on the SCN5A gene encoding cardiac sodium channel, which has a prevalence of 1&#x02013;2,000 to 1 to 5,000 (<a href="#B10">Chockalingam and Wilde, 2012</a>; <a href="#B51">Mariani et al., 2024</a>). It is characterized by abnormal ECG recordings (ST-segment elevation) and accounts for &#x0223c;4&#x02013;12% of sudden cardiac deaths cases in children and young athletes and 10%&#x02013;20% of sudden cardiac deaths in infant (<a href="#B10">Chockalingam and Wilde, 2012</a>; <a href="#B51">Mariani et al., 2024</a>). Similarly, catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but fatal channelopathy that has a prevalence of &#x0223c;1 per 10,000 (<a href="#B88">Tester et al., 2012</a>; <a href="#B31">Jim&#x000e9;nez-J&#x000e1;imez et al., 2015</a>; <a href="#B41">Lahrouchi et al., 2017</a>). It is caused by mutations on RyR2 and calsequestrin 2 (CASQ2) genes that can cause sudden cardiac death, especially in pediatric populations (<a href="#B51">Mariani et al., 2024</a>). Notably, a highly lethal short QT syndrome (SQTS) has a cumulative risk of cardiac events of 40% by 40&#x000a0;years and has a prevalence of 0.02%&#x02013;0.1% in adults (<a href="#B17">Ferrero-Miliani et al., 2010</a>; <a href="#B25">Guerrier et al., 2015</a>). Thus, the prevalence and lethality associated with these inherited arrhythmias underscore the need to deeply understand their mechanistic pathways and establish novel therapies to treat such fatal conditions.</p><p class="mb15">In addition to the genetic mutations, epigenetic regulations caused by non-coding RNAs, DNA methylation and histone modifications are also being implicated in the pathogenesis of arrhythmias (<a href="#B46">Lozano-Velasco et al., 2020</a>; <a href="#B96">Wang and Tu, 2022</a>). Additionally, insults imposed by metabolic risk factors, such as diabetes, impairs cardiac voltage-gated ion channels and put patients at increased risk of developing diabetic cardiomyopathy, ventricular dysfunction, arrhythmias, and heart failure (<a href="#B62">Ozturk et al., 2021</a>). Also, anti-cancer drugs, such as Tyrosine Kinase Inhibitors, pose a substantial threat of QT prolongation and atrial fibrillation (AFib) for cancer patients (<a href="#B9">Cheng et al., 2021</a>). Notably, inherited cardiac channelopathies (ICC) often exhibit incomplete penetrance and variable expressivity while gender, racial, ethnic, and social factors also cause variable susceptibility to develop cardiac diseases, clearly indicating the intricate pathogenic signaling web and the need to establish personalized cardiac disease modelling and therapeutic screening (<a href="#B20">Giudicessi and Ackerman, 2013</a>; <a href="#B24">Graham, 2015</a>; <a href="#B61">Ntusi and Sliwa, 2021</a>).</p><p class="mb15">Human cardiac tissue is the gold standard to understand patient-specific disease mechanisms; however, it is not feasible to consistently obtain invasive biopsies of cardiac tissues from patients nor it is an scalable approach to utilize the short-lived extracted cardiomyocytes for multiple mechanistic and therapeutic studies (<a href="#B60">Nijak et al., 2021</a>). Thus, it is essential to have an accessible and scalable <em>in vitro</em> model system that will reflect the phenotypic characteristics of human cardiomyocytes and carry genomic traits of an individual patient. In this respect, heterologous cell culture systems, including HEK293 cells, Xenopus oocytes and Chinese hamster ovary, provide useful models to understand disease mechanisms (<a href="#B54">Meijer van Putten et al., 2015</a>). However, such cellular systems do not carry the genome of the individual patient and may lack accessory channel subunits, or other native cardiac proteins, present in the human cardiomyocytes (<a href="#B75">Selga et al., 2018</a>). Thus, such heterologous cell cultures may not definitively represent patient-specific disease phenotypes. Additionally, transgenic animals provide vital <em>in vitro</em> information but these models do not fully recapitulate the human genome and cardiac electro-pathophysiology (<a href="#B56">Moretti et al., 2010</a>; <a href="#B54">Meijer van Putten et al., 2015</a>). For instance, the mouse heart beat is almost 8 times faster than of humans and mouse cardiac repolarization depends mainly on <em>I</em><sub>to</sub>, <em>I</em><sub>K, slow1</sub>, <em>I</em><sub>K, slow2</sub> and <em>I</em><sub>SS</sub> ion currents while the repolarization in human cardiomyocytes is mainly dependent on <em>I</em><sub>Ks</sub> and <em>I</em><sub>Kr</sub> (<a href="#B18">Garg et al., 2018a</a>). To overcome some of these limitations, human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have evolved as a promising tool in personalized cardiac disease modeling and drug screening (<a href="#B103">Yoshida and Yamanaka, 2017</a>).</p><p class="mb15">In this review we aim to provide in-depth information on how iPSCs, iPSC-CMs, and patient-specific iPSC-CMs-based arrhythmia models have evolved in the field and how such iPSC-CMs capture <em>in vitro</em> electrophysiological characteristics. Also, we will examine recent developments on 3D disease models, high-throughput screening, all-optical platforms, and patient-independent iPSC-CMs-based arrhythmia models using CRISPR/Cas9 to illuminate how such developments have enabled efficient recapitulation of <em>in vitro</em> electrophysiological characteristics in a rapid, non-invasive and high-throughput manner. Next, we will discuss concerns on the structural and functional immaturity of human iPSC-CM and review some novel technologies, such as gene-editing and optogenetics that are instrumental in tuning their functional characteristics. Finally, we will briefly review some recent clinical studies and breakthroughs on the human iPSC-CMs for personalized cardiotoxicity screening and regenerative medicine to provide insight on the translational impact of iPSC-CMs in disease modeling, drug screening and therapeutic medicine. Our overall goal is to understand the application and challenges of human iPSC-CMs and examine novel technologies that can strengthen their scope in arrhythmia modeling.</p><a id="h3" name="h3"></a><h2>2 Patient-specific/human iPSC-CMs and their applications in modeling arrhythmias</h2><p class="mb15">Unlike human embryonic cells, human iPSCs are not hindered by ethical concerns. Interestingly, they are almost inexhaustible and genetically editable, providing an opportunity to create a library of genetic variants causing arrhythmias, establish isogenic controls and identify the pathogenic variants from emerging unknown variants. These methods are crucial for risk stratification in clinical care management, uncover mechanistic signaling pathways, and test potential life-saving therapies to treat specific variant-induced arrhythmogenic syndromes in a high-throughput manner (<a href="#B30">Hylind et al., 2018</a>; <a href="#B98">Wu et al., 2019</a>; <a href="#B29">Huang et al., 2021</a>). The overall role of iPSC-CMs in personalized therapeutic screening, drug development and personalized medicine is illustrated in <a href="#F1">Figure 1</a>. The iPSC-CMs will greatly aid in the early diagnosis and targeted therapies of ICC and cardiomyopathies, generally threatened by severe ventricular arrhythmias and sudden cardiac arrest (<a href="#B58">Napolitano et al., 2012</a>; <a href="#B16">Fern&#x000e1;ndez-Falgueras et al., 2017</a>; <a href="#B79">Simons et al., 2023</a>). Thus, in the subsequent paragraphs we will review on the early landmark discoveries on iPSCs, patient/human iPSC-CMs, and their evolution on the human arrhythmia modeling.</p><div class="DottedLine"></div><div class="Imageheaders">Figure 1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg" name="Figure1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg" alt="www.frontiersin.org" id="F1" loading="lazy">
  </picture>
</a><p><b>Figure 1</b>. An illustrative representation showing the generation of patient-specific iPSC-CMs and their role in cardiac disease modeling and personalized medicine.</p></div><div class="clear"></div><div class="DottedLine"></div><a id="h3-1" name="h3-1"></a><h3 class="pt0">2.1 Early landmark discoveries</h3><p class="mb0">In early 2006, Takahashi and Yamanaka identified four critical transcription factors, known as Yamanaka factors- Oct3/4, Sox2, Klf4 and c-Myc (OSKM) and they were able to reprogram skin fibroblasts of mice into iPSCs (<a href="#B84">Takahashi and Yamanaka, 2006</a>). They later found that the OSKM cocktail can also reprogram human fibroblasts into iPSCs (<a href="#B83">Takahashi et al., 2007</a>). Since then, enormous work has been done to improve iPSC reprogramming, enhance their pluripotency and improve their differentiation (<a href="#B72">Romito and Cobellis, 2016</a>; <a href="#B45">Liu et al., 2020</a>). Thus, as of now, iPSCs can be derived from virtually any mature somatic cell of a patient, such as from blood, skin, hair or urine samples, and can be differentiated into cells of all three germ layers, such as neuronal cells, pancreatic cells, alveolar cells, hepatocytes, blood cells, kidney tubule cells, skeletal muscle cells, and cardiomyocytes (<a href="#B2">Adegunsoye et al., 2023</a>). For instance, a flowchart depicting the differentiation of iPSCs into iPSC-CMs via biphasic activation and inhibition of Wnt signaling (<a href="#B33">Joshi et al., 2022</a>) is illustrated in <a href="#F2">Figure 2</a>. Importantly, following reprogramming, iPSCs retain the genomic traits of the donor cells, reflect the phenotypic differences caused by variations in the genetic makeup, and are immunologically similar to the host cells (<a href="#B69">Pourrier and Fedida, 2020</a>; <a href="#B55">Micheu and Rosca, 2021</a>; <a href="#B2">Adegunsoye et al., 2023</a>). This has allowed patient-specific iPSC-CMs to closely mimic the genetic, cellular and immunological characteristics of the disease phenotype.</p><div class="DottedLine"></div><div class="Imageheaders">Figure 2</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg" name="Figure2" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg" alt="www.frontiersin.org" id="F2" loading="lazy">
  </picture>
</a><p><b>Figure 2</b>. An illustration showing the differentiation, metabolic purification and maturation of iPSC-CMs. iPSCs are differentiated into iPSC-CMs via biphasic activation and inhibition of Wnt signaling, non-iPSC-CMs were removed from cultures via metabolic purification, and the purified iPSC-CMs were allowed to grow and mature via long-term culture.</p></div><div class="clear"></div><div class="DottedLine"></div><a id="h3-2" name="h3-2"></a><h3 class="pt0">2.2 Early Utilization of iPSC-CMs for Disease Modeling.</h3><p class="mb0">Nearly 15&#x000a0;years ago, the Karl-Ludwig Laugwitz lab became the first group to utilize patient-derived iPSC-CMs for modeling a long-QT syndrome (LQTS), an ICC characterized by prolonged QT interval, ventricular tachyarrhythmia and sudden cardiac death (<a href="#B56">Moretti et al., 2010</a>). In their study, they screened a family affected by LQTS 1 and identified a mutation in the KCNQ1 gene (R190Q) that encodes the delayed rectifier I<sub>Ks</sub> current. They obtained dermal fibroblasts from two family members and from two healthy controls, reprogramed them into iPSCs, differentiated them into iPSC-CMs, and finally characterized the cells. The action potential duration (APD) of the ventricular and atrial cells, derived from LQTS patients, were significantly prolonged when compared to those derived from healthy controls. In addition, R190Q-KCNQ1 mutation displayed severe channel trafficking defects and the mutated iPSC-CMs displayed 70%&#x02013;80% reduction in <em>I</em><sub>KS</sub> current and higher susceptibility to isoproterenol-induced tachyarrhythmia, which was rescued with beta blocker (<a href="#B56">Moretti et al., 2010</a>). Thus, this was the first study to provide evidence regarding the scope of iPSC-CMs in recapitulating patient-specific channelopathy <em>in vitro</em>.</p><p class="mb0">In 2011, the Chris Denning lab examined the scope of iPSC-CM as an <em>in vitro</em> humanized drug evaluation platform for inherited LQTS (<a href="#B52">Matsa et al., 2011</a>). They reprogrammed iPSCs from skin fibroblasts of a patient with LQTS type 2, having a mutation in KCNH2 gene (G1681 A) (that encodes the potassium ion channel <em>I</em><sub>Kr</sub>), differentiated them into functional cardiomyocytes and compared the sensitivity of control iPSC-CM vs. the patient-derived LQT2-iPSC CM with agonists and antagonists of &#x003b2;-adrenergic receptors and of potassium channels. They found that LQT2&#x02013;iPSC-CM exhibited prolonged APD and increased sensitivity to early after depolarizations (EADs) with isoprenaline treatment, compared to control iPSC-CM, and such events were rescued by &#x003b2;-blockers. In addition, <em>I</em><sub>Kr</sub> channel blocker (E4031) caused EADs in 30% of the LQT2&#x02013;iPSC-CM while the potassium channel enhancers (nicorandil and PD-118057) shortened APD by more than 17%, demonstrating the efficacy of these drugs in normalizing the prolonged repolarization of CM with mutation in KCNH2 gene (<a href="#B52">Matsa et al., 2011</a>). In another study, the &#x00160;aric group examined the utility of iPSC-CMs, derived from patients having RYR2 mutation (<a href="#B14">Fatima et al., 2011</a>). They reported that iPSC-CMs derived from dermal fibroblasts of patient with inherited CPVT1 (caused by mutation in the RYR2 p.F2483I), exhibited arrhythmias and delayed afterdepolarizations (DADs) after catecholaminergic stimulation. Compared to control iPSC-CMs, CPVT1-iPSC-CMs demonstrated higher amplitudes and longer durations of spontaneous Ca<sup>2&#x0002b;</sup> release events at basal state and the CICR events continued after repolarization, and such phenomena were eliminated with cytosolic cAMP levels with forskolin (<a href="#B14">Fatima et al., 2011</a>). These foundational studies highlight the ability of patient-derived iPSC-CMs in modeling variant-induced arrhythmogenesis <em>in vitro</em>.</p><a id="h3-3" name="h3-3"></a><h3 class="pt0">2.3 The growth of iPSC-CM modeling for multiple variants</h3><p class="mb0">Since aforementioned pioneering studies, numerous other studies have shown the ability of patient-derived iPSC-CMs in capturing specific variant-induced arrhythmias, such as LQTS, SQTS, CPVT, Timothy syndrome, and BrS, which are the results of genetic mutations in cardiac ion channels, transporters, or key cardiac proteins, such as KCNQ1 (LQTS1), KCNH2 (LQTS2), RYR2 (CPVT1), CASQ2 (CPVT2) (<a href="#B93">van Mil et al., 2018</a>; <a href="#B69">Pourrier and Fedida, 2020</a>). <a href="#B82">Sun et al., 2023</a> reported that iPSC-CMs, derived from a SCN5A mutation-positive (D356Y) BrS family with severely affected proband, showed higher arrhythmias, slower depolarization and irregular calcium signaling when compared to controls. Furthermore, iPSC-CMs derived from asymptomatic mutation carriers were milder than that of proband iPSC-CMs, highlighting the ability of patient-specific iPSC-CMs in revealing phenotypic severity of BrS (<a href="#B82">Sun et al., 2023</a>). Notably, CRISPR has provided an opportunity to rapidly expand the scope of iPSC-CMs in disease modeling and establish patient-independent human iPSC-CM-based models to uncover mechanistic pathways of genetic variants causing arrhythmias. For example, Chavali et al. introduced a CACNA1C-p.N639T variant in an unrelated but already established healthy human iPSC line using CRISPR/Cas9, differentiated them into iPSC-CMs and reported that the variant showed prolonged action potential and slowing of voltage-dependent inactivation of Ca<sub>V</sub>1.2 currents (<a href="#B8">Chavali et al., 2019</a>). Similarly, Shafaattalab et al. introduced a heterozygous I79N &#x000b1; TNNT2 variant into human iPSCs, differentiated them into iPSC-CMs and demonstrated that the variant iPSC-CMs exhibited- 1) lower intracellular Ca<sup>2&#x0002b;</sup> transients, 2) clear pattern of alternans for both voltage (V<sub>m</sub>) and Ca<sup>2&#x0002b;</sup> transients when paced at frequencies &#x0003e;75&#x000a0;bpm, 3) significant upregulation of atrial natriuretic peptide, brain natriuretic peptide, ECM remodeling and Notch signaling components, when compared to the isogenic controls (<a href="#B76">Shafaattalab et al., 2021</a>). In another study a homozygous Na<sub>V</sub>1.5 KO iPSC line, established using CRISPR/Cas9 and differentiated into cardiomyocytes showed: 1) lower Na<sup>&#x0002b;</sup> currents, 2) reduced action potential amplitudes, and 3) delayed propagation of Ca<sup>2&#x0002b;</sup> waves, where such abnormal electrophysiological functions were rescued by WT Na<sub>V</sub>1.5 channel expression in the KO iPSC-CMs (<a href="#B68">Pierre et al., 2021</a>). Additional findings from foundational studies and current studies on human/patient-specific iPSC-CMs to understand the role of ion channel mutations and their functional modifications during channelopathies are provided in <a href="#SM1">Supplementary Table 1</a>. In brief, iPSC-CMs recapitulate the <em>in vitro</em> electrophysiological characteristics of ionic currents, action potentials, calcium transients, proarrhythmogenic and arrhythmogenic events, and provide physiologically relevant disease models and drug screening platforms (<a href="#B93">van Mil et al., 2018</a>; <a href="#B69">Pourrier and Fedida, 2020</a>; <a href="#B55">Micheu and Rosca, 2021</a>).</p><a id="h3-4" name="h3-4"></a><h3 class="pt0">2.4 Pros and cons of human iPSC-CMs versus other models</h3><p class="mb0">Human/patient-specific iPSC-CMs carry human/patient-specific genome, reflect human cardiac electrophysiology, and provide an almost unlimited supply of cells for investigation. Thus, iPSC-CMs are preferred in disease modeling over heterologous cell cultures and animal models (<a href="#T1">Table 1</a>). For example, <a href="#B75">Selga et al. (2018)</a> compared the functional characteristics of sodium current in iPSC-CMs derived from a patient diagnosed with BrS and having a mutation in the SCN5A gene (c.1100G&#x0003e;A), with those from transfected tsA201 cells, carrying the same mutation. They reported that patient-derived iPSC-CMs showed: 1) a significant reduction (45%) in the peak <em>I</em><sub>Na</sub> density, 2) the I<sub>Na</sub>-voltage activation curve was shifted by 7.42&#x000a0;mV and 3) the <em>I</em><sub>Na</sub>-voltage inactivation curve was negatively shifted by 8.5&#x000a0;mV compared to the control iPSC-CMs. Interestingly, transfected tsA201 cells also showed a significant drop in peak <em>I</em><sub>Na</sub> by &#x0223c; 50% when compared to wild type (WT) controls, but these cells did not show any voltage-dependent changes in kinetic properties of the sodium current that was observed in patient and control iPSC-CMs. Thus, the patient-specific genetic background, not just the specific gene variant, could affect overall expression of cardiac-specific proteins and thereby guide bio-functional characteristics of the ion channel currents (<a href="#B75">Selga et al., 2018</a>).</p><div class="DottedLine"></div><div class="Imageheaders">Table 1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg" name="Table1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy">
  </picture>
</a><p><b>Table 1</b>. A comparison on the advantages and disadvantages of animal models, heterologous cell culture models and iPSC-CMs in arrhythmias research.</p></div><div class="clear"></div><div class="DottedLine"></div><p class="mb0">Nevertheless iPSC-CMs are hindered by their immature structural and ion channel characteristics when compared to native cardiomyocytes. To address such limitations, recent developments in cell reprogramming, differentiation and maturation strategies (<a href="#h6">Section 5</a>) have positively impacted their scope in clinical studies for disease modeling and drug screening. As an example, a recent clinical study &#x0201c;Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells&#x0201d; (study location- France) was designed to generate patient-specific iPSCs and iPSC-CMs to study the molecular mechanisms of cardiomyopathies generated due to genetic defects [NCT03696628]. In the study, iPSCs were generated from peripheral blood mononuclear cells (PBMCs), using integration-free Sendai virus gene-delivery method, from three different Duchenne Muscular Dystrophy patients (&#x0003c;17&#x000a0;years, harboring deletions of exons 1, 52 and 55 in the dystrophin gene). The reprogrammed iPSCs showed normal karyotypes, pluripotency status and differentiated into iPSC-CMs using embryoid body formation (<a href="#B81">Souidi et al., 2020</a>). Thus, although there is room for improvement, human/patient-specific iPSC-CMs provide an unlimited and instrumental platform in modeling arrhythmias due to multiple emerging variants and in understanding their mechanistic pathways.</p><a id="h4" name="h4"></a><h2>3 Roles of 3D culture, gene editing and all-optical platforms in arrhythmia research</h2><a id="h4-1" name="h4-1"></a><h3 class="pt0">3.1 Tissue engineering platforms and beyond</h3><p class="mb0">The emergence of 3D models of iPSC-CMs, such as organoids, cell sheets and engineered heart tissues (EHT), have provided iPSC-CMs with additional methodologies to mimic <em>in vitro</em> cardiac events, such as tissue contractility, AP conduction velocity, origin, and propagation of re-entrant waves that are not attainable in traditional 2D cultures (<a href="#B79">Simons et al., 2023</a>). Notably, the Lior Gepstein lab reported that iPSC-CMs, derived from dermal fibroblasts from a symptomatic SQTS patient having an N588K variant in the KCNH2 gene exhibited: 1) shortened APD, 2) increased <em>I</em><sub>Kr</sub> current density, and 3) increased channel protein expression compared to the healthy and isogenic controls at the cellular level (<a href="#B77">Shinnawi et al., 2019</a>). Using optical mapping techniques, it was found that iPSC-CM-derived cardiac cell sheets exhibited shortened APD and increased susceptibility for sustained spiral waves at the tissue level, and such arrhythmogenic events were rescued with quinidine and disopyramide but not with sotalol. In another study, Goldfracht et al. examined the utility of EHT for modeling LQTS2 and CPVT2 (<a href="#B21">Goldfracht et al., 2019</a>). They created EHTs by combining healthy or patient-specific iPSC-CMs with an ECM gel (derived from porcine cardiac tissues), allowed the cell-gel mixture to condense as rings within circular casting molds and they were transferred them into a passive stretching device for maturation. The optical recording data demonstrated significantly longer APD values measured in the LQTS2 derived EHT compared to their healthy control counterparts. Also, the CPVT2-ECM derived EHTs, but not their healthy counterparts, showed irregular calcium transients upon isoproterenol treatment (10&#x000a0;&#x000b5;m) and the occurrence and severity of such abnormal calcium activity was significantly lower when compared to the single-celled CPVT2-iPSC-CM counterparts, possibly due to higher electrotonic interactions in 3D. This implies 3D models are more clinically relevant in capturing <em>in vitro</em> electrophysiological features, when compared to 2D, as very frequent and very severe arrhythmogenic responses seen with single cells are often incompatible with life (<a href="#B21">Goldfracht et al., 2019</a>).</p><a id="h4-2" name="h4-2"></a><h3 class="pt0">3.2 Identification and validation of new variants with genetic testing</h3><p class="mb0">The incorporation of genetic testing as a clinical component for ICC patients has enabled the identification of hundreds of novel variants. However, this poses a significant challenge of identifying numerous emerging variants of uncertain significance (VUS) as normal or pathological, which is crucial for early risk stratification in clinical care (<a href="#B19">Garg et al., 2018b</a>; <a href="#B30">Hylind et al., 2018</a>). It has been reported that iPSC-CMs derived from a LQT2 patient having a novel missense variant (T983I) in the KCNH2 gene exhibited: 1) a significant prolongation in APD, 2) reduction of <em>I</em><sub>Kr</sub>, 3) reduction of hERG protein levels, and 4) higher pro-arrhythmogenic events compared to its healthy counterparts (<a href="#B19">Garg et al., 2018b</a>). Notably, precise genomic correction of VUS iPSC-CM using CRISPR/Cas9 rescued the abnormal electrophysiological behavior while the introduction of the homozygous variant in the healthy cells elicited hallmarks of LQTS, implicating the pathogenic role of the KCNH2<sup>T983I</sup> variant (<a href="#B19">Garg et al., 2018b</a>).</p><p class="mb0">Thus, CRISPR-based genome editing tools can greatly aid in the early identification of unknown arrhythmogenic variants. Moreover, novel CRISPR-based interference and activation system (CRISPRi/a) have emerged to overcome the concerns of double strand break-induced cellular toxicity and permanent gene-editing-induced phenotypic changes in iPSCs and iPSC-CMs (<a href="#B26">Haapaniemi et al., 2018</a>; <a href="#B89">Tian et al., 2019</a>). CRISPRi/a uses deactivated Cas9 (dCas9) enzyme linked to an effecter (an activator or a repressor) of gene transcription along with guide RNA (gRNA) provides reliable, reversible and spatiotemporal control of genetic modulation. In this regard, a recent study showed no significant effect of the CRISPRi components (DOX and dCas9-KRAB), on protein and mRNA levels of the ion channels of interest nor on the specific electrophysiological parameters in iPSC-CMs and clearly delineates that the observed physiological effects (such as APD80 prolongation and slowing of conduction velocity) were solely due to CRISPRi knockdown of KCNJ2 and GJA1 respectively in iPSC-CMs when gene edited using the DOX-inducible (Tet-on) dCas9-KRAB system (<a href="#B27">Han and Entcheva, 2023</a>). Thus, novel CRISPR-based methods demonstrate a reliable gene editing platform to faithfully decipher gene-phenotype relations for arrhythmia research.</p><a id="h4-3" name="h4-3"></a><h3 class="pt0">3.3 Novel use of all-optical platforms for iPSC-CM modeling</h3><p class="mb0">There is growing concern regarding the increasing cost, lengthy time, and the explosion in the number of candidate drugs to be tested for emerging arrhythmogenic variants. While classic patch-clamp electrophysiology requires physical contact and is a low throughput method, current automated systems significantly enhance the throughput, such as Multichannel Electrode Arrays (MEA), xCELLigence, and Fluorometric Imaging Plate Reader (FLIPR). Yest these systems cannot characterize tissue-level or multicellular effects, in 2D or 3D, respectively (<a href="#B39">Klimas et al., 2016</a>). Fortunately, the birth of all-optical platforms, which is a merger of optogenetics and optical mapping methods, provides an opportunity for contactless actuation and readout of electrophysiological signals, offering tremendous potential for high-throughput functional readout for variant screenings and drug discovery (<a href="#B39">Klimas et al., 2016</a>; <a href="#B4">Baines et al., 2024</a>). Notably, the Emilia Entcheva lab has previously described an automated all-optical system (OptoDyCE) for capturing cardiac electrophysiology at the cellular/multicellular level (<a href="#B39">Klimas et al., 2016</a>). This innovative system utilizes: 1) low-power LED light sources, 2) iPSC-CMs expressing light-gated cation channel Channelrhodopsin (iPSC-CMs-ChR2) where ChR2 acts as optogenetic actuator to enable optical pacing of the human iPSC-CMs, 3) optical sensors to record voltage (di-4-ANBDQBS) and intracellular calcium (Rhod-4a.m.) signals from the human iPSC-CMs, 4) multicellular samples in 96-wells, in 2D or 3D format, for HT capabilities, 5) a custom-built inverted microscope, high speed camera, and 6) custom-software for data analysis. As proof of concept, the system was able to perform dynamic drug-dose testing (using multi-beat pacing protocol) on 96-well format in less than 10&#x000a0;min, with the ability to record &#x0003e;30,000 cell readouts per 96-well plate, examine records at both global and cellular scale and foun pro-arrhythmic risks from voltage, calcium or contraction responses (<a href="#B39">Klimas et al., 2016</a>). Recently the Entcheva lab has demonstrated another low-cost OptoDyCE-plate that can be used for the readout of cardiac function, providing data on change in APD and calcium transient duration (CTD) in human iPSC-CMs under spontaneous and paced, electrical or optogenetic (utilizing iPSC-CMs-ChR2 cells), conditions in standard 96 (or 3D electrospun PCL isotropic and anisotropic wells) and 384-well plate formats (<a href="#B28">Heinson et al., 2023</a>). Using this system, investigators successfully tested the action of 4 drugs, dofetilide, cisapride, vanoxerine and nifedipine, on human iPSC-CMs and reported that:- 1) the first 3 drugs induced pacing frequency-dependent APD80 prolongation while the latter drug shortened APD80, 2) all 4 drugs showed pronounced APD effect at slower pacing rates while the effects were reduced at higher pacing rates, and 3) CTD80 changes under paced conditions were much smaller with the drugs (<a href="#B28">Heinson et al., 2023</a>). These reports clearly depict that a synergy of iPSC-CMs, gene editing, high-throughput platform, and all-optical system would allow acquisition of massive amount of electrophysiological data, under static or dynamic conditions, in a non-invasive and real-time manner; thus offering a crucial platform to rapidly and efficiently capture electrophysiological features of multiple variants while simultaneously screening candidate drugs. Additional findings on such state-of-art iPSC-CM-based arrhythmia studies utilizing 3D models, CRISPR-Cas9 mediated gene editing, optogenetics, and optical platform are summarized in <a href="#T2">Table 2</a>. In summary, by utilizing iPSC-CMs, 3D-culture models, CRISPR-based gene modulation, and all-optical platform, it is feasible to obtain real-time and high-throughput physiologically relevant electrophysiological data that offers unique potential in gaining mechanistic insights for emerging arrhythmia variants <em>in vitro</em> and will provide innovative platform for the discovery of novel therapies.</p><div class="DottedLine"></div><div class="Imageheaders">Table 2</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg" name="Table2" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg" alt="www.frontiersin.org" id="T2" loading="lazy">
  </picture>
</a><p><b>Table 2</b>. State-of-art iPSC-CM-based arrhythmia studies utilizing 3D models, CRISPR-Cas9 mediated gene editing, Optogenetics and Optical mapping platform.</p></div><div class="clear"></div><div class="DottedLine"></div><a id="h5" name="h5"></a><h2>4 Challenges of using iPSC-CMs in arrhythmia research and clinical care</h2><a id="h5-1" name="h5-1"></a><h3 class="pt0">4.1 Variations in iPSCs</h3><p class="mb0">Clearly, human iPSC-CMs are invaluable tools for modeling arrhythmias and in understanding their mechanistic pathways; however, they exhibit some limitations in personalized screening and cardiotoxicity studies. One of the limitations of iPSC-CMs in personalized arrhythmia modeling and mechanistic studies stems from the variations in iPSCs themselves that may arise due to differences in: 1) tissue source and donor characteristics, 2) reprogramming methods, 3) culture conditions, and 4) clonal variations in iPSCs derived from the same donor and generated under the same reprogramming event, all which affects their pluripotency, differentiation potential and phenotypic characteristics (<a href="#B27">Han and Entcheva, 2023</a>; <a href="#B59">Nath et al., 2023</a>).</p><a id="h5-2" name="h5-2"></a><h3 class="pt0">4.2 Biophysical characteristics of ion channels</h3><p class="mb0">In a recent study, Jonathan M Cordeiro and his group demonstrated that human iPSC-CMs and adult cardiomyocytes show a similar block of sodium current (<em>I</em><sub>Na</sub>) with lidocaine under voltage clamp but not under current clamp, suggesting a clear difference in the biophysical properties of <em>I</em><sub>Na</sub> (<a href="#B22">Goodrow et al., 2018</a>). This may be due to the co-presence of fetal (exon 6 A) and adult (exon 6) isoforms of Na<sub>v</sub>1.5 in iPSC-CMs or differences in the ratios of channel pore-forming &#x003b1; and accessory &#x003b2; subunits (the latter facilitates in the trafficking of Nav1.5 to the membrane) in the iPSC-CMs, compared to native cardiomyocytes (<a href="#B22">Goodrow et al., 2018</a>). Another study reported no difference in <em>I</em><sub>Na</sub> and action potential upstroke velocity (V<sub>max</sub>) in human iPSC-CM derived from 3 BrS patients who tested negative for coding region mutations in the known BrS-associated genes, when compared to iPSC-CM derived from healthy controls (<a href="#B94">Veerman et al., 2016</a>). However, in another study (but under the same experimental system), loss of sodium channel function was detected, as reduced <em>I</em><sub>Na</sub> and <em>V</em><sub>max</sub><em>,</em> in iPSC-CMs harboring a single sodium channel mutation SCN5A-1795insD (<a href="#B6">Bezzina et al., 1999</a>). Such findings suggest: 1) ion channel dysfunction, mainly cardiac sodium channel, may not be the sole cause of arrhythmias in BrS (<a href="#B94">Veerman et al., 2016</a>), 2) there may be possible involvement of other membrane proteins, cytoskeletal proteins or extracellular structural changes, such as fibrosis, in channelopathies, (<a href="#B63">Paci et al., 2020</a>), and 3) the immature ion channel expression in iPSC-CM may fail to detect subtle differences in ionic currents and their biophysical characteristics in certain arrhythmic syndromes, inferring the need of more detailed analysis of iPSC-CM disease phenotypes, including proteomics and transcriptomics, to model arrhythmias <em>in vitro</em> (<a href="#B79">Simons et al., 2023</a>). Hence, it is critical to conduct the study design and interpret the results on iPSC-CMs in arrhythmia research with care.</p><a id="h5-3" name="h5-3"></a><h3 class="pt0">4.3 Structural, electrophysiological and metabolic immaturity</h3><p class="mb0">Another limitation of iPSC-CM in cardiac research stems from the challenge that iPSC-CMs are structurally, electro-physiologically, and metabolically more immature than native cardiomyocytes. iPSC-CMs: 1) lack definitive t-tubules, 2) lack or have rudimentary Ca<sup>2&#x0002b;</sup> handling components such as RyR2, SERCA, calsequestrin, 3) exhibit slower upstroke velocity, shorter plateau phase or repolarization due to lower levels of Na<sup>&#x0002b;</sup> and L-type Ca<sup>2&#x0002b;</sup> channels, 4) possess automaticity due to lower current density of Kir<sub>2.1</sub>-encoding <em>I</em><sub>K1</sub>, conferring them more proarrhythmic and depolarized at resting membrane potential than native cardiomyocytes (<a href="#B63">Paci et al., 2020</a>; <a href="#B105">Zhou et al., 2023</a>). A thorough comparison on the ultrastructural, contractile, electrophysiological, and metabolic characteristics of iPSC-CMs with those of the adult cardiomyocytes is presented in <a href="#SM1">Supplementary Table 2</a>. In brief, human iPSC-CMs are limited by their structural and functional immaturity, such as lack of definitive t-tubules, poor Ca<sup>2&#x0002b;</sup> handling machinery, unrestricted presence of gap junctions all over the cell membrane, depolarized resting membrane potential conferring differences in the activation of voltage-dependent ion channels, differences in the ion channel expression levels etc., which needs careful attention to boost the translational impact of iPSC-CM in disease modeling and regenerative medicine. Thus, it is crucial to implement strategies to address the limitations of iPSCs and post-differentiated iPSC-CMs for reliable arrhythmia research.</p><a id="h6" name="h6"></a><h2>5 Overcoming the challenges of iPSCs and iPSC-CMs in arrhythmia modeling</h2><p class="mb15">iPSCs derived from different donors may show phenotypic variations due to multiple genetic and epigenetic differences; hence, it is necessary to have isogenic controls for specific variants to correctly interpret the mechanistic findings (<a href="#B77">Shinnawi et al., 2019</a>). Additionally, it is crucial to compare results of mutated/diseased iPSC-CMs with their corresponding isogenic controls, produced under same reprogramming and culture conditions (<a href="#B103">Yoshida and Yamanaka, 2017</a>). Importantly, multiple strategies are being investigated to improve the maturity of iPSC-CMs and reduce their barriers in disease modeling, drug screening and regenerative medicine. Methods, such as long-term culture, electrical stimulation, mechanical stress, substrate stiffness, and biochemical stimulation (e.g., hormonal stimulation, paracrine signaling, metabolic modulation etc.) are being widely investigated to enhance structural and functional maturity in iPSC-CMs (<a href="#B90">Tu et al., 2018</a>; <a href="#B100">Wu et al., 2021</a>). We have illustrated some common and novel approaches for functional and structural modification of iPSC-CMs in <a href="#F3">Figure 3</a>. We will briefly summarize some of the salient points and explore their scope in arrhythmia research and medicine in the following paragraphs.</p><div class="DottedLine"></div><div class="Imageheaders">Figure 3</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg" name="Figure3" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg" alt="www.frontiersin.org" id="F3" loading="lazy">
  </picture>
</a><p><b>Figure 3</b>. A schematic representation to show common and novel approaches that are being investigated to modify the functional and structural properties of iPSC-CMs.</p></div><div class="clear"></div><div class="DottedLine"></div><a id="h6-1" name="h6-1"></a><h3 class="pt0">5.1 Culture duration</h3><p class="mb0">It has been hypothesized that prolonged cell culture times could promote maturation of iPSC-CMs originated from the fact that it takes almost a decade for native cardiomyocytes <em>in vitro</em> to acquire their adult structural phenotypes (<a href="#B67">Peters et al., 1994</a>; <a href="#B95">Vreeker et al., 2014</a>). In this aspect, Lundy et al. reported that iPSC-CMs with prolonged culture duration (80&#x02013;120&#x000a0;days) exhibit more mature structural and functional properties, such as increased cell size and anisotropy, a higher proportion of multinucleated cells, tight and orderly arrangement of myofibrils, a significant improvement in sarcomere contractile performance, and increase in calcium release and reuptake (<a href="#B48">Lundy et al., 2013</a>). Similarly, other groups have reported the appearance of mature Z-bands, A-bands, H-bands, I-bands when culture duration of iPSC-CMs was increased to 180 days while M-band emerged lately when the culture was further prolonged to a year (<a href="#B35">Kamakura et al., 2013</a>). Interestingly, it has recently been reported that late-stage iPSC-CM (aged &#x0003e;50&#x000a0;days) post-differentiation shows significantly larger <em>I</em><sub>Ca,L</sub> density, <em>I</em><sub>Ca,L</sub> evoked Ca<sup>2&#x0002b;</sup> transients, and <em>I</em><sub>Na</sub> and <em>I</em><sub>K1</sub>, conferring them increased upstroke velocity and reduced APD (<a href="#B74">Seibertz et al., 2023</a>).</p><a id="h6-2" name="h6-2"></a><h3 class="pt0">5.2 Electrical stimulation</h3><p class="mb0">Since electrical signals play a fundamental role in the growth and development of the heart, electrical stimulation holds a potential to influence the maturity of iPSC-CM (<a href="#B100">Wu et al., 2021</a>). Tan et al. reported that an endogenous electrical microenvironment provides structural and functional improvements to iPSC-CM, such as increased expression of cardiac troponin I and synchronized beating of the cardiomyocytes, which they achieved by incorporating trace amount of electrically conductive silicon nanowires (&#x0223c;0.004% w/v) in otherwise scaffold-free 3D iPSC-CM spheroids (<a href="#B87">Tan et al., 2015</a>). They further reported that such nano-wired iPSC-CMs synergize with exogenous electrical stimulation as demonstrated by higher 1) cell-cell junction (Cx43, N-cadherin), 2) contractile machinery, 3) Ca<sup>2&#x0002b;</sup> handling protein RyR2 expression, 4) Ca<sup>2&#x0002b;</sup> release, but a significant reduction in the spontaneous beating of iPSC cardiac spheroids, addressing a major issue of automaticity with the iPSC-CMs (<a href="#B71">Richards et al., 2016</a>). Further, Ma et al. reported the scope of cardiac-mimetic exogenous electrical pulses in enhancing the differentiation and functional maturation of iPSC-CMs, which was confirmed by a notable increase in intracellular Ca<sup>2&#x0002b;</sup> levels and RYR2 expressions via Ca<sup>2&#x0002b;/</sup>PKC/ERK signaling pathway (<a href="#B49">Ma et al., 2018</a>). Similarly, Yoshida et al. demonstrated that a week regimen of electrical stimulation (2&#x000a0;Hz), using electrically conductive PVA-based permeable microchamber and carbon-based cyto-compatible electrodes, promotes expressions of myocardial structural proteins, such as cardiac troponin T and sarcomere-like structures in iPSC-CMs (<a href="#B102">Yoshida et al., 2019</a>).</p><a id="h6-3" name="h6-3"></a><h3 class="pt0">5.3 Mechanical stimulation</h3><p class="mb0">Given the heart&#x02019;s intrinsic role as a pump, mechanical stress also holds the potential to significantly influence CM maturity. Leonard et al. reported that progressive incremental mechanical stimulation in the form of applied afterload increases the sarcomere length, cardiomyocyte area and elongation, and calcium handling of iPSC-CMs in EHT, where such benefits plateaus at moderate afterload conditions (0.45&#x000a0;&#x003bc;N/&#x003bc;m) and is pathological at high afterload condition (9.2&#x000a0;&#x003bc;N/&#x003bc;m) (<a href="#B42">Leonard et al., 2018</a>). Similarly, <a href="#B1">Abilez et al. (2018)</a> demonstrated that passive stretch, guided by computational modeling, modulates the alignment and calcium dynamics of iPSC-CMs within an engineered heart muscle (EHM). Interestingly, they reported that passive stretch, along with fibroblast co-culture, in 3D EHM and culture duration enhanced the maturity of iPSC-CMs, as elicited by increased gene expression of troponin-T (<em>TNNT2</em>), calveolin-3 (<em>CAV3</em>), &#x003b2;-adrenergic receptors (<em>ADRB1</em>), and potassium (<em>KCNJ2</em>) and calcium (<em>CACNA1C</em>) ion channels (<a href="#B1">Abilez et al., 2018</a>).</p><a id="h6-4" name="h6-4"></a><h3 class="pt0">5.4 Biochemical signaling and cellular interactions</h3><p class="mb0">Postnatal hormones are known to significantly influence cardiomyocyte maturity (<a href="#B106">Scuderi and Butcher, 2017</a>). Specifically, the incorporation of thyroid hormones and glucocorticoids have been pivotal in heart maturation during development (<a href="#B107">Li et al., 2014</a>) (<a href="#B108">Rog-Zielinska et al., 2015</a>). Triiodothyronine (T3)-treated iPSC-CMs developed elongated morphology, longer sarcomeres, increased mitochondrial activity, and improved calcium handling (<a href="#B3">Ahmed et al., 2020</a>). Notably, Parikh et al. reported that enriching the iPSC-CM medium with Triiodothyronine (T3) and Dexamethasone (Dex) during days 16&#x02013;30, followed by single-cell culture on Matrigel mattress for next 5&#x000a0;days, provided 1) development of extensive T-tubule network, 2) promoted RyR2 structural organization, 3) enhanced and uniform calcium release characteristic of E-C coupling in ventricle, and 4) enhanced functional coupling between L-type Ca channels and RyR2 (<a href="#B64">Parikh et al., 2017</a>). Apart from biochemical signaling, direct cellular interactions or indirect paracrine signaling in a native cardiac tissue are also known to influence cardiomyocyte maturity (<a href="#B86">Talman and Kivel&#x000e4;, 2018</a>). Thus, iPSC-CM maturation strategies have also utilized methods to mimic those cellular interactions <em>in vitro</em>, such as by co-culturing iPSC-CM with endothelial cells, cardiac fibroblasts, epicardial cells, and smooth muscle cells (<a href="#B101">Yang et al., 2023</a>). Interestingly, Kowalski et al. recently reported that co-culturing immature human iPSC-CMs with mouse sympathetic ganglion neurons (SN) promotes gene expression of mature cardiac structures (e.g., TNNT2, MYL2), ion channels (KCNH2, KCNQ1, KCNJ2, SCN5A), Na<sup>&#x0002b;</sup>-Ca<sup>2&#x0002b;</sup> exchanger (SLC8A1), calcium handling machinery (ATP2A2, RYR2, PLN) whereas culture of cardiomyocytes with isoproterenol alone did not cause changes in gene expression, inferring the vital role of direct cell-cell interactions in cardiomyocyte maturation (<a href="#B40">Kowalski et al., 2022</a>). Further, they reported that such iPSC-CM, co-cultured with SN, elicited higher connexin-43 gap junction expression, sarcomere organization, and higher amplitudes of calcium transients but slower calcium relaxation compared to monoculture controls (<a href="#B40">Kowalski et al., 2022</a>).</p><a id="h6-5" name="h6-5"></a><h3 class="pt0">5.5 Gene editing</h3><p class="mb0">Gene editing provides an opportunity to directly probe the genomic characteristics and thereby influence the expression and function of the ion channels, dyad membrane proteins or other structural proteins, and tailor electrophysiological, structural and metabolic changes in iPSC-CMs. For example, <a href="#B105">Zhou et al. (2023)</a> reported that iPSC-CMs, when overexpressed with KCNJ2 via lentiviral transduction method, showed significant protein expression of K<sub>ir</sub>2.1 and current density of K<sub>ir</sub>2.1-encoding I<sub>K1</sub>. They also showed that such K<sub>ir</sub>2.1-over expressed iPSC-CMs acquired quiescent phenotypes, which required pacing to elicit action potentials and the induced action potentials were abrogated by I<sub>K1</sub> blocker BaCl<sub>2</sub>, clearly showing the precise functional effect of the K<sub>ir</sub>2.1 gene overexpression on iPSC-CMs (<a href="#B105">Zhou et al., 2023</a>). They also reported that KCNJ2 overexpression significantly hyperpolarized the diastolic potential, shortened APD, increased maximal upstroke velocity, improved Ca<sup>2&#x0002b;</sup> signaling, and mitochondrial energy metabolism of the iPSC-CMs (<a href="#B105">Zhou et al., 2023</a>). In this aspect, <a href="#B54">Meijer van Putten et al., 2015</a>, reported the role of I<sub><em>K1</em></sub> in improving maturity of iPSC-CMs by injecting <em>in silico</em> I<sub>k1</sub>, with a peak outward density of 4&#x02013;6&#x000a0;pA/pF, to the spontaneously beating iPSC-CMs and showed that the cells exhibited 1) ventricle-like action potential morphology, 2) improved resting membrane potential towards the physiological range (&#x02212;80&#x000a0;mV), 3) increased maximum upstroke velocity (&#x0003e;150&#x000a0;V/s), and 4) proarrhythmic action potential changes, upon injection of both loss-of-function and gain-of-function I<sub>K1</sub>, associated with short QT syndrome and Andersen-Tawil syndrome (<a href="#B54">Meijer van Putten et al., 2015</a>). Interestingly, Vaidyanathan et al. demonstrated that iPSC-CMs, with adenoviral-mediated I<sub>K1</sub>-enhancement, showed 1) absence of spontaneous beating, 2) stable resting membrane potentials at around &#x02212;80&#x000a0;mV, and 3) twofold increase in cell size and membrane capacitance. Notably, such I<sub>K1</sub>-enhanced iPSC-CMs, harboring F97C-CAV3 long QT9 mutation, showed increase in APD and late sodium current, representing a more mature arrhythmia model with I<sub>K1</sub> enhancement (<a href="#B91">Vaidyanathan et al., 2016</a>). In another study, using transcription activator-like effector nuclease (TALENs)-based gene editing platform, Wheelwright et al. induces expression of adult cardiac troponin I isoform in iPSC-CM and showed that iPSC-CMs depicted adult-like cardiac contractile features, such as faster relaxation kinetics under baseline and &#x003b2;-adrenergic stimulation, when compared to unedited iPSC-CMs (<a href="#B97">Wheelwright et al., 2020</a>). These studies suggest that gene editing can tailor the expression and characteristics of ion channels and of other cardiac proteins to confer maturity to iPSC-CM for reliable arrhythmia modeling and regenerative medicine.</p><a id="h6-6" name="h6-6"></a><h3 class="pt0">5.6 Optogenetics</h3><p class="mb0">An early study by Professor Yue and his team in 2014 demonstrated the ability to optically manipulate and map action potentials of neonatal rat ventricular cardiomyocytes (NRVM) by using excitatory/ inhibitory optogenetic actuators and all-optical system (<a href="#B65">Park et al., 2014</a>). In brief, using blue light pulses (447&#x000a0;nm, 7.2&#x000a0;mW/mm<sup>2</sup>, 51&#x000a0;ms), they elicited action potentials on electrically unstimulated NRVM, expressing light-gated cation channel (ChR2), and simultaneously mapped their voltage signals via optical activation (655&#x000a0;nm) of red-shifted voltage dye (PGH1). They also demonstrated that electrically stimulated action potentials in NRVM, expressing eNpHR3.0 (an improved version of light-driven chloride pump halorhodopsin), were silenced with green light pulses (1.4&#x02013;0.67&#x000a0;mW/mm<sup>2</sup>, 530&#x000a0;nm) (<a href="#B65">Park et al., 2014</a>). Interestingly, they also reported that electrically paced ChR2-expressing cardiomyocytes showed APD prolongation when illuminated with blue light (447&#x000a0;nm) during the repolarization phase (<a href="#B65">Park et al., 2014</a>). Furthermore, Professor Spundich and his team reported that NRVM cardiomyocytes expressing anion channelrhodopsin from Guillardia theta (GtACRs), showed shortening in APDs when illuminated with green light pulses (510&#x000a0;nm) during the repolarization phase, where the extent of APD shortening was directly proportional to the light intensity (0&#x02013;230&#x000a0;&#x000b5;W/ mm<sup>2</sup>) (<a href="#B23">Govorunova et al., 2016</a>). Although these pioneering studies were done on NRVM, these studies clearly depict: 1) how electrophysiological characteristics of iPSC-CMs can be probed via light-activated opsins, which induces light-dependent reversible, unipolar depolarizing (via ChR2 activation) or hyperpolarizing (via GtACRs activation) currents, 2) the implications of such optogenetic tools in basic cardiac research and disease modeling (such as LQTS and SQTS), and 3) the scope of all-optical system in capturing real-time and non-invasive cellular electrophysiology.</p><p class="mb0">We recently reported optogenetic-based interrogation of action potential and calcium transients of iPSC-CM in a rapid, reversible and targeted manner (<a href="#B33">Joshi et al., 2022</a>). Using CRISPR/Cas 9 genome editing tool, human iPSC-CMs were expressed with algal-derived transmembrane protein, ChR2 (iPSC-CMs-ChR2), that acts as light-gated cation channel (<a href="#B33">Joshi et al., 2022</a>). Also, both control and iPSC-CMs-ChR2 were co-expressed with CCND2 and luciferin. The iPSC-CMs-ChR2 were- 1) labelled with calcium (Rhod-2 AM) or voltage-specific (RH237) dyes, 2) illuminated with blue light (460&#x000a0;nM, 1.6&#x000a0;mW/ mm<sup>2</sup>), 3) and their calcium transients and membrane voltage were optically mapped using MiCAM03 N256 Single Camera System (Scimedia Ltd., United States), and 4) data was analyzed using BV Workbench (Version 2.7.2, Scimedia, United States). We found that functional characteristics of calcium repolarization and excitability of action potential in iPSC-CMs can be successfully modulated non-invasively, reversibly and instantaneously by activating light-gated ChR2 ion channel expressed in the iPSC-CMs (<a href="#B33">Joshi et al., 2022</a>). In brief, blue light activation on control iPSC-CMs (not expressing ChR2) did not show any impact on the Ca<sup>2&#x0002b;</sup> transient repolarization time, but the iPSC-CMs-ChR2 showed prolonged Ca<sup>2&#x0002b;</sup> transient repolarization time and a delay in the initiation of new action potential with blue light (<a href="#F4">Figure 4</a>). In the same study, we also demonstrated that blue light was able to interrogate, in real-time, myocardial functions, such as pressure, volume and ECG, of the infarcted SCID mice receiving iPSC-CMs-ChR2, but not in the mice receiving the control iPSC-CMs (<a href="#F5">Figure 5</a>), which underscores the translational impact of optogenetics in probing the electrophysiological characteristics at both cellular and organ-level (<a href="#B33">Joshi et al., 2022</a>).</p><div class="DottedLine"></div><div class="Imageheaders">Figure 4</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg" name="Figure4" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg" alt="www.frontiersin.org" id="F4" loading="lazy">
  </picture>
</a><p><b>Figure 4</b>. Functional effect of blue light (460&#x000a0;nm) on the human iPSC-CMs-ChR2. The light activation on control iPSC-CMs (not expressing ChR2) did not show any impact on the Ca<sup>2&#x0002b;</sup> transient repolarization time <b>(A)</b>, top panel. The iPSC-CMs-ChR2 showed prolonged Ca<sup>2&#x0002b;</sup> transient repolarization time <b>(A)</b>, lower panel and a pause in the initiation of new action potential <b>(B)</b> when activated with blue light (<a href="#B33">Joshi et al., 2022</a>).</p></div><div class="clear"></div><div class="DottedLine"></div><div class="Imageheaders">Figure 5</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg" name="Figure5" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg" alt="www.frontiersin.org" id="F5" loading="lazy">
  </picture>
</a><p><b>Figure 5</b>. Functional changes in the myocardial functions using Optogenetics. A schematic illustration of the Optogenetic system utilized in the study <b>(A)</b>. Left ventricular pressure (red), volume (blue), and ECG (green) were simultaneously recorded, using P-V loop, from anesthetized, open-chest SCID mice 6&#x000a0;months after infarction and intracardiac injection of control (upper panel) or iPSC-CMs-ChR2 (middle and lower panels) before, during, and after blue light illumination. Left panels show tracings from the same animals at expanded time scales (LabChart Scales 500:1 and 20:1). The blue horizontal lines indicate the duration of light pulses <b>(B)</b>. At the onset of PVC, a significant reduction in systolic ventricular pressure (P<sub>max</sub>) was recorded with light activation in mice receiving ChR2 <b>(C)</b> (<a href="#B33">Joshi et al., 2022</a>).</p></div><div class="clear"></div><div class="DottedLine"></div><p class="mb0">Apart from ChR2, other diverse group of transmembrane opsins, such as light-activated outwardly directed sodium pumps, yellow-light activated inwardly directed chloride pump (NpHR), calcium translocating channelrhodopsin variant (CaTCh) etc., have evolved over the past decade in cardiac research and medicine (<a href="#B15">Ferenczi et al., 2019</a>; <a href="#B32">Joshi et al., 2019</a>). In a recent study, Quach et al. demonstrated the scope of optogenetic-based dynamic current clamp platform to non-invasively tune the action potential of iPSC-CMs to a more mature phenotype (<a href="#B70">Quach et al., 2018</a>). In brief, they introduced Archaerhodopsin TP009 (ArchT) opsin in iPSC-CMs to optically induce outward-current mimicking I<sub>K1</sub>, which is otherwise insufficient in the iPSC-CMs, and showed that 1) optically clamped iPSC-CMs showed more adult-like action potential morphology, similar to those when injected with I<sub>K1</sub> by traditional patch clamp, and 2) the effects of I<sub>Kr</sub> inhibition on iPSC-CMs were similar, when clamped optically or via means of standard electrodes, clearly depicting the scope of non-invasive and scalable optical dynamic clamping in drug screening and disease modeling (<a href="#B70">Quach et al., 2018</a>). Notably, optogenetic tools have shown the ability not only in modulating the direction and flow of specific ion channel currents, but novel optogenetic tools can also successfully control intracellular signal pathways, such as Gs signaling, Wnt signaling and TGF-&#x003b2; signaling, with spatiotemporal precision (<a href="#B32">Joshi et al., 2019</a>; <a href="#B99">Wu et al., 2023</a>). Thus, optogenetics offers unique capabilities in probing functional and biological characteristics of iPSC-CMs; hence, it can exert an influential role in the forefront of arrhythmia research and therapeutic medicine.</p><a id="h7" name="h7"></a><h2>6 The scope of iPSC-CMs beyond disease modeling</h2><a id="h7-1" name="h7-1"></a><h3 class="pt0">6.1 Personalized cardiotoxicity screening</h3><p class="mb0">The overall goal of this review paper is to examine the scope and challenges of using iPSC-CMs in arrhythmia modeling from basic science research and translational perspective. However, it should not be forgotten that human/patient-derived iPSC-CMs also hold significant potential on personalized cardiotoxicity screening and regenerative medicine. A clinical study on &#x0201c;Generation of Induced Pluripotent Stem Cell Derived Cardiomyocytes From Patients Exposed to Trastuzumab Therapy for Breast Cancer&#x0201d; (study location- Memorial Sloan Kettering Cancer Center, NY) uses skin biopsy of the patients, transform them into cardiomyocytes and aims to understand cardiotoxicity mechanisms in breast cancer patients, treated with anti-cancer drugs such as- Doxorubicin and Herceptin [NCT02772367]. Another study by Professor Joseph Wu and his team have also utilized human iPSC-CMs to understand the cellular mechanisms of trastuzumab-induced cardiac dysfunction (<a href="#B38">Kitani et al., 2019</a>). They utilized 1) control iPSC-CMs which were derived from Stanford Cardiovascular Institute iPSC Biobank and 2) patient-specific iPSC-CMs which were derived from PBMCs of breast cancer patients, previously treated with trastuzumab and with or without drug-induced cardiac dysfunctions. They reported that clinically relevant doses of trastuzumab significantly impacted- 1) the contractile and Ca<sup>2&#x0002b;</sup> handling characteristics and 2) mitochondrial function and cardiac energy metabolism of control iPSC-CMs. Interestingly, they demonstrated that iPSC-CMs generated from patients, who experienced severe cardiac dysfunctions with trastuzumab, were more vulnerable to trastuzumab treatment than the iPSC-CMs derived from patients, who did not exhibit cardiac dysfunction with trastuzumab therapy (<a href="#B38">Kitani et al., 2019</a>). These studies underscore the translational impact of patient-specific iPSC-CMs in personalized drug-induced cardiotoxicity screening.</p><a id="h7-2" name="h7-2"></a><h3 class="pt0">6.2 Cardiac regenerative medicine</h3><p class="mb0">Human/-patient-specific iPSC-CMs are also being utilized globally in multiple clinical studies to improve cardiac function and tissue regeneration. In clinical studies, autologous or allogeneic, iPSC-CMs are delivered either as single cells, spheroids, sheets, or patches to treat patients with heart failures or congenital heart defects [NCT05566600, NCT04696328, NCT04945018, NCT04982081, and NCT05647213]. A recent clinical trial by Professor Shigeru Miyagawa and his team (Osaka University, Japan) aimed to confirm the safety profile of allogenic iPSC-CMs transplantation in heart failure patients (<a href="#B37">Kawamura et al., 2023</a>). In their study, they transplanted iPSC-CMs-based cardiac patches on the patients having 1) ischemic cardiomyopathy, 2) left ventricular ejection fraction of 35% or less and 3) heart failure symptoms of New York Heart Association class III or greater, despite existing therapies such as revascularization. Surgically, three iPSC-CM-based circular patches (each containing 3.3&#x0002a;10<sup>7</sup> cells and diameter of 3.5&#x000a0;cm) were transplanted on the left ventricular anterior and the lateral wall and fixed. The patients were given immunosuppressants for 3 months after the surgery and were observed for up to a year. In the first 3 cases of the trial, they observed 1) improvement in heart failure symptoms, 2) no transplant-related adverse outcomes, such as tumor formation, during the observation period, and 3) 2 of the 3 patients showed improvements in left ventricular contractility and myocardial blood flow, demonstrating the feasibility and safety of utilizing allogenic human iPSC-CMs for treating heart diseases (<a href="#B37">Kawamura et al., 2023</a>). Since the n-values of this study is low, it is hard to draw a definitive conclusion on the therapeutic efficacy and possible concerns of immune rejections on using such allogenic transplants. Nevertheless, novel developments on hypoimmunogenic and universal iPSC lines, using CRISPR/Cas9 (<a href="#B104">Zhao et al., 2020</a>), can greatly circumvent concerns of immune rejection with allogenic iPSC-CMs and help to establish off-the-shelf iPSC-CMs-based allogenic patches, which can reduce the time and cost needed to generate autologous grafts and could lower dependency on the donor organs.</p><a id="h8" name="h8"></a><h2>7 Summary and Future directions</h2><p class="mb15">Limited availability of human cardiac tissues necessitates the need of an accessible and scalable human-derived cell/tissue system that carries patient genetic information and expresses native cardiomyocyte-like structural and functional properties. Patient-derived iPSCs provide an inexhaustible source to obtain differentiated cells of all three germ layers in a reproducible manner. Specifically, current reprogramming and differentiation protocols have made it feasible to reliably obtain human iPSC-CMs that retain the genomic traits of the donor and exhibit the cellular and electrophysiological characteristics of the native cardiomyocytes. Thus, iPSC-CMs, derived from symptomatic or asymptomatic patients, are invaluable, accessible and scalable tools to understand the cellular and molecular mechanisms of channelopathies. Thus, in this review, we summarized several foundational and recent studies to provide in-depth knowledge on how patient-specific iPSC-CMs are utilized to model patient-specific arrhythmias that originated due to mutations on specific ion channel or dyad protein. We also highlighted recent advancements in CRISPR/Cas9 that have enabled us to establish patient-independent, variant-induced iPSC-CMs-based arrhythmia models. Next, we also examined developments on 3D models, such as iPSC-CMs-based cell sheets and patches, that capture <em>in vitro</em> electrophysiological characteristics in a more physiologically relevant manner, compared to 2D models. Notably, we also examined that such iPSC-CMs-based 3D patches have been transplanted in patients with ischemic cardiomyopathy to induce their myocardial tissue regeneration and improve myocardial functions. We further examined that a synergy of iPSC-CMs, gene editing, 3D models, all-optical, and high-throughput platform allow rapid acquisition of electrophysiological data in non-invasive and real-time manner, offering a platform to screen large number of emerging variants and investigate potential drugs/ therapies. Furthermore, we examined potential pitfalls of using iPSC-CM-based disease models that may arise due to differences in the expression level of ion channels or in their biophysical properties, highlighting the need to conduct iPSC-CM-based study and interpret the results with proper care. For example, iPSC-CMs are proarrhythmic when compared to their native counterparts; hence, such effects that arise due to the electrophysiological immaturity of iPSC-CMs should not be confused with the drug toxicity. This underscores the need to keep adequate experimental controls and isogenic controls of iPSC-CM for arrhythmia research. Importantly, we also examined that gene editing and optogenetics provide unique opportunity to tailor the functional characteristics of the ion channels or signaling components in the iPSC-CMs, allowing us to better understand the role of specific ion channel and signaling pathways in healthy or diseased conditions.</p><p class="mb15">Our studies and genome-wide association studies have shown that arrhythmias arise not only due to mutations in ion channels but also due to mutations in genes encoding cytoskeletal proteins (&#x003b2;2 spectrin), adapter proteins (Ankyrin 2), ECM, fibrosis, cardio-genesis, and cell-cell coupling. Thus, it is crucial that <em>in vitro</em> arrhythmia modeling should address the complex disease phenotype thath can partly be achieved by differentiating iPSCs into different cardiac cells, culturing them in 3D (as organoids or patches) and providing them with appropriate biomechanical and electrical stimulus. Such biomimetic 3D model would allow to comprehend the specific role of cellular or signaling components in eliciting arrhythmias. In addition, integration of such 3D culture models with high-throughput screening platform would allow rapid characterization of the variants and their targets in a physiologically relevant manner. More importantly, such high-throughput-based <em>in vitro</em> iPSC-CM arrhythmia models, in conjunction with reliable gene editing technology and all-optical technology, would provide reliable disease templates to rapidly and reliably screen large number of emerging arrhythmogenic variants and test novel therapies, while simultaneously reducing the time and cost of pre-clinical research.</p><a id="h9" name="h9"></a><h2>Author contributions</h2><p class="mb0">JJ: Funding acquisition, Formal Analysis, Visualization, Methodology, Investigation, Data curation, Writing&#x02013;review and editing, Writing&#x02013;original draft, Conceptualization. CA: Writing&#x02013;original draft, Visualization, Formal Analysis, Data curation. NS: Writing&#x02013;original draft, Visualization, Formal Analysis, Data curation. SG: Writing&#x02013;original draft, Formal Analysis, Data curation. SS: Writing&#x02013;review and editing, Supervision, Resources, Methodology, Funding acquisition, Formal Analysis, Conceptualization.</p><a id="h10" name="h10"></a><h2>Funding</h2><p class="mb0">The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Institutes of Health T32 Postdoctoral Fellowship Award T32HL149637 (JJ), NIH R01 HL160590, Frick Fund (GF483501, SAS is Bob Frick Research Chair in Heart Failure and Arrhythmia), and DOIM Pilot Award (GR120502, SAS).</p><a id="h11" name="h11"></a><h2>Acknowledgments</h2><p class="mb03">The authors would like to thank Professors Loren E Wold, Isabelle Deschenes, Hua Zhu, and Thomas Hund for their continual support and guidance. The authors also would like to thank Bob and Corrine Frick (SAS: Bob Frick Research Chair in Heart Failure and Arrhythmia).</p><a id="h12" name="h12"></a><h2>Conflict of interest</h2><p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p><a id="h13" name="h13"></a><h2>Publisher&#x02019;s note</h2><p class="mb15">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p><a id="h14" name="h14"></a><h2>Supplementary material</h2><p class="mb15" id="SM1">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fphys.2024.1475152/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphys.2024.1475152/full&#x00023;supplementary-material</a></p><a id="h15" name="h15"></a><h2>References</h2><div class="References"><p class="ReferencesCopy1"><a name="B1" id="B1"></a>Abilez O. J., Tzatzalos E., Yang H., Zhao M.-T., Jung G., Z&#x000f6;llner A. M., et al. (2018). Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling. <em>Stem Cells</em> 36, 265&#x02013;277. doi:10.1002/stem.2732</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29086457/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/stem.2732">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Passive+stretch+induces+structural+and+functional+maturation+of+engineered+heart+muscle+as+predicted+by+computational+modeling&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B2" id="B2"></a>Adegunsoye A., Gonzales N. M., Gilad Y. (2023). Induced pluripotent stem cells in disease biology and the evidence for their <em>in vitro</em> utility. <em>Annu. Rev. Genet.</em> 57, 341&#x02013;360. doi:10.1146/annurev-genet-022123-090319</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37708421/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1146/annurev-genet-022123-090319">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Induced+pluripotent+stem+cells+in+disease+biology+and+the+evidence+for+their+in+vitro+utility&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B3" id="B3"></a>Ahmed R. E., Anzai T., Chanthra N., Uosaki H. (2020). A brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes. <em>Front. Cell Dev. Biol.</em> 8, 178. doi:10.3389/fcell.2020.00178</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32266260/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fcell.2020.00178">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+brief+review+of+current+maturation+methods+for+human+induced+pluripotent+stem+cells-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B4" id="B4"></a>Baines O., Sha R., Kalla M., Holmes A. P., Efimov I. R., Pavlovic D., et al. (2024). Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review. <em>Europace</em> 26, euae017. doi:10.1093/europace/euae017</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38227822/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1093/europace/euae017">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optical+mapping+and+optogenetics+in+cardiac+electrophysiology+research+and+therapy:+a+state-of-the-art+review&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B5" id="B5"></a>Barbuti A., Benzoni P., Campostrini G., Dell&#x02019;Era P. (2016). Human derived cardiomyocytes: a decade of knowledge after the discovery of induced pluripotent stem cells. <em>Dev. Dyn.</em> 245, 1145&#x02013;1158. doi:10.1002/dvdy.24455</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27599668/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/dvdy.24455">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+derived+cardiomyocytes:+a+decade+of+knowledge+after+the+discovery+of+induced+pluripotent+stem+cells&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B6" id="B6"></a>Bezzina C., Veldkamp M. W., van Den Berg M. P., Postma A. V., Rook M. B., Viersma J. W., et al. (1999). A single Na(&#x0002b;) channel mutation causing both long-QT and Brugada syndromes. <em>Circ. Res.</em> 85, 1206&#x02013;1213. doi:10.1161/01.res.85.12.1206</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/10590249/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/01.res.85.12.1206">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+single+Na(+)+channel+mutation+causing+both+long-QT+and+Brugada+syndromes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B7" id="B7"></a>Burnett S. D., Blanchette A. D., Chiu W. A., Rusyn I. (2021). Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an <em>in vitro</em> model in toxicology: strengths and weaknesses for hazard identification and risk characterization. <em>Expert Opin. Drug Metab. Toxicol.</em> 17, 887&#x02013;902. doi:10.1080/17425255.2021.1894122</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33612039/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1080/17425255.2021.1894122">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+induced+pluripotent+stem+cell+(iPSC)-derived+cardiomyocytes+as+an+in+vitro+model+in+toxicology:+strengths+and+weaknesses+for+hazard+identification+and+risk+characterization&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B8" id="B8"></a>Chavali N. V., Kryshtal D. O., Parikh S. S., Wang L., Glazer A. M., Blackwell D. J., et al. (2019). Patient-independent human induced pluripotent stem cell model: a new tool for rapid determination of genetic variant pathogenicity in long QT syndrome. <em>Heart rhythm.</em> 16, 1686&#x02013;1695. doi:10.1016/j.hrthm.2019.04.031</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31004778/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.hrthm.2019.04.031">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-independent+human+induced+pluripotent+stem+cell+model:+a+new+tool+for+rapid+determination+of+genetic+variant+pathogenicity+in+long+QT+syndrome&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B9" id="B9"></a>Cheng M., Yang F., Liu J., Yang D., Zhang S., Yu Y., et al. (2021). Tyrosine Kinase inhibitors-induced arrhythmias: from molecular mechanisms, pharmacokinetics to therapeutic strategies. <em>Front. Cardiovasc Med.</em> 8, 758010. doi:10.3389/fcvm.2021.758010</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34869670/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fcvm.2021.758010">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Tyrosine+Kinase+inhibitors-induced+arrhythmias:+from+molecular+mechanisms,+pharmacokinetics+to+therapeutic+strategies&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B10" id="B10"></a>Chockalingam P., Wilde A. (2012). The multifaceted cardiac sodium channel and its clinical implications. <em>Heart</em> 98, 1318&#x02013;1324. doi:10.1136/heartjnl-2012-301784</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22875823/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1136/heartjnl-2012-301784">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+multifaceted+cardiac+sodium+channel+and+its+clinical+implications&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B11" id="B11"></a>Davis R. P., van den Berg C. W., Casini S., Braam S. R., Mummery C. L. (2011). Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. <em>Trends Mol. Med.</em> 17, 475&#x02013;484. doi:10.1016/j.molmed.2011.05.001</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21703926/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.molmed.2011.05.001">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Pluripotent+stem+cell+models+of+cardiac+disease+and+their+implication+for+drug+discovery+and+development&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B12" id="B12"></a>Derbala M. H., Guo A. S., Mohler P. J., Smith S. A. (2018). The role of &#x003b2;II spectrin in cardiac health and disease. <em>Life Sci.</em> 192, 278&#x02013;285. doi:10.1016/j.lfs.2017.11.009</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29128512/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.lfs.2017.11.009">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+role+of+II+spectrin+in+cardiac+health+and+disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B13" id="B13"></a>El Refaey M. M., Mohler P. J. (2017). Ankyrins and spectrins in cardiovascular biology and disease. <em>Front. Physiol.</em> 8, 852. doi:10.3389/fphys.2017.00852</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29163198/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fphys.2017.00852">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Ankyrins+and+spectrins+in+cardiovascular+biology+and+disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B14" id="B14"></a>Fatima A., Xu G., Shao K., Papadopoulos S., Lehmann M., Arn&#x000e1;iz-Cot J. J., et al. (2011). <em>In vitro</em> modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. <em>Cell Physiol. Biochem.</em> 28, 579&#x02013;592. doi:10.1159/000335753</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22178870/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1159/000335753">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=In+vitro+modeling+of+ryanodine+receptor+2+dysfunction+using+human+induced+pluripotent+stem+cells&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B15" id="B15"></a>Ferenczi E. A., Tan X., Huang C. L.-H. (2019). Principles of optogenetic methods and their application to cardiac experimental systems. <em>Front. Physiol.</em> 10, 1096. doi:10.3389/fphys.2019.01096</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31572204/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fphys.2019.01096">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Principles+of+optogenetic+methods+and+their+application+to+cardiac+experimental+systems&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B16" id="B16"></a>Fern&#x000e1;ndez-Falgueras A., Sarquella-Brugada G., Brugada J., Brugada R., Campuzano O. (2017). Cardiac channelopathies and sudden death: recent clinical and genetic advances. <em>Biol. (Basel)</em> 6, 7. doi:10.3390/biology6010007</p><p class="ReferencesCopy2"><a href="https://doi.org/10.3390/biology6010007">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Cardiac+channelopathies+and+sudden+death:+recent+clinical+and+genetic+advances&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B17" id="B17"></a>Ferrero-Miliani L., Holst A. G., Pehrson S., Morling N., Bundgaard H. (2010). Strategy for clinical evaluation and screening of sudden cardiac death relatives. <em>Fundam. Clin. Pharmacol.</em> 24, 619&#x02013;635. doi:10.1111/j.1472-8206.2010.00864.x</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20698891/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1111/j.1472-8206.2010.00864.x">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Strategy+for+clinical+evaluation+and+screening+of+sudden+cardiac+death+relatives&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B18" id="B18"></a>Garg P., Garg V., Shrestha R., Sanguinetti M. C., Kamp T. J., Wu J. C. (2018a). Human induced pluripotent stem cell-derived cardiomyocytes as models for cardiac channelopathies: a primer for non-electrophysiologists. <em>Circ. Res.</em> 123, 224&#x02013;243. doi:10.1161/CIRCRESAHA.118.311209</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29976690/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCRESAHA.118.311209">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+induced+pluripotent+stem+cell-derived+cardiomyocytes+as+models+for+cardiac+channelopathies:+a+primer+for+non-electrophysiologists&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B19" id="B19"></a>Garg P., Oikonomopoulos A., Chen H., Li Y., Lam C. K., Sallam K., et al. (2018b). Genome editing of induced pluripotent stem cells to decipher cardiac channelopathy variant. <em>J. Am. Coll. Cardiol.</em> 72, 62&#x02013;75. doi:10.1016/j.jacc.2018.04.041</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29957233/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.jacc.2018.04.041">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genome+editing+of+induced+pluripotent+stem+cells+to+decipher+cardiac+channelopathy+variant&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B20" id="B20"></a>Giudicessi J. R., Ackerman M. J. (2013). Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. <em>Transl. Res.</em> 161, 1&#x02013;14. doi:10.1016/j.trsl.2012.08.005</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22995932/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.trsl.2012.08.005">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Determinants+of+incomplete+penetrance+and+variable+expressivity+in+heritable+cardiac+arrhythmia+syndromes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B21" id="B21"></a>Goldfracht I., Efraim Y., Shinnawi R., Kovalev E., Huber I., Gepstein A., et al. (2019). Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications. <em>Acta Biomater.</em> 92, 145&#x02013;159. doi:10.1016/j.actbio.2019.05.016</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31075518/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.actbio.2019.05.016">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Engineered+heart+tissue+models+from+hiPSC-derived+cardiomyocytes+and+cardiac+ECM+for+disease+modeling+and+drug+testing+applications&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B22" id="B22"></a>Goodrow R. J., Desai S., Treat J. A., Panama B. K., Desai M., Nesterenko V. V., et al. (2018). Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes. <em>J. Pharmacol. Toxicol. Methods</em> 90, 19&#x02013;30. doi:10.1016/j.vascn.2017.11.001</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29128504/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.vascn.2017.11.001">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Biophysical+comparison+of+sodium+currents+in+native+cardiac+myocytes+and+human+induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B23" id="B23"></a>Govorunova E. G., Cunha S. R., Sineshchekov O. A., Spudich J. L. (2016). Anion channelrhodopsins for inhibitory cardiac optogenetics. <em>Sci. Rep.</em> 6, 33530. doi:10.1038/srep33530</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27628215/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/srep33530">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Anion+channelrhodopsins+for+inhibitory+cardiac+optogenetics&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B24" id="B24"></a>Graham G. (2015). Disparities in cardiovascular disease risk in the United States. <em>Curr. Cardiol. Rev.</em> 11, 238&#x02013;245. doi:10.2174/1573403x11666141122220003</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25418513/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.2174/1573403x11666141122220003">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Disparities+in+cardiovascular+disease+risk+in+the+United+States&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B25" id="B25"></a>Guerrier K., Kwiatkowski D., Czosek R. J., Spar D. S., Anderson J. B., Knilans T. K. (2015). Short QT interval prevalence and clinical outcomes in a pediatric population. <em>Circ. Arrhythm. Electrophysiol.</em> 8, 1460&#x02013;1464. doi:10.1161/CIRCEP.115.003256</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26386018/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCEP.115.003256">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Short+QT+interval+prevalence+and+clinical+outcomes+in+a+pediatric+population&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B26" id="B26"></a>Haapaniemi E., Botla S., Persson J., Schmierer B., Taipale J. (2018). CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. <em>Nat. Med.</em> 24, 927&#x02013;930. doi:10.1038/s41591-018-0049-z</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29892067/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41591-018-0049-z">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=CRISPR-Cas9+genome+editing+induces+a+p53-mediated+DNA+damage+response&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B27" id="B27"></a>Han J. L., Entcheva E. (2023). Gene modulation with CRISPR-based tools in human iPSC-cardiomyocytes. <em>Stem Cell Rev. Rep.</em> 19, 886&#x02013;905. doi:10.1007/s12015-023-10506-4</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36656467/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s12015-023-10506-4">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Gene+modulation+with+CRISPR-based+tools+in+human+iPSC-cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B28" id="B28"></a>Heinson Y. W., Han J. L., Entcheva E. (2023). OptoDyCE-plate as an affordable high throughput imager for all optical cardiac electrophysiology. <em>bioRxiv</em> 29 (08). doi:10.1101/2023.08.29.555447</p><p class="ReferencesCopy2"><a href="https://doi.org/10.1101/2023.08.29.555447">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=OptoDyCE-plate+as+an+affordable+high+throughput+imager+for+all+optical+cardiac+electrophysiology&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B29" id="B29"></a>Huang J., Feng Q., Wang L., Zhou B. (2021). Human pluripotent stem cell-derived cardiac cells: application in disease modeling, cell therapy, and drug discovery. <em>Front. Cell Dev. Biol.</em> 9, 655161. doi:10.3389/fcell.2021.655161</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33869218/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fcell.2021.655161">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+pluripotent+stem+cell-derived+cardiac+cells:+application+in+disease+modeling,+cell+therapy,+and+drug+discovery&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B30" id="B30"></a>Hylind R. J., Chandler S. F., Skinner J. R., Abrams D. J. (2018). Genetic testing for inherited cardiac arrhythmias: current state-of-the-art and future avenues. <em>J. Innov. Card. Rhythm Manag.</em> 9, 3406&#x02013;3416. doi:10.19102/icrm.2018.091102</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32494476/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.19102/icrm.2018.091102">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genetic+testing+for+inherited+cardiac+arrhythmias:+current+state-of-the-art+and+future+avenues&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B31" id="B31"></a>Jim&#x000e9;nez-J&#x000e1;imez J., Peinado R., Grima E. Z., Segura F., Mori&#x000f1;a P., S&#x000e1;nchez Mu&#x000f1;oz J. J., et al. (2015). Diagnostic approach to unexplained cardiac arrest (from the FIVI-gen study). <em>Am. J. Cardiol.</em> 116, 894&#x02013;899. doi:10.1016/j.amjcard.2015.06.030</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26189708/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.amjcard.2015.06.030">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Diagnostic+approach+to+unexplained+cardiac+arrest+(from+the+FIVI-gen+study)&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B32" id="B32"></a>Joshi J., Rubart M., Zhu W. (2019). Optogenetics: background, methodological advances and potential applications for cardiovascular research and medicine. <em>Front. Bioeng. Biotechnol.</em> 7, 466. doi:10.3389/fbioe.2019.00466</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32064254/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fbioe.2019.00466">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optogenetics:+background,+methodological+advances+and+potential+applications+for+cardiovascular+research+and+medicine&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B33" id="B33"></a>Joshi J., Xu B., Rubart M., Chang Y., Bao X., Chaliki H. P., et al. (2022). Optogenetic control of engrafted human induced pluripotent stem cell-derived cardiomyocytes in live mice: a proof-of-concept study. <em>Cells</em> 11, 951. doi:10.3390/cells11060951</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/35326403/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/cells11060951">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optogenetic+control+of+engrafted+human+induced+pluripotent+stem+cell-derived+cardiomyocytes+in+live+mice:+a+proof-of-concept+study&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B34" id="B34"></a>Joukar S. (2021). A comparative review on heart ion channels, action potentials and electrocardiogram in rodents and human: extrapolation of experimental insights to clinic. <em>Lab. Anim. Res.</em> 37, 25. doi:10.1186/s42826-021-00102-3</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34496976/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1186/s42826-021-00102-3">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+comparative+review+on+heart+ion+channels,+action+potentials+and+electrocardiogram+in+rodents+and+human:+extrapolation+of+experimental+insights+to+clinic&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B35" id="B35"></a>Kamakura T., Makiyama T., Sasaki K., Yoshida Y., Wuriyanghai Y., Chen J., et al. (2013). Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. <em>Circ. J.</em> 77, 1307&#x02013;1314. doi:10.1253/circj.cj-12-0987</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23400258/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1253/circj.cj-12-0987">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Ultrastructural+maturation+of+human-induced+pluripotent+stem+cell-derived+cardiomyocytes+in+a+long-term+culture&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B36" id="B36"></a>Kawaguchi N., Nakanishi T. (2023). Animal disease models and patient-iPS-cell-derived <em>in vitro</em> disease models for cardiovascular biology-how close to disease? <em>Biol. (Basel)</em> 12, 468. doi:10.3390/biology12030468</p><p class="ReferencesCopy2"><a href="https://doi.org/10.3390/biology12030468">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Animal+disease+models+and+patient-iPS-cell-derived+in+vitro+disease+models+for+cardiovascular+biology-how+close+to+disease?&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B37" id="B37"></a>Kawamura T., Ito Y., Ito E., Takeda M., Mikami T., Taguchi T., et al. (2023). Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports. <em>Front. Cardiovasc Med.</em> 10, 1182209. doi:10.3389/fcvm.2023.1182209</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37781295/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fcvm.2023.1182209">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Safety+confirmation+of+induced+pluripotent+stem+cell-derived+cardiomyocyte+patch+transplantation+for+ischemic+cardiomyopathy:+first+three+case+reports&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B38" id="B38"></a>Kitani T., Ong S.-G., Lam C. K., Rhee J.-W., Zhang J. Z., Oikonomopoulos A., et al. (2019). Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer. <em>Circulation</em> 139, 2451&#x02013;2465. doi:10.1161/CIRCULATIONAHA.118.037357</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30866650/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCULATIONAHA.118.037357">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human-induced+pluripotent+stem+cell+model+of+trastuzumab-induced+cardiac+dysfunction+in+patients+with+breast+cancer&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B39" id="B39"></a>Klimas A., Ambrosi C. M., Yu J., Williams J. C., Bien H., Entcheva E. (2016). OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology. <em>Nat. Commun.</em> 7, 11542. doi:10.1038/ncomms11542</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27161419/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/ncomms11542">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=OptoDyCE+as+an+automated+system+for+high-throughput+all-optical+dynamic+cardiac+electrophysiology&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B40" id="B40"></a>Kowalski W. J., Garcia-Pak I. H., Li W., Uosaki H., Tampakakis E., Zou J., et al. (2022). Sympathetic neurons regulate cardiomyocyte maturation in culture. <em>Front. Cell Dev. Biol.</em> 10, 850645. doi:10.3389/fcell.2022.850645</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/35359438/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fcell.2022.850645">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Sympathetic+neurons+regulate+cardiomyocyte+maturation+in+culture&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B41" id="B41"></a>Lahrouchi N., Raju H., Lodder E. M., Papatheodorou E., Ware J. S., Papadakis M., et al. (2017). Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome. <em>J. Am. Coll. Cardiol.</em> 69, 2134&#x02013;2145. doi:10.1016/j.jacc.2017.02.046</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28449774/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.jacc.2017.02.046">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Utility+of+post-mortem+genetic+testing+in+cases+of+sudden+arrhythmic+death+syndrome&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B42" id="B42"></a>Leonard A., Bertero A., Powers J. D., Beussman K. M., Bhandari S., Regnier M., et al. (2018). Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues. <em>J. Mol. Cell Cardiol.</em> 118, 147&#x02013;158. doi:10.1016/j.yjmcc.2018.03.016</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29604261/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.yjmcc.2018.03.016">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Afterload+promotes+maturation+of+human+induced+pluripotent+stem+cell+derived+cardiomyocytes+in+engineered+heart+tissues&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B107" id="B107"></a>Li M., Iismaa S. E., Naqvi N., Nicks A., Husain A., Graham R. M. (2014). Thyroid hormone action in postnatal heart development. <em>Stem Cell Res.</em> 13 (3 Pt B), 582&#x02013;591. doi:10.1016/j.scr.2014.07.001</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25087894/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.scr.2014.07.001">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Thyroid+hormone+action+in+postnatal+heart+development&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B43" id="B43"></a>Liang P., Sallam K., Wu H., Li Y., Itzhaki I., Garg P., et al. (2016). Patient-specific and genome-edited induced pluripotent stem cell-derived cardiomyocytes elucidate single-cell phenotype of Brugada syndrome. <em>J. Am. Coll. Cardiol.</em> 68, 2086&#x02013;2096. doi:10.1016/j.jacc.2016.07.779</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27810048/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.jacc.2016.07.779">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-specific+and+genome-edited+induced+pluripotent+stem+cell-derived+cardiomyocytes+elucidate+single-cell+phenotype+of+Brugada+syndrome&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B44" id="B44"></a>Lippi M., Stadiotti I., Pompilio G., Sommariva E. (2020). Human cell modeling for cardiovascular diseases. <em>Int. J. Mol. Sci.</em> 21, 6388. doi:10.3390/ijms21176388</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32887493/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/ijms21176388">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+cell+modeling+for+cardiovascular+diseases&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B45" id="B45"></a>Liu G., David B. T., Trawczynski M., Fessler R. G. (2020). Advances in pluripotent stem cells: history, mechanisms, technologies, and applications. <em>Stem Cell Rev. Rep.</em> 16, 3&#x02013;32. doi:10.1007/s12015-019-09935-x</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31760627/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s12015-019-09935-x">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Advances+in+pluripotent+stem+cells:+history,+mechanisms,+technologies,+and+applications&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B46" id="B46"></a>Lozano-Velasco E., Franco D., Aranega A., Daimi H. (2020). Genetics and epigenetics of atrial fibrillation. <em>Int. J. Mol. Sci.</em> 21, 5717. doi:10.3390/ijms21165717</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32784971/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/ijms21165717">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genetics+and+epigenetics+of+atrial+fibrillation&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B47" id="B47"></a>Lu F., Pu W. T. (2020). The architecture and function of cardiac dyads. <em>Biophys. Rev.</em> 12, 1007&#x02013;1017. doi:10.1007/s12551-020-00729-x</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32661902/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s12551-020-00729-x">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+architecture+and+function+of+cardiac+dyads&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B48" id="B48"></a>Lundy S. D., Zhu W.-Z., Regnier M., Laflamme M. A. (2013). Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. <em>Stem Cells Dev.</em> 22, 1991&#x02013;2002. doi:10.1089/scd.2012.0490</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23461462/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1089/scd.2012.0490">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Structural+and+functional+maturation+of+cardiomyocytes+derived+from+human+pluripotent+stem+cells&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B49" id="B49"></a>Ma R., Liang J., Huang W., Guo L., Cai W., Wang L., et al. (2018). Electrical stimulation enhances cardiac differentiation of human induced pluripotent stem cells for myocardial infarction therapy. <em>Antioxid. Redox Signal</em> 28, 371&#x02013;384. doi:10.1089/ars.2016.6766</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27903111/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1089/ars.2016.6766">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Electrical+stimulation+enhances+cardiac+differentiation+of+human+induced+pluripotent+stem+cells+for+myocardial+infarction+therapy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B50" id="B50"></a>Manfra O., Frisk M., Louch W. E. (2017). Regulation of cardiomyocyte T-tubular structure: opportunities for therapy. <em>Curr. Heart Fail Rep.</em> 14, 167&#x02013;178. doi:10.1007/s11897-017-0329-9</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28447290/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s11897-017-0329-9">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Regulation+of+cardiomyocyte+T-tubular+structure:+opportunities+for+therapy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B51" id="B51"></a>Mariani M. V., Pierucci N., Fanisio F., Laviola D., Silvetti G., Piro A., et al. (2024). Inherited arrhythmias in the pediatric population: an updated overview. <em>Med. Kaunas.</em> 60, 94. doi:10.3390/medicina60010094</p><p class="ReferencesCopy2"><a href="https://doi.org/10.3390/medicina60010094">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Inherited+arrhythmias+in+the+pediatric+population:+an+updated+overview&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B52" id="B52"></a>Matsa E., Rajamohan D., Dick E., Young L., Mellor I., Staniforth A., et al. (2011). Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. <em>Eur. Heart J.</em> 32, 952&#x02013;962. doi:10.1093/eurheartj/ehr073</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21367833/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1093/eurheartj/ehr073">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Drug+evaluation+in+cardiomyocytes+derived+from+human+induced+pluripotent+stem+cells+carrying+a+long+QT+syndrome+type+2+mutation&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B53" id="B53"></a>Maurissen T. L., Kawatou M., L&#x000f3;pez-D&#x000e1;vila V., Minatoya K., Yamashita J. K., Woltjen K. (2024). Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues. <em>Sci. Rep.</em> 14, 2586. doi:10.1038/s41598-024-52871-1</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38297132/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41598-024-52871-1">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modeling+mutation-specific+arrhythmogenic+phenotypes+in+isogenic+human+iPSC-derived+cardiac+tissues&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B54" id="B54"></a>Meijer van Putten R. M. E., Mengarelli I., Guan K., Zegers J. G., van Ginneken A. C. G., Verkerk A. O., et al. (2015). Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual Ik1. <em>Front. Physiol.</em> 6, 7. doi:10.3389/fphys.2015.00007</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25691870/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fphys.2015.00007">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Ion+channelopathies+in+human+induced+pluripotent+stem+cell+derived+cardiomyocytes:+a+dynamic+clamp+study+with+virtual+Ik1&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B55" id="B55"></a>Micheu M. M., Rosca A.-M. (2021). Patient-specific induced pluripotent stem cells as &#x0201c;disease-in-a-dish&#x0201d; models for inherited cardiomyopathies and channelopathies - 15 years of research. <em>World J. Stem Cells</em> 13, 281&#x02013;303. doi:10.4252/wjsc.v13.i4.281</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33959219/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.4252/wjsc.v13.i4.281">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-specific+induced+pluripotent+stem+cells+as+disease-in-a-dish+models+for+inherited+cardiomyopathies+and+channelopathies+-+15+years+of+research&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B56" id="B56"></a>Moretti A., Bellin M., Welling A., Jung C. B., Lam J. T., Bott-Fl&#x000fc;gel L., et al. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. <em>N. Engl. J. Med.</em> 363, 1397&#x02013;1409. doi:10.1056/NEJMoa0908679</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20660394/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1056/NEJMoa0908679">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-specific+induced+pluripotent+stem-cell+models+for+long-QT+syndrome&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B57" id="B57"></a>Musa H., Murphy N. P., Curran J., Higgins J. D., Webb T. R., Makara M. A., et al. (2016). Common human ANK2 variant confers <em>in vivo</em> arrhythmia phenotypes. <em>Heart rhythm.</em> 13, 1932&#x02013;1940. doi:10.1016/j.hrthm.2016.06.012</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27298202/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.hrthm.2016.06.012">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Common+human+ANK2+variant+confers+in+vivo+arrhythmia+phenotypes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B58" id="B58"></a>Napolitano C., Bloise R., Monteforte N., Priori S. G. (2012). Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. <em>Circulation</em> 125, 2027&#x02013;2034. doi:10.1161/CIRCULATIONAHA.111.055947</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22529064/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCULATIONAHA.111.055947">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Sudden+cardiac+death+and+genetic+ion+channelopathies:+long+QT,+Brugada,+short+QT,+catecholaminergic+polymorphic+ventricular+tachycardia,+and+idiopathic+ventricular+fibrillation&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B59" id="B59"></a>Nath S. C., Menendez L., Friedrich Ben-Nun I. (2023). Overcoming the variability of iPSCs in the manufacturing of cell-based therapies. <em>Int. J. Mol. Sci.</em> 24, 16929. doi:10.3390/ijms242316929</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38069252/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/ijms242316929">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Overcoming+the+variability+of+iPSCs+in+the+manufacturing+of+cell-based+therapies&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B60" id="B60"></a>Nijak A., Saenen J., Labro A. J., Schepers D., Loeys B. L., Alaerts M. (2021). iPSC-cardiomyocyte models of Brugada syndrome-achievements, challenges and future perspectives. <em>Int. J. Mol. Sci.</em> 22, 2825. doi:10.3390/ijms22062825</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33802229/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/ijms22062825">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=iPSC-cardiomyocyte+models+of+Brugada+syndrome-achievements,+challenges+and+future+perspectives&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B61" id="B61"></a>Ntusi N. A. B., Sliwa K. (2021). Impact of racial and ethnic disparities on patients with dilated cardiomyopathy: JACC focus seminar 7/9. <em>J. Am. Coll. Cardiol.</em> 78, 2580&#x02013;2588. doi:10.1016/j.jacc.2021.10.021</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34887144/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.jacc.2021.10.021">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Impact+of+racial+and+ethnic+disparities+on+patients+with+dilated+cardiomyopathy:+JACC+focus+seminar+7/9&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B62" id="B62"></a>Ozturk N., Uslu S., Ozdemir S. (2021). Diabetes-induced changes in cardiac voltage-gated ion channels. <em>World J. Diabetes</em> 12, 1&#x02013;18. doi:10.4239/wjd.v12.i1.1</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33520105/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.4239/wjd.v12.i1.1">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Diabetes-induced+changes+in+cardiac+voltage-gated+ion+channels&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B63" id="B63"></a>Paci M., Penttinen K., Pekkanen-Mattila M., Koivum&#x000e4;ki J. T. (2020). Arrhythmia mechanisms in human induced pluripotent stem cell-derived cardiomyocytes. <em>J. Cardiovasc Pharmacol.</em> 77, 300&#x02013;316. doi:10.1097/FJC.0000000000000972</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33323698/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1097/FJC.0000000000000972">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Arrhythmia+mechanisms+in+human+induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B64" id="B64"></a>Parikh S. S., Blackwell D. J., Gomez-Hurtado N., Frisk M., Wang L., Kim K., et al. (2017). Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes. <em>Circ. Res.</em> 121, 1323&#x02013;1330. doi:10.1161/CIRCRESAHA.117.311920</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28974554/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCRESAHA.117.311920">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Thyroid+and+glucocorticoid+hormones+promote+functional+T-tubule+development+in+human-induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B65" id="B65"></a>Park S. A., Lee S.-R., Tung L., Yue D. T. (2014). Optical mapping of optogenetically shaped cardiac action potentials. <em>Sci. Rep.</em> 4, 6125. doi:10.1038/srep06125</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25135113/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/srep06125">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optical+mapping+of+optogenetically+shaped+cardiac+action+potentials&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B66" id="B66"></a>Park S.-J., Zhang D., Qi Y., Li Y., Lee K. Y., Bezzerides V. J., et al. (2019). Insights into the pathogenesis of catecholaminergic polymorphic ventricular tachycardia from engineered human heart tissue. <em>Circulation</em> 140, 390&#x02013;404. doi:10.1161/CIRCULATIONAHA.119.039711</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31311300/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCULATIONAHA.119.039711">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Insights+into+the+pathogenesis+of+catecholaminergic+polymorphic+ventricular+tachycardia+from+engineered+human+heart+tissue&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B67" id="B67"></a>Peters N. S., Severs N. J., Rothery S. M., Lincoln C., Yacoub M. H., Green C. R. (1994). Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. <em>Circulation</em> 90, 713&#x02013;725. doi:10.1161/01.cir.90.2.713</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/8044940/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/01.cir.90.2.713">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Spatiotemporal+relation+between+gap+junctions+and+fascia+adherens+junctions+during+postnatal+development+of+human+ventricular+myocardium&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B68" id="B68"></a>Pierre M., Djemai M., Poulin H., Chahine M. (2021). NaV1.5 knockout in iPSCs: a novel approach to study NaV1.5 variants in a human cardiomyocyte environment. <em>Sci. Rep.</em> 11, 17168. doi:10.1038/s41598-021-96474-6</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34433864/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41598-021-96474-6">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=NaV1.5+knockout+in+iPSCs:+a+novel+approach+to+study+NaV1.5+variants+in+a+human+cardiomyocyte+environment&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B69" id="B69"></a>Pourrier M., Fedida D. (2020). The emergence of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as a platform to model arrhythmogenic diseases. <em>Int. J. Mol. Sci.</em> 21, 657. doi:10.3390/ijms21020657</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31963859/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/ijms21020657">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+emergence+of+human+induced+pluripotent+stem+cell-derived+cardiomyocytes+(hiPSC-CMs)+as+a+platform+to+model+arrhythmogenic+diseases&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B70" id="B70"></a>Quach B., Krogh-Madsen T., Entcheva E., Christini D. J. (2018). Light-activated dynamic clamp using iPSC-derived cardiomyocytes. <em>Biophys. J.</em> 115, 2206&#x02013;2217. doi:10.1016/j.bpj.2018.10.018</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30447994/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.bpj.2018.10.018">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Light-activated+dynamic+clamp+using+iPSC-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B71" id="B71"></a>Richards D. J., Tan Y., Coyle R., Li Y., Xu R., Yeung N., et al. (2016). Nanowires and electrical stimulation synergistically improve functions of hiPSC cardiac spheroids. <em>Nano Lett.</em> 16, 4670&#x02013;4678. doi:10.1021/acs.nanolett.6b02093</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27328393/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1021/acs.nanolett.6b02093">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Nanowires+and+electrical+stimulation+synergistically+improve+functions+of+hiPSC+cardiac+spheroids&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B108" id="B108"></a>Rog-Zielinska E. A., Craig M. A., Manning J. R., Richardson R. V., Gowans G. J., Dunbar D. R., et al. (2015). Glucocorticoids promote structural and functional maturation of foetal cardiomyocytes: a role for PGC-1&#x003b1;. <em>Cell Death Differ.</em> 22 (7), 1106&#x02013;1116. doi:10.1038/cdd.2014.181</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25361084/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/cdd.2014.181">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Glucocorticoids+promote+structural+and+functional+maturation+of+foetal+cardiomyocytes:+a+role+for+PGC-1&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B72" id="B72"></a>Romito A., Cobellis G. (2016). Pluripotent stem cells: current understanding and future directions. <em>Stem Cells Int.</em> 2016, 9451492. doi:10.1155/2016/9451492</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26798367/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1155/2016/9451492">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Pluripotent+stem+cells:+current+understanding+and+future+directions&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B73" id="B73"></a>Scoote M., Poole-Wilson P. A., Williams A. J. (2003). The therapeutic potential of new insights into myocardial excitation-contraction coupling. <em>Heart</em> 89, 371&#x02013;376. doi:10.1136/heart.89.4.371</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/12639859/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1136/heart.89.4.371">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+therapeutic+potential+of+new+insights+into+myocardial+excitation-contraction+coupling&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B106" id="B106"></a>Scuderi G. J., Butcher J. (2017). Naturally engineered maturation of cardiomyocytes. <em>Front. Cell. Dev. Biol.</em>, 5&#x02013;50. doi:10.3389/fcell.2017.00050</p><p class="ReferencesCopy2"><a href="https://doi.org/10.3389/fcell.2017.00050">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Naturally+engineered+maturation+of+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B74" id="B74"></a>Seibertz F., Sutanto H., D&#x000fc;lk R., Pronto J. R. D., Springer R., Rapedius M., et al. (2023). Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes. <em>Basic Res. Cardiol.</em> 118, 14. doi:10.1007/s00395-022-00973-0</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37020075/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s00395-022-00973-0">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Electrophysiological+and+calcium-handling+development+during+long-term+culture+of+human-induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B75" id="B75"></a>Selga E., Sendfeld F., Martinez-Moreno R., Medine C. N., Tura-Ceide O., Wilmut S. I., et al. (2018). Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient. <em>J. Mol. Cell Cardiol.</em> 114, 10&#x02013;19. doi:10.1016/j.yjmcc.2017.10.002</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29024690/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.yjmcc.2017.10.002">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Sodium+channel+current+loss+of+function+in+induced+pluripotent+stem+cell-derived+cardiomyocytes+from+a+Brugada+syndrome+patient&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B76" id="B76"></a>Shafaattalab S., Li A. Y., Gunawan M. G., Kim B., Jayousi F., Maaref Y., et al. (2021). Mechanisms of arrhythmogenicity of hypertrophic cardiomyopathy-associated troponin T (TNNT2) variant I79N. <em>Front. Cell Dev. Biol.</em> 9, 787581. doi:10.3389/fcell.2021.787581</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34977031/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fcell.2021.787581">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Mechanisms+of+arrhythmogenicity+of+hypertrophic+cardiomyopathy-associated+troponin+T+(TNNT2)+variant+I79N&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B77" id="B77"></a>Shinnawi R., Shaheen N., Huber I., Shiti A., Arbel G., Gepstein A., et al. (2019). Modeling reentry in the short QT syndrome with human-induced pluripotent stem cell-derived cardiac cell sheets. <em>J. Am. Coll. Cardiol.</em> 73, 2310&#x02013;2324. doi:10.1016/j.jacc.2019.02.055</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31072576/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.jacc.2019.02.055">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modeling+reentry+in+the+short+QT+syndrome+with+human-induced+pluripotent+stem+cell-derived+cardiac+cell+sheets&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B78" id="B78"></a>Shiti A., Arbil G., Shaheen N., Huber I., Setter N., Gepstein L. (2023). Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome. <em>J. Mol. Cell Cardiol.</em> 183, 42&#x02013;53. doi:10.1016/j.yjmcc.2023.08.003</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37579942/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.yjmcc.2023.08.003">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Utilizing+human+induced+pluripotent+stem+cells+to+study+atrial+arrhythmias+in+the+short+QT+syndrome&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B79" id="B79"></a>Simons E., Loeys B., Alaerts M. (2023). iPSC-derived cardiomyocytes in inherited cardiac arrhythmias: pathomechanistic discovery and drug development. <em>Biomedicines</em> 11, 334. doi:10.3390/biomedicines11020334</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36830871/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/biomedicines11020334">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=iPSC-derived+cardiomyocytes+in+inherited+cardiac+arrhythmias:+pathomechanistic+discovery+and+drug+development&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B80" id="B80"></a>Smith S. A., Sturm A. C., Curran J., Kline C. F., Little S. C., Bonilla I. M., et al. (2015). Dysfunction in the &#x003b2;II spectrin-dependent cytoskeleton underlies human arrhythmia. <em>Circulation</em> 131, 695&#x02013;708. doi:10.1161/CIRCULATIONAHA.114.013708</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25632041/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCULATIONAHA.114.013708">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Dysfunction+in+the+II+spectrin-dependent+cytoskeleton+underlies+human+arrhythmia&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B81" id="B81"></a>Souidi M., Am&#x000e9;dro P., Meyer P., Desprat R., Lema&#x000ee;tre J.-M., Rivier F., et al. (2020). Generation of three Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). <em>Stem Cell Res.</em> 49, 102094. doi:10.1016/j.scr.2020.102094</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33246213/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.scr.2020.102094">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Generation+of+three+Duchenne+muscular+dystrophy+patient-specific+induced+pluripotent+stem+cell+lines+DMD_YoTaz_PhyMedEXp,+DMD_RaPer_PhyMedEXp,+DMD_OuMen_PhyMedEXp+(INSRMi008-A,+INSRMi009-A+and+INSRMi010-A)&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B82" id="B82"></a>Sun Y., Su J., Wang X., Wang J., Guo F., Qiu H., et al. (2023). Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome. <em>EBioMedicine</em> 95, 104741. doi:10.1016/j.ebiom.2023.104741</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37544203/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.ebiom.2023.104741">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-specific+iPSC-derived+cardiomyocytes+reveal+variable+phenotypic+severity+of+Brugada+syndrome&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B83" id="B83"></a>Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. <em>Cell</em> 131, 861&#x02013;872. doi:10.1016/j.cell.2007.11.019</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18035408/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.cell.2007.11.019">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Induction+of+pluripotent+stem+cells+from+adult+human+fibroblasts+by+defined+factors&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B84" id="B84"></a>Takahashi K., Yamanaka S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. <em>Cell</em> 126, 663&#x02013;676. doi:10.1016/j.cell.2006.07.024</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/16904174/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.cell.2006.07.024">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Induction+of+pluripotent+stem+cells+from+mouse+embryonic+and+adult+fibroblast+cultures+by+defined+factors&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B85" id="B85"></a>Takaki T., Inagaki A., Chonabayashi K., Inoue K., Miki K., Ohno S., et al. (2019). Optical recording of action potentials in human induced pluripotent stem cell-derived cardiac single cells and monolayers generated from long QT syndrome type 1 patients. <em>Stem Cells Int.</em> 2019, 7532657. doi:10.1155/2019/7532657</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30956674/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1155/2019/7532657">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optical+recording+of+action+potentials+in+human+induced+pluripotent+stem+cell-derived+cardiac+single+cells+and+monolayers+generated+from+long+QT+syndrome+type+1+patients&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B86" id="B86"></a>Talman V., Kivel&#x000e4; R. (2018). Cardiomyocyte-endothelial cell interactions in cardiac remodeling and regeneration. <em>Front. Cardiovasc Med.</em> 5, 101. doi:10.3389/fcvm.2018.00101</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30175102/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fcvm.2018.00101">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Cardiomyocyte-endothelial+cell+interactions+in+cardiac+remodeling+and+regeneration&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B87" id="B87"></a>Tan Y., Richards D., Xu R., Stewart-Clark S., Mani S. K., Borg T. K., et al. (2015). Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells. <em>Nano Lett.</em> 15, 2765&#x02013;2772. doi:10.1021/nl502227a</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25826336/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1021/nl502227a">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Silicon+nanowire-induced+maturation+of+cardiomyocytes+derived+from+human+induced+pluripotent+stem+cells&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B88" id="B88"></a>Tester D. J., Medeiros-Domingo A., Will M. L., Haglund C. M., Ackerman M. J. (2012). Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. <em>Mayo Clin. Proc.</em> 87, 524&#x02013;539. doi:10.1016/j.mayocp.2012.02.017</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22677073/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.mayocp.2012.02.017">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Cardiac+channel+molecular+autopsy:+insights+from+173+consecutive+cases+of+autopsy-negative+sudden+unexplained+death+referred+for+postmortem+genetic+testing&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B89" id="B89"></a>Tian R., Gachechiladze M. A., Ludwig C. H., Laurie M. T., Hong J. Y., Nathaniel D., et al. (2019). CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. <em>Neuron</em> 104, 239&#x02013;255. doi:10.1016/j.neuron.2019.07.014</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31422865/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.neuron.2019.07.014">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=CRISPR+interference-based+platform+for+multimodal+genetic+screens+in+human+iPSC-derived+neurons&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B90" id="B90"></a>Tu C., Chao B. S., Wu J. C. (2018). Strategies for improving the maturity of human induced pluripotent stem cell-derived cardiomyocytes. <em>Circ. Res.</em> 123, 512&#x02013;514. doi:10.1161/CIRCRESAHA.118.313472</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30355143/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCRESAHA.118.313472">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Strategies+for+improving+the+maturity+of+human+induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B91" id="B91"></a>Vaidyanathan R., Markandeya Y. S., Kamp T. J., Makielski J. C., January C. T., Eckhardt L. L. (2016). Ik1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes. <em>Am. J. Physiol. Heart Circ. Physiol.</em> 310, H1611&#x02013;H1621. doi:10.1152/ajpheart.00481.2015</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27059077/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1152/ajpheart.00481.2015">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Ik1-enhanced+human-induced+pluripotent+stem+cell-derived+cardiomyocytes:+an+improved+cardiomyocyte+model+to+investigate+inherited+arrhythmia+syndromes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B92" id="B92"></a>van den Brink L., Grandela C., Mummery C. L., Davis R. P. (2020). Inherited cardiac diseases, pluripotent stem cells, and genome editing combined-the past, present, and future. <em>Stem Cells</em> 38, 174&#x02013;186. doi:10.1002/stem.3110</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31664757/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/stem.3110">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Inherited+cardiac+diseases,+pluripotent+stem+cells,+and+genome+editing+combined-the+past,+present,+and+future&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B93" id="B93"></a>van Mil A., Balk G. M., Neef K., Buikema J. W., Asselbergs F. W., Wu S. M., et al. (2018). Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential. <em>Cardiovasc Res.</em> 114, 1828&#x02013;1842. doi:10.1093/cvr/cvy208</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30169602/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1093/cvr/cvy208">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modelling+inherited+cardiac+disease+using+human+induced+pluripotent+stem+cell-derived+cardiomyocytes:+progress,+pitfalls,+and+potential&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B94" id="B94"></a>Veerman C. C., Mengarelli I., Guan K., Stauske M., Barc J., Tan H. L., et al. (2016). hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities. <em>Sci. Rep.</em> 6, 30967. doi:10.1038/srep30967</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27485484/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/srep30967">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=hiPSC-derived+cardiomyocytes+from+Brugada+Syndrome+patients+without+identified+mutations+do+not+exhibit+clear+cellular+electrophysiological+abnormalities&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B95" id="B95"></a>Vreeker A., van Stuijvenberg L., Hund T. J., Mohler P. J., Nikkels P. G. J., van Veen T. A. B. (2014). Assembly of the cardiac intercalated disk during pre- and postnatal development of the human heart. <em>PLoS One</em> 9, e94722. doi:10.1371/journal.pone.0094722</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24733085/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1371/journal.pone.0094722">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Assembly+of+the+cardiac+intercalated+disk+during+pre-+and+postnatal+development+of+the+human+heart&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B96" id="B96"></a>Wang M., Tu X. (2022). The genetics and epigenetics of ventricular arrhythmias in patients without structural heart disease. <em>Front. Cardiovasc Med.</em> 9, 891399. doi:10.3389/fcvm.2022.891399</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/35783865/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3389/fcvm.2022.891399">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+genetics+and+epigenetics+of+ventricular+arrhythmias+in+patients+without+structural+heart+disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B97" id="B97"></a>Wheelwright M., Mikkila J., Bedada F. B., Mandegar M. A., Thompson B. R., Metzger J. M. (2020). Advancing physiological maturation in human induced pluripotent stem cell-derived cardiac muscle by gene editing an inducible adult troponin isoform switch. <em>Stem Cells</em> 38, 1254&#x02013;1266. doi:10.1002/stem.3235</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32497296/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/stem.3235">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Advancing+physiological+maturation+in+human+induced+pluripotent+stem+cell-derived+cardiac+muscle+by+gene+editing+an+inducible+adult+troponin+isoform+switch&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B98" id="B98"></a>Wu J. C., Garg P., Yoshida Y., Yamanaka S., Gepstein L., Hulot J.-S., et al. (2019). Towards precision medicine with human iPSCs for cardiac channelopathies. <em>Circ. Res.</em> 125, 653&#x02013;658. doi:10.1161/CIRCRESAHA.119.315209</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31465267/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCRESAHA.119.315209">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Towards+precision+medicine+with+human+iPSCs+for+cardiac+channelopathies&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B99" id="B99"></a>Wu J. Y., Yeager K., Tavakol D. N., Morsink M., Wang B., Soni R. K., et al. (2023). Directed differentiation of human iPSCs into mesenchymal lineages by optogenetic control of TGF-&#x003b2; signaling. <em>Cell Rep.</em> 42, 112509. doi:10.1016/j.celrep.2023.112509</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37178118/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.celrep.2023.112509">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Directed+differentiation+of+human+iPSCs+into+mesenchymal+lineages+by+optogenetic+control+of+TGF-+signaling&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B100" id="B100"></a>Wu P., Deng G., Sai X., Guo H., Huang H., Zhu P. (2021). Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes. <em>Biosci. Rep.</em> 41, BSR20200833. doi:10.1042/BSR20200833</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33057659/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1042/BSR20200833">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Maturation+strategies+and+limitations+of+induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B101" id="B101"></a>Yang H., Yang Y., Kiskin F. N., Shen M., Zhang J. Z. (2023). Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes. <em>Stem Cell Res. Ther.</em> 14, 228. doi:10.1186/s13287-023-03470-w</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37649113/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1186/s13287-023-03470-w">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Recent+advances+in+regulating+the+proliferation+or+maturation+of+human-induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B102" id="B102"></a>Yoshida S., Sumomozawa K., Nagamine K., Nishizawa M. (2019). Hydrogel microchambers integrated with organic electrodes for efficient electrical stimulation of human iPSC-derived cardiomyocytes. <em>Macromol. Biosci.</em> 19, e1900060. doi:10.1002/mabi.201900060</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31038841/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/mabi.201900060">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Hydrogel+microchambers+integrated+with+organic+electrodes+for+efficient+electrical+stimulation+of+human+iPSC-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B103" id="B103"></a>Yoshida Y., Yamanaka S. (2017). Induced pluripotent stem cells 10 Years later: for cardiac applications. <em>Circ. Res.</em> 120, 1958&#x02013;1968. doi:10.1161/CIRCRESAHA.117.311080</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28596174/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCRESAHA.117.311080">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Induced+pluripotent+stem+cells+10+Years+later:+for+cardiac+applications&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B104" id="B104"></a>Zhao W., Lei A., Tian L., Wang X., Correia C., Weiskittel T., et al. (2020). Strategies for genetically engineering hypoimmunogenic universal pluripotent stem cells. <em>iScience</em> 23, 101162. doi:10.1016/j.isci.2020.101162</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32502965/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.isci.2020.101162">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Strategies+for+genetically+engineering+hypoimmunogenic+universal+pluripotent+stem+cells&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B105" id="B105"></a>Zhou J., Cui B., Wang X., Wang H., Zheng J., Guo F., et al. (2023). Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes. <em>Stem Cell Res. Ther.</em> 14, 92. doi:10.1186/s13287-023-03312-9</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37061738/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1186/s13287-023-03312-9">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Overexpression+of+KCNJ2+enhances+maturation+of+human-induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=">Google Scholar</a></p></div><a id="h16" name="h16"></a><h2>Glossary</h2><div class="DottedLine"></div><div class="Imageheaders"></div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg" name="Table3" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg" alt="www.frontiersin.org" id="udT1" loading="lazy">
  </picture>
</a></div><div class="clear"></div><div class="DottedLine"></div></div><div class="thinLineM20"></div><div class="AbstractSummary"><p><span>Keywords:</span> iPSCs, patient-specific iPSC-CMs, <em>in vitro</em> arrhythmia models, ion channels, personalized medicine, CRISPR, gene editing, optogenetics</p><p><span>Citation:</span> Joshi J, Albers C, Smole N, Guo S and Smith SA (2024) Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions. <em>Front. Physiol.</em> 15:1475152. doi: 10.3389/fphys.2024.1475152</p><p id="timestamps"><span>Received:</span> 02 August 2024; <span>Accepted:</span> 28 August 2024;<br><span>Published:</span> 12 September 2024.</p><div><p>Edited by:</p> <a href="https://loop.frontiersin.org/people/22602/overview">David R. Van Wagoner</a>, Case Western Reserve University, United States</div><div><p>Reviewed by:</p> <a href="https://loop.frontiersin.org/people/1881221/overview">Mena Abdelsayed</a>, Lankenau Institute for Medical Research, United States<br><a href="https://loop.frontiersin.org/people/2596873/overview">Carlo Lavalle</a>, Sapienza University of Rome, Italy</div><p><span>Copyright</span> &#x000a9; 2024 Joshi, Albers, Smole, Guo and Smith. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY).</a> The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p><p><span>&#x0002a;Correspondence:</span> Sakima A. Smith, <a id="encmail">c2FraW1hLnNtaXRoQG9zdW1jLmVkdQ==</a></p><div class="clear"></div></div>
</div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fphys.2024.1475152" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">8,3K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1,8K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">20</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/1475152#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fphys.2024.1475152" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fphys.2024.1475152" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/22602/overview" data-event="editorInfo-a-davidRVanWagoner" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">D</span><span class="notranslate">R</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">David  R Van Wagoner</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Cleveland Clinic Lerner College of Medicine, School of Medicine, Case Western Reserve University, United States</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/1881221/overview" data-event="editorInfo-a-menaAbdelsayed" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">M</span><span class="notranslate">A</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Mena  Abdelsayed</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Lankenau Institute for Medical Research, United States</div></div></a><a href="https://loop.frontiersin.org/people/2596873/overview" data-event="editorInfo-a-carloLavalle" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">C</span><span class="notranslate">L</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Carlo  Lavalle</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Faculty of Medicine and Dentistry, Sapienza University of Rome, Italy</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal"><li><a href="#h1">Abstract</a></li><li><a href="#h2">1 Introduction</a></li><li><a href="#h3">2 Patient-specific/human iPSC-CMs and their applications in modeling arrhythmias</a></li><li><a href="#h4">3 Roles of 3D culture, gene editing and all-optical platforms in arrhythmia research</a></li><li><a href="#h5">4 Challenges of using iPSC-CMs in arrhythmia research and clinical care</a></li><li><a href="#h6">5 Overcoming the challenges of iPSCs and iPSC-CMs in arrhythmia modeling</a></li><li><a href="#h7">6 The scope of iPSC-CMs beyond disease modeling</a></li><li><a href="#h8">7 Summary and Future directions</a></li><li><a href="#h9">Author contributions</a></li><li><a href="#h10">Funding</a></li><li><a href="#h11">Acknowledgments</a></li><li><a href="#h12">Conflict of interest</a></li><li><a href="#h13">Publisher&#x02019;s note</a></li><li><a href="#h14">Supplementary material</a></li><li><a href="#h15">References</a></li><li><a href="#h16">Glossary</a></li></ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fphys.2024.1475152" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/physiology/articles/10.3389/fphys.2024.1475152/full",["Reactive",16],{"main":17,"user":583,"article":584,"articleHub":845,"mainHeader":849},{"ibar":18,"footer":312,"newsletterComponent":-1,"snackbarItem":394,"toggleShowSnackbar":395,"contentfulJournal":396,"graphJournal":483,"settingsFeaturesSwitchers":487,"templateToggleBanner":488,"tenantConfig":548},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":243,"aboutJournal":244,"mainLinks":293,"journalLinks":300,"helpCenterLink":309},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=1&fieldid=65&specialtyid=0&entitytype=2&entityid=210",{"id":115,"name":116,"slug":117,"sections":118},210,"Frontiers in Physiology","physiology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211,215,219,223,227,231,235,239],{"id":120,"name":121,"slug":122},230,"Aquatic Physiology","aquatic-physiology",{"id":124,"name":125,"slug":126},157,"Autonomic Neuroscience","autonomic-neuroscience",{"id":128,"name":129,"slug":130},1328,"Avian Physiology","avian-physiology",{"id":132,"name":133,"slug":134},667,"Biophysics","biophysics",{"id":136,"name":137,"slug":138},211,"Cardiac Electrophysiology","cardiac-electrophysiology",{"id":140,"name":141,"slug":142},2468,"Cell Physiology","cell-physiology",{"id":144,"name":145,"slug":146},1393,"Chronobiology","chronobiology",{"id":148,"name":149,"slug":150},579,"Clinical and Translational Physiology","clinical-and-translational-physiology",{"id":152,"name":153,"slug":154},212,"Computational Physiology and Medicine","computational-physiology-and-medicine",{"id":156,"name":157,"slug":158},214,"Craniofacial Biology and Dental Research","craniofacial-biology-and-dental-research",{"id":160,"name":161,"slug":162},1346,"Developmental Physiology","developmental-physiology",{"id":164,"name":165,"slug":166},1331,"Environmental, Aviation and Space Physiology","environmental-aviation-and-space-physiology",{"id":168,"name":169,"slug":170},215,"Exercise Physiology","exercise-physiology",{"id":172,"name":173,"slug":174},216,"Gastrointestinal Sciences","gastrointestinal-sciences",{"id":176,"name":177,"slug":178},218,"Integrative Physiology","integrative-physiology",{"id":180,"name":181,"slug":182},229,"Invertebrate Physiology","invertebrate-physiology",{"id":184,"name":185,"slug":186},444,"Lipid and Fatty Acid Research","lipid-and-fatty-acid-research",{"id":188,"name":189,"slug":190},670,"Medical Physics and Imaging","medical-physics-and-imaging",{"id":192,"name":193,"slug":194},213,"Membrane Physiology and Membrane Biophysics","membrane-physiology-and-membrane-biophysics",{"id":196,"name":197,"slug":198},2071,"Metabolic Physiology","metabolic-physiology",{"id":200,"name":201,"slug":202},232,"Mitochondrial Research","mitochondrial-research",{"id":204,"name":205,"slug":206},1496,"Physio-logging","physio-logging",{"id":208,"name":209,"slug":210},1386,"Red Blood Cell Physiology","red-blood-cell-physiology",{"id":212,"name":213,"slug":214},219,"Redox Physiology","redox-physiology",{"id":216,"name":217,"slug":218},222,"Renal Physiology and Pathophysiology","renal-physiology-and-pathophysiology",{"id":220,"name":221,"slug":222},2527,"Reproductive and Mating Physiology","reproductive-and-mating-physiology",{"id":224,"name":225,"slug":226},224,"Respiratory Physiology and Pathophysiology","respiratory-physiology-and-pathophysiology",{"id":228,"name":229,"slug":230},2275,"Skeletal Physiology","skeletal-physiology",{"id":232,"name":233,"slug":234},2965,"Skin Physiology","skin-physiology",{"id":236,"name":237,"slug":238},221,"Striated Muscle Physiology","striated-muscle-physiology",{"id":240,"name":241,"slug":242},225,"Vascular Physiology","vascular-physiology","Sections",[245,269],{"title":246,"links":247},"Scope",[248,251,254,257,260,263,266],{"text":249,"url":250,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/physiology/about#about-editors",{"text":252,"url":253,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/physiology/about#about-scope",{"text":255,"url":256,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/physiology/about#about-facts",{"text":258,"url":259,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/physiology/about#about-submission",{"text":261,"url":262,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/physiology/about#about-open",{"text":264,"url":265,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/physiology/about#copyright-statement",{"text":267,"url":268,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/physiology/about#about-quality",{"title":270,"links":271},"For authors",[272,275,278,281,284,287,290],{"text":273,"url":274,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/physiology/for-authors/why-submit",{"text":276,"url":277,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/physiology/for-authors/article-types",{"text":279,"url":280,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/physiology/for-authors/author-guidelines",{"text":282,"url":283,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/physiology/for-authors/editor-guidelines",{"text":285,"url":286,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/physiology/for-authors/publishing-fees",{"text":288,"url":289,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/physiology/for-authors/submission-checklist",{"text":291,"url":292,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/physiology/for-authors/contact-editorial-office",[294,297],{"text":295,"url":296,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":298,"url":299,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[301,304,306],{"text":302,"url":303,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":305,"target":27,"ariaLabel":28},"research-topics",{"text":307,"url":308,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":310,"url":311,"target":77,"ariaLabel":310},"Help center","https://helpcenter.frontiersin.org",{"blocks":313,"socialLinks":367,"copyright":391,"termsAndConditionsUrl":392,"privacyPolicyUrl":393},[314,328,338,352],{"title":315,"links":316},"Guidelines",[317,319,322,325,327],{"text":279,"url":318,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":320,"url":321,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":323,"url":324,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":282,"url":326,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":329,"links":330},"Explore",[331,332,335,337],{"text":302,"url":299,"target":27,"ariaLabel":28},{"text":333,"url":334,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":336,"url":296,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":339,"links":340},"Outreach",[341,344,347,351],{"text":342,"url":92,"target":77,"ariaLabel":343},"Frontiers Forum ","Frontiers Forum website",{"text":345,"url":346,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":348,"url":349,"target":77,"ariaLabel":350},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":353,"links":354},"Connect",[355,356,360,363,366],{"text":310,"url":311,"target":77,"ariaLabel":310},{"text":357,"url":358,"target":77,"ariaLabel":359},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":361,"url":111,"target":27,"ariaLabel":362},"Contact us ","Subscribe to newsletter",{"text":364,"url":365,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[368,376,381,386],{"link":369,"type":372,"color":373,"icon":374,"size":375,"hiddenText":13},{"text":370,"url":371,"target":77,"ariaLabel":370},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":377,"type":372,"color":373,"icon":380,"size":375,"hiddenText":13},{"text":378,"url":379,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":382,"type":372,"color":373,"icon":385,"size":375,"hiddenText":13},{"text":383,"url":384,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":387,"type":372,"color":373,"icon":390,"size":375,"hiddenText":13},{"text":388,"url":389,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":397,"identifier":115,"name":116,"slug":117,"banner":398,"description":476,"mission":477,"palette":478,"impactFactor":479,"citeScore":480,"citations":481,"showTagline":28,"twitter":482},"Journal",[399],{"id":400,"src":401,"name":402,"tags":403,"type":435,"width":436,"height":437,"idHash":438,"archive":439,"brandId":440,"limited":439,"fileSize":441,"isPublic":442,"original":443,"copyright":19,"extension":444,"thumbnails":446,"dateCreated":454,"description":455,"orientation":456,"userCreated":457,"watermarked":439,"dateModified":454,"datePublished":458,"ecsArchiveFiles":459,"propertyOptions":460,"property_Channel":465,"property_Sub-Type":467,"property_Asset_Type":469,"activeOriginalFocusPoint":471,"property_Office_Department":474},"8661D86F-DC44-47C3-8EDF5AC7C3010522","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/webimage-175D1AF6-D0D7-457F-9F3319DF25C432BF.png","FPHYS_Main Visual_Red_Website",[404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,430,431,432,433,434],"medical","anatomical","healthy","athlete","muscular","chest","organs","education","health","system","anatomy","bones","person","shape","biology","male","shoulders","muscle","nature","face","science","torso","fitness","skeleton","man","illustration","skin","medicine","body","3d","human","image",5000,3750,"1748dd1e17cf8710",0,"22C10171-81B3-4DA6-99342F272A32E8BB",7157365,1,"https://brand.frontiersin.org/m/1748dd1e17cf8710/original/FPHYS_Main-Visual_Red_Website.jpg",[445],"jpg",{"mini":447,"thul":448,"webimage":401,"Guidelines":449,"WebsiteJpg_XL":450,"WebsiteWebP_L":451,"WebsiteWebP_M":452,"WebsiteWebP_XL":453},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/mini-C3B0E16A-BAEB-48B5-91EB5B674F1EF10C.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/thul-E9E052B8-3DB0-4F07-93D30E218A898731.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/Guidelines-FPHYS_Main Visual_Red_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/WebsiteJpg_XL-FPHYS_Main Visual_Red_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/WebsiteWebP_L-FPHYS_Main Visual_Red_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/WebsiteWebP_M-FPHYS_Main Visual_Red_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8661D86F-DC44-47C3-8EDF5AC7C3010522/CADBD0FC-2672-4E45-A7D1A3BAE338337E/WebsiteWebP_XL-FPHYS_Main Visual_Red_Website.webp","2022-06-27T10:00:47Z","Human anatomy showing face, head, shoulders and back muscular system, bone structure and vascular system.; Shutterstock ID 342678791; purchase_order: Main Visual; job: ; client: ; other:","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[461,462,463,464],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[466],"frontiersin_org",[468],"Main_Visual",[470],"Photography",{"x":472,"y":473},2500,1875,[475],"Publishing","The most cited physiology journal, promoting a multidisciplinary approach to the physiology of living systems - from the subcellular and molecular domains to the intact organism and its interaction with the environment.","\u003Cp>Frontiers in Physiology explores the physiology of living systems across all levels, from the molecular and subcellular to the intact organism and its interaction with the environment.\u003C/p>\n\n\u003Cp>Led by Field Chief Editor Prof John D Imig (University of Arkansas for Medical Sciences, USA) and indexed in Scopus, Web of Science (SCIE), PubMed Central (PMC), and DOAJ, the journal welcomes human and animal studies across all areas of physiology, including technologies for investigating physiological function. Topics of interest include, but are not limited to:\u003C/p>\n\u003Cul>\n  \u003Cli>avian, aquatic, and invertebrate physiology\u003C/li>\n  \u003Cli>biophysics, medical physics and imaging\u003C/li>\n  \u003Cli>cancer-related physiology and pathophysiology\u003C/li>\n  \u003Cli>cardiac electrophysiology\u003C/li>\n  \u003Cli>cell, membrane, metabolic, mitochondrial and redox physiology\u003C/li>\n  \u003Cli>chronobiology\u003C/li>\n  \u003Cli>computational physiology and medicine\u003C/li>\n  \u003Cli>craniofacial, tooth, skin, skeletal, and striated muscle physiology\u003C/li>\n  \u003Cli>developmental physiology\u003C/li>\n  \u003Cli>environmental, aviation, and space physiology\u003C/li>\n  \u003Cli>exercise physiology\u003C/li>\n  \u003Cli>gastrointestinal and physiology\u003C/li>\n  \u003Cli>integrative, clinical, and translational physiology\u003C/li>\n  \u003Cli>neurophysiology and autonomic neuroscience\u003C/li>\n  \u003Cli>physio-logging\u003C/li>\n  \u003Cli>reproductive and mating physiology\u003C/li>\n  \u003Cli>respiratory, vascular, renal and red blood cell physiology.\u003C/li>\n\u003C/ul>\n\n\u003Cp>Frontiers in Physiology particularly welcomes studies that support and advance the UNs Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being.\u003C/p>\n\n\u003Cp>Manuscripts that focus solely on clinical or medical research, including cancer studies, traditional medicine, and patient prognosis, are not suitable for publication in this journal. Additionally, research that is purely statistical or computational, such as regression analysis or network analysis, without a clear physiological context or application, is not within the scope of this journal.\u003C/p>\n\n\u003Cp>Frontiers in Physiology welcomes cancer-related research which focuses on the physiology and pathophysiology of the disease from cellular mechanisms to altered organ physiology. Should a manuscript purely focus on cancer etiology, cancer bioinformatics identifying novel biomarkers, cancer treatments, and cancer disease progression, it will not be considered in scope for the journal. Similarly, manuscripts on disease etiology, purely pathological processes, identification of novel biomarkers, and the progression, treatment, or management of disease  including clinical trials, and pilot studies  or purely bibliometric studies are not suitable for publication in this journal, and will be redirected to Frontiers in Medicine or Frontiers in Oncology as appropriate. Case reports will be considered in specified sections for publication in this journal. Please check section scope descriptions.\u003C/p>\n\n\u003Cp>Frontiers journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information. Manuscripts not adhering to these standards will not be considered.\u003Cp>\n\n\u003Cp>Frontiers in Physiology is committed to understanding how body components work together to maintain a healthy state by communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.\u003C/p>","red","4 .0","6.1","420871","@FrontPhysiol",{"id":115,"name":116,"slug":117,"abbreviation":484,"isOnline":13,"isOpenForSubmissions":13,"citeScore":485,"impactFactor":486},"fphys",7.3,3.4,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":395},{"isPublic":13,"allowCompanyUsers":395,"whiteListEmails":489,"enableAllJournals":13,"whiteListJournals":511},[490,491,492,493,494,495,496,497,498,495,499,500,501,502,503,504,505,506,507,508,509,510],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[512,513,514,515,516,517,442,518,519,520,521,522,523,524,525,526,527,528,529,530,531,532,533,534,535,536,537,538,539,540,541,542,543,544,545,546,547],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":442,"name":442,"availableJournalPages":549,"announcement":553},[303,308,305,550,551,552],"volumes","about","community-reviewers",{"__typename":554,"sys":555,"preHeader":42,"title":557,"description":558,"image":559,"link":581},"Announcement",{"id":556},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[560],{"archive":439,"brandId":440,"copyright":28,"dateCreated":561,"dateModified":562,"datePublished":563,"description":28,"extension":564,"fileSize":566,"height":567,"id":568,"isPublic":439,"limited":439,"name":569,"orientation":456,"original":28,"thumbnails":570,"type":435,"watermarked":439,"width":577,"videoPreviewURLs":578,"tags":579,"textMetaproperties":580,"src":571},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[565],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":571,"thul":572,"mini":573,"WebsiteWebP_L":574,"WebsiteWebP_M":575,"Guidelines":576},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":582,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":585,"isPreviewPage":395,"hasSupplementalData":395,"showCrossmarkWidget":13,"articleTemplate":723,"currentArticlePageMetaInfo":724,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":586,"doi":587,"title":588,"acceptanceDate":589,"receptionDate":590,"publicationDate":591,"lastModifiedDate":592,"isPublished":13,"abstract":593,"researchTopic":594,"articleType":600,"stage":603,"keywords":605,"authors":614,"editors":650,"reviewers":660,"journal":678,"section":685,"impactMetrics":687,"volume":691,"articleVolume":692,"relatedArticles":693,"isPublishedV2":395,"contents":694,"files":697},1475152,"10.3389/fphys.2024.1475152","Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions",["Date","2024-08-28T15:46:22.000Z"],["Date","2024-08-02T22:31:16.000Z"],["Date","2024-09-12T00:00:00.000Z"],["Date","2025-11-26T02:41:30.375Z"],"Ion channels and cytoskeletal proteins in the cardiac dyad play a critical role in maintaining excitation-contraction (E-C) coupling and in providing cardiac homeostasis. However, functional changes in these dyad proteins, whether induced by genetic, epigenetic, metabolic, therapeutic, or environmental factors disrupt normal cardiac electrophysiology, leading to abnormal E-C coupling and arrhythmias. Animal models and heterologous cell cultures provide platforms to elucidate the pathogenesis of arrhythmias for basic cardiac research; however, these traditional systems do not truly reflect human cardiac electro-pathophysiology. Notably, patients with the same genetic variants of inherited channelopathies (ICC) often exhibit incomplete penetrance and variable expressivity which underscores the need to establish patient-specific disease models to comprehend the mechanistic pathways of arrhythmias and determine personalized therapies. Patient-specific induced pluripotent stem cells-derived cardiomyocytes (iPSC-CMs) inherit the genetic background of the patient and reflect the electrophysiological characteristics of the native cardiomyocytes. Thus, iPSC-CMs provide an innovative and translational platform in cardiac disease modeling and therapeutic screening. In this review, we will examine how patient-specific iPSC-CMs historically evolved to model arrhythmia syndromes in a dish, and their utility in understanding the role of specific ion channels and their functional characteristics in causing arrhythmias. We will also examine utility of CRISPR/Cas9 to establish patient-independent, variant-induced arrhythmia models. Next, we will examine the limitations of using human iPSC-CMs with respect to in vitro arrhythmia modeling that stems from variations in iPSCs or toxicity due to gene editing on iPSC or iPSC-CMs and explore how such hurdles are being addressed. Importantly, we will also discuss how novel 3D iPSC-CM models better capture in vivo characteristics and how all-optical platforms provide non-invasive and high-throughput electrophysiological data that is useful for stratification of emerging arrhythmogenic variants and drug discovery. Finally, we will examine strategies to improve iPSC-CM maturity, including powerful gene editing and optogenetic tools that can introduce/modify specific ion channels in the iPSC-CMs and tailor cellular and functional characteristics. We anticipate that an elegant synergy of iPSCs, novel gene editing, 3D-culture models, and all-optical platforms will offer a high-throughput template to faithfully recapitulate in  vivo arrhythmogenic events necessary for personalized arrhythmia monitoring and drug screening.",{"id":595,"title":596,"articlesCount":597,"isMagazinePage":13,"slug":598,"isOpenForSubmission":395,"views":599},25491,"Functional Modifications of Ion Channels in Arrhythmogenesis",6,"functional-modifications-of-ion-channels-in-arrhythmogenesis",36661,{"id":601,"name":602},27,"Review",{"id":604,"name":19},18,[606,607,608,609,610,611,612,613],"iPSCs","patient-specific iPSC-CMs","in vitro arrhythmia models","Ion Channels","personalized medicine","CRISPR","gene editing","optogenetics Font: Italic Formatted: Font: Italic Formatted: Normal",[615,624,631,637,643],{"id":616,"firstName":617,"middleName":19,"lastName":618,"givenNames":619,"isCorresponding":395,"isProfilePublic":13,"userId":616,"email":-1,"affiliations":620},2069611,"Jyotsna","Joshi","Jyotsna ",[621],{"organizationName":622,"countryName":623,"cityName":19,"stateName":19,"zipCode":19},"Department of Internal Medicine","United States",{"id":625,"firstName":626,"middleName":19,"lastName":627,"givenNames":628,"isCorresponding":395,"isProfilePublic":13,"userId":625,"email":-1,"affiliations":629},2808208,"Cora","Albers","Cora ",[630],{"organizationName":622,"countryName":623,"cityName":19,"stateName":19,"zipCode":19},{"id":439,"firstName":632,"middleName":19,"lastName":633,"givenNames":634,"isCorresponding":395,"isProfilePublic":395,"userId":439,"email":-1,"affiliations":635},"Nathan","Smole","Nathan ",[636],{"organizationName":622,"countryName":623,"cityName":19,"stateName":19,"zipCode":19},{"id":439,"firstName":638,"middleName":19,"lastName":639,"givenNames":640,"isCorresponding":395,"isProfilePublic":395,"userId":439,"email":-1,"affiliations":641},"Shuliang","Guo","Shuliang ",[642],{"organizationName":622,"countryName":623,"cityName":19,"stateName":19,"zipCode":19},{"id":644,"firstName":645,"middleName":19,"lastName":646,"givenNames":647,"isCorresponding":395,"isProfilePublic":13,"userId":644,"email":-1,"affiliations":648},49757,"Sakima A.","Smith","Sakima A. ",[649],{"organizationName":622,"countryName":623,"cityName":19,"stateName":19,"zipCode":19},[651],{"id":652,"firstName":653,"middleName":654,"lastName":655,"givenNames":656,"isCorresponding":395,"isProfilePublic":13,"userId":652,"email":-1,"affiliations":657},22602,"David","R","Van Wagoner","David  R",[658],{"organizationName":659,"countryName":623,"cityName":19,"stateName":19,"zipCode":19},"Cleveland Clinic Lerner College of Medicine, School of Medicine, Case Western Reserve University",[661,669],{"id":662,"firstName":663,"middleName":19,"lastName":664,"givenNames":665,"isCorresponding":395,"isProfilePublic":13,"userId":662,"email":-1,"affiliations":666},1881221,"Mena","Abdelsayed","Mena ",[667],{"organizationName":668,"countryName":623,"cityName":19,"stateName":19,"zipCode":19},"Lankenau Institute for Medical Research",{"id":670,"firstName":671,"middleName":19,"lastName":672,"givenNames":673,"isCorresponding":395,"isProfilePublic":13,"userId":670,"email":-1,"affiliations":674},2596873,"Carlo","Lavalle","Carlo ",[675],{"organizationName":676,"countryName":677,"cityName":19,"stateName":19,"zipCode":19},"Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Faculty of Medicine and Dentistry, Sapienza University of Rome","Italy",{"id":115,"slug":117,"name":116,"shortName":679,"electronicISSN":680,"field":681,"specialtyId":28,"journalSectionPaths":683},"Front. Physiol.","1664-042X",{"id":682,"domainId":442},65,[684],{"section":685},{"id":136,"name":137,"slug":138,"specialtyId":686},132,{"views":688,"downloads":689,"citations":690},8323,1769,20,15,"Volume 15 - 2024",[],{"titleHtml":588,"fullTextHtml":695,"menuHtml":696},"\u003Cdiv class=\"JournalAbstract\">\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2069611\" class=\"user-id-2069611\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2069611/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Jyotsna Joshi\">Jyotsna Joshi\u003C/a>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2808208\" class=\"user-id-2808208\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2808208/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Cora Albers\">Cora Albers\u003C/a>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Nathan Smole\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Nathan Smole\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Shuliang Guo\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Shuliang Guo\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/49757\" class=\"user-id-49757\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/49757/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Sakima A. Smith&#xa;\">Sakima A. Smith\u003C/a>&#x0002a;\u003C/span>\u003C/div>\u003Cul class=\"notes\">\u003Cli>Department of Internal Medicine, Division of Cardiology, College of Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH, United States\u003C/li>\u003C/ul>\u003Cp class=\"mb15\">Ion channels and cytoskeletal proteins in the cardiac dyad play a critical role in maintaining excitation-contraction (E-C) coupling and provide cardiac homeostasis. Functional changes in these dyad proteins, whether induced by genetic, epigenetic, metabolic, therapeutic, or environmental factors, can disrupt normal cardiac electrophysiology, leading to abnormal E-C coupling and arrhythmias. Animal models and heterologous cell cultures provide platforms to elucidate the pathogenesis of arrhythmias for basic cardiac research; however, these traditional systems do not truly reflect human cardiac electro-pathophysiology. Notably, patients with the same genetic variants of inherited channelopathies (ICC) often exhibit incomplete penetrance and variable expressivity which underscores the need to establish patient-specific disease models to comprehend the mechanistic pathways of arrhythmias and determine personalized therapies. Patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) inherit the genetic background of the patient and reflect the electrophysiological characteristics of the native cardiomyocytes. Thus, iPSC-CMs provide an innovative and translational pivotal platform in cardiac disease modeling and therapeutic screening. In this review, we will examine how patient-specific iPSC-CMs historically evolved to model arrhythmia syndromes in a dish, and their utility in understanding the role of specific ion channels and their functional characteristics in causing arrhythmias. We will also examine how CRISPR/Cas9 have enabled the establishment of patient-independent and variant-induced iPSC-CMs-based arrhythmia models. Next, we will examine the limitations of using human iPSC-CMs with respect to \u003Cem>in vitro\u003C/em> arrhythmia modeling that stems from variations in iPSCs or toxicity due to gene editing on iPSC or iPSC-CMs and explore how such hurdles are being addressed. Importantly, we will also discuss how novel 3D iPSC-CM models can better capture \u003Cem>in vitro\u003C/em> characteristics and how all-optical platforms provide non-invasive and high- throughput electrophysiological data that is useful for stratification of emerging arrhythmogenic variants and drug discovery. Finally, we will examine strategies to improve iPSC-CM maturity, including powerful gene editing and optogenetic tools that can introduce/modify specific ion channels in iPSC-CMs and tailor cellular and functional characteristics. We anticipate that an elegant synergy of iPSCs, novel gene editing, 3D- culture models, and all-optical platforms will offer a high-throughput template to faithfully recapitulate \u003Cem>in vitro\u003C/em> arrhythmogenic events necessary for personalized arrhythmia monitoring and drug screening process.\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\u003Cdiv class=\"JournalFullText\">\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>1 Introduction\u003C/h2>\u003Cp class=\"mb15\">The human cardiac junctional dyad is a highly evolved signal amplification and transduction system with an intricate assembly of ion channels and membrane proteins. In concert, the sarcoplasmic reticulum (SR) and transverse tubule (TT) translates the wave of sarcolemmal depolarization to the TT to induce calcium-induced calcium release (CICR) from internal SR stores leading to excitation-contraction (E-C) coupling (\u003Ca href=\"#B73\">Scoote et al., 2003\u003C/a>; \u003Ca href=\"#B50\">Manfra et al., 2017\u003C/a>; \u003Ca href=\"#B47\">Lu and Pu, 2020\u003C/a>). Ion channels and membrane proteins play fundamental roles in maintaining E-C coupling, and cardiac membrane cytoskeletal proteins and adapter proteins, such as spectrins and ankyrins, play a critical role in the post-translational targeting and localization of key proteins, such as the sodium/calcium exchanger (NCX), sodium/potassium ATPase (Na/K-ATPase), inositol triphosphate receptor (InsP3R), and ryanodine receptor 2 (RyR2) (\u003Ca href=\"#B80\">Smith et al., 2015\u003C/a>; \u003Ca href=\"#B13\">El Refaey and Mohler, 2017\u003C/a>; \u003Ca href=\"#B12\">Derbala et al., 2018\u003C/a>). However, mutations in the genes encoding ion channels and myocyte structural components (e.g., Ankyrins, &#x003b2;II spectrin, Connexin 43, COL12A1 and ANGPTL2), disturbs cardiac electromechanical homeostasis and contribute to cardiac channelopathies and inherited arrhythmias (\u003Ca href=\"#B20\">Giudicessi and Ackerman, 2013\u003C/a>; \u003Ca href=\"#B57\">Musa et al., 2016\u003C/a>; \u003Ca href=\"#B46\">Lozano-Velasco et al., 2020\u003C/a>; \u003Ca href=\"#B96\">Wang and Tu, 2022\u003C/a>). An important example is Brugada syndrome (BrS), an inherited channelopathy caused by mutations on the SCN5A gene encoding cardiac sodium channel, which has a prevalence of 1&#x02013;2,000 to 1 to 5,000 (\u003Ca href=\"#B10\">Chockalingam and Wilde, 2012\u003C/a>; \u003Ca href=\"#B51\">Mariani et al., 2024\u003C/a>). It is characterized by abnormal ECG recordings (ST-segment elevation) and accounts for &#x0223c;4&#x02013;12% of sudden cardiac deaths cases in children and young athletes and 10%&#x02013;20% of sudden cardiac deaths in infant (\u003Ca href=\"#B10\">Chockalingam and Wilde, 2012\u003C/a>; \u003Ca href=\"#B51\">Mariani et al., 2024\u003C/a>). Similarly, catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but fatal channelopathy that has a prevalence of &#x0223c;1 per 10,000 (\u003Ca href=\"#B88\">Tester et al., 2012\u003C/a>; \u003Ca href=\"#B31\">Jim&#x000e9;nez-J&#x000e1;imez et al., 2015\u003C/a>; \u003Ca href=\"#B41\">Lahrouchi et al., 2017\u003C/a>). It is caused by mutations on RyR2 and calsequestrin 2 (CASQ2) genes that can cause sudden cardiac death, especially in pediatric populations (\u003Ca href=\"#B51\">Mariani et al., 2024\u003C/a>). Notably, a highly lethal short QT syndrome (SQTS) has a cumulative risk of cardiac events of 40% by 40&#x000a0;years and has a prevalence of 0.02%&#x02013;0.1% in adults (\u003Ca href=\"#B17\">Ferrero-Miliani et al., 2010\u003C/a>; \u003Ca href=\"#B25\">Guerrier et al., 2015\u003C/a>). Thus, the prevalence and lethality associated with these inherited arrhythmias underscore the need to deeply understand their mechanistic pathways and establish novel therapies to treat such fatal conditions.\u003C/p>\u003Cp class=\"mb15\">In addition to the genetic mutations, epigenetic regulations caused by non-coding RNAs, DNA methylation and histone modifications are also being implicated in the pathogenesis of arrhythmias (\u003Ca href=\"#B46\">Lozano-Velasco et al., 2020\u003C/a>; \u003Ca href=\"#B96\">Wang and Tu, 2022\u003C/a>). Additionally, insults imposed by metabolic risk factors, such as diabetes, impairs cardiac voltage-gated ion channels and put patients at increased risk of developing diabetic cardiomyopathy, ventricular dysfunction, arrhythmias, and heart failure (\u003Ca href=\"#B62\">Ozturk et al., 2021\u003C/a>). Also, anti-cancer drugs, such as Tyrosine Kinase Inhibitors, pose a substantial threat of QT prolongation and atrial fibrillation (AFib) for cancer patients (\u003Ca href=\"#B9\">Cheng et al., 2021\u003C/a>). Notably, inherited cardiac channelopathies (ICC) often exhibit incomplete penetrance and variable expressivity while gender, racial, ethnic, and social factors also cause variable susceptibility to develop cardiac diseases, clearly indicating the intricate pathogenic signaling web and the need to establish personalized cardiac disease modelling and therapeutic screening (\u003Ca href=\"#B20\">Giudicessi and Ackerman, 2013\u003C/a>; \u003Ca href=\"#B24\">Graham, 2015\u003C/a>; \u003Ca href=\"#B61\">Ntusi and Sliwa, 2021\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">Human cardiac tissue is the gold standard to understand patient-specific disease mechanisms; however, it is not feasible to consistently obtain invasive biopsies of cardiac tissues from patients nor it is an scalable approach to utilize the short-lived extracted cardiomyocytes for multiple mechanistic and therapeutic studies (\u003Ca href=\"#B60\">Nijak et al., 2021\u003C/a>). Thus, it is essential to have an accessible and scalable \u003Cem>in vitro\u003C/em> model system that will reflect the phenotypic characteristics of human cardiomyocytes and carry genomic traits of an individual patient. In this respect, heterologous cell culture systems, including HEK293 cells, Xenopus oocytes and Chinese hamster ovary, provide useful models to understand disease mechanisms (\u003Ca href=\"#B54\">Meijer van Putten et al., 2015\u003C/a>). However, such cellular systems do not carry the genome of the individual patient and may lack accessory channel subunits, or other native cardiac proteins, present in the human cardiomyocytes (\u003Ca href=\"#B75\">Selga et al., 2018\u003C/a>). Thus, such heterologous cell cultures may not definitively represent patient-specific disease phenotypes. Additionally, transgenic animals provide vital \u003Cem>in vitro\u003C/em> information but these models do not fully recapitulate the human genome and cardiac electro-pathophysiology (\u003Ca href=\"#B56\">Moretti et al., 2010\u003C/a>; \u003Ca href=\"#B54\">Meijer van Putten et al., 2015\u003C/a>). For instance, the mouse heart beat is almost 8 times faster than of humans and mouse cardiac repolarization depends mainly on \u003Cem>I\u003C/em>\u003Csub>to\u003C/sub>, \u003Cem>I\u003C/em>\u003Csub>K, slow1\u003C/sub>, \u003Cem>I\u003C/em>\u003Csub>K, slow2\u003C/sub> and \u003Cem>I\u003C/em>\u003Csub>SS\u003C/sub> ion currents while the repolarization in human cardiomyocytes is mainly dependent on \u003Cem>I\u003C/em>\u003Csub>Ks\u003C/sub> and \u003Cem>I\u003C/em>\u003Csub>Kr\u003C/sub> (\u003Ca href=\"#B18\">Garg et al., 2018a\u003C/a>). To overcome some of these limitations, human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have evolved as a promising tool in personalized cardiac disease modeling and drug screening (\u003Ca href=\"#B103\">Yoshida and Yamanaka, 2017\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">In this review we aim to provide in-depth information on how iPSCs, iPSC-CMs, and patient-specific iPSC-CMs-based arrhythmia models have evolved in the field and how such iPSC-CMs capture \u003Cem>in vitro\u003C/em> electrophysiological characteristics. Also, we will examine recent developments on 3D disease models, high-throughput screening, all-optical platforms, and patient-independent iPSC-CMs-based arrhythmia models using CRISPR/Cas9 to illuminate how such developments have enabled efficient recapitulation of \u003Cem>in vitro\u003C/em> electrophysiological characteristics in a rapid, non-invasive and high-throughput manner. Next, we will discuss concerns on the structural and functional immaturity of human iPSC-CM and review some novel technologies, such as gene-editing and optogenetics that are instrumental in tuning their functional characteristics. Finally, we will briefly review some recent clinical studies and breakthroughs on the human iPSC-CMs for personalized cardiotoxicity screening and regenerative medicine to provide insight on the translational impact of iPSC-CMs in disease modeling, drug screening and therapeutic medicine. Our overall goal is to understand the application and challenges of human iPSC-CMs and examine novel technologies that can strengthen their scope in arrhythmia modeling.\u003C/p>\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>2 Patient-specific/human iPSC-CMs and their applications in modeling arrhythmias\u003C/h2>\u003Cp class=\"mb15\">Unlike human embryonic cells, human iPSCs are not hindered by ethical concerns. Interestingly, they are almost inexhaustible and genetically editable, providing an opportunity to create a library of genetic variants causing arrhythmias, establish isogenic controls and identify the pathogenic variants from emerging unknown variants. These methods are crucial for risk stratification in clinical care management, uncover mechanistic signaling pathways, and test potential life-saving therapies to treat specific variant-induced arrhythmogenic syndromes in a high-throughput manner (\u003Ca href=\"#B30\">Hylind et al., 2018\u003C/a>; \u003Ca href=\"#B98\">Wu et al., 2019\u003C/a>; \u003Ca href=\"#B29\">Huang et al., 2021\u003C/a>). The overall role of iPSC-CMs in personalized therapeutic screening, drug development and personalized medicine is illustrated in \u003Ca href=\"#F1\">Figure 1\u003C/a>. The iPSC-CMs will greatly aid in the early diagnosis and targeted therapies of ICC and cardiomyopathies, generally threatened by severe ventricular arrhythmias and sudden cardiac arrest (\u003Ca href=\"#B58\">Napolitano et al., 2012\u003C/a>; \u003Ca href=\"#B16\">Fern&#x000e1;ndez-Falgueras et al., 2017\u003C/a>; \u003Ca href=\"#B79\">Simons et al., 2023\u003C/a>). Thus, in the subsequent paragraphs we will review on the early landmark discoveries on iPSCs, patient/human iPSC-CMs, and their evolution on the human arrhythmia modeling.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">Figure 1\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg\" name=\"Figure1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg\" alt=\"www.frontiersin.org\" id=\"F1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>Figure 1\u003C/b>. An illustrative representation showing the generation of patient-specific iPSC-CMs and their role in cardiac disease modeling and personalized medicine.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ca id=\"h3-1\" name=\"h3-1\">\u003C/a>\u003Ch3 class=\"pt0\">2.1 Early landmark discoveries\u003C/h3>\u003Cp class=\"mb0\">In early 2006, Takahashi and Yamanaka identified four critical transcription factors, known as Yamanaka factors- Oct3/4, Sox2, Klf4 and c-Myc (OSKM) and they were able to reprogram skin fibroblasts of mice into iPSCs (\u003Ca href=\"#B84\">Takahashi and Yamanaka, 2006\u003C/a>). They later found that the OSKM cocktail can also reprogram human fibroblasts into iPSCs (\u003Ca href=\"#B83\">Takahashi et al., 2007\u003C/a>). Since then, enormous work has been done to improve iPSC reprogramming, enhance their pluripotency and improve their differentiation (\u003Ca href=\"#B72\">Romito and Cobellis, 2016\u003C/a>; \u003Ca href=\"#B45\">Liu et al., 2020\u003C/a>). Thus, as of now, iPSCs can be derived from virtually any mature somatic cell of a patient, such as from blood, skin, hair or urine samples, and can be differentiated into cells of all three germ layers, such as neuronal cells, pancreatic cells, alveolar cells, hepatocytes, blood cells, kidney tubule cells, skeletal muscle cells, and cardiomyocytes (\u003Ca href=\"#B2\">Adegunsoye et al., 2023\u003C/a>). For instance, a flowchart depicting the differentiation of iPSCs into iPSC-CMs via biphasic activation and inhibition of Wnt signaling (\u003Ca href=\"#B33\">Joshi et al., 2022\u003C/a>) is illustrated in \u003Ca href=\"#F2\">Figure 2\u003C/a>. Importantly, following reprogramming, iPSCs retain the genomic traits of the donor cells, reflect the phenotypic differences caused by variations in the genetic makeup, and are immunologically similar to the host cells (\u003Ca href=\"#B69\">Pourrier and Fedida, 2020\u003C/a>; \u003Ca href=\"#B55\">Micheu and Rosca, 2021\u003C/a>; \u003Ca href=\"#B2\">Adegunsoye et al., 2023\u003C/a>). This has allowed patient-specific iPSC-CMs to closely mimic the genetic, cellular and immunological characteristics of the disease phenotype.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">Figure 2\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg\" name=\"Figure2\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g002.jpg\" alt=\"www.frontiersin.org\" id=\"F2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>Figure 2\u003C/b>. An illustration showing the differentiation, metabolic purification and maturation of iPSC-CMs. iPSCs are differentiated into iPSC-CMs via biphasic activation and inhibition of Wnt signaling, non-iPSC-CMs were removed from cultures via metabolic purification, and the purified iPSC-CMs were allowed to grow and mature via long-term culture.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ca id=\"h3-2\" name=\"h3-2\">\u003C/a>\u003Ch3 class=\"pt0\">2.2 Early Utilization of iPSC-CMs for Disease Modeling.\u003C/h3>\u003Cp class=\"mb0\">Nearly 15&#x000a0;years ago, the Karl-Ludwig Laugwitz lab became the first group to utilize patient-derived iPSC-CMs for modeling a long-QT syndrome (LQTS), an ICC characterized by prolonged QT interval, ventricular tachyarrhythmia and sudden cardiac death (\u003Ca href=\"#B56\">Moretti et al., 2010\u003C/a>). In their study, they screened a family affected by LQTS 1 and identified a mutation in the KCNQ1 gene (R190Q) that encodes the delayed rectifier I\u003Csub>Ks\u003C/sub> current. They obtained dermal fibroblasts from two family members and from two healthy controls, reprogramed them into iPSCs, differentiated them into iPSC-CMs, and finally characterized the cells. The action potential duration (APD) of the ventricular and atrial cells, derived from LQTS patients, were significantly prolonged when compared to those derived from healthy controls. In addition, R190Q-KCNQ1 mutation displayed severe channel trafficking defects and the mutated iPSC-CMs displayed 70%&#x02013;80% reduction in \u003Cem>I\u003C/em>\u003Csub>KS\u003C/sub> current and higher susceptibility to isoproterenol-induced tachyarrhythmia, which was rescued with beta blocker (\u003Ca href=\"#B56\">Moretti et al., 2010\u003C/a>). Thus, this was the first study to provide evidence regarding the scope of iPSC-CMs in recapitulating patient-specific channelopathy \u003Cem>in vitro\u003C/em>.\u003C/p>\u003Cp class=\"mb0\">In 2011, the Chris Denning lab examined the scope of iPSC-CM as an \u003Cem>in vitro\u003C/em> humanized drug evaluation platform for inherited LQTS (\u003Ca href=\"#B52\">Matsa et al., 2011\u003C/a>). They reprogrammed iPSCs from skin fibroblasts of a patient with LQTS type 2, having a mutation in KCNH2 gene (G1681 A) (that encodes the potassium ion channel \u003Cem>I\u003C/em>\u003Csub>Kr\u003C/sub>), differentiated them into functional cardiomyocytes and compared the sensitivity of control iPSC-CM vs. the patient-derived LQT2-iPSC CM with agonists and antagonists of &#x003b2;-adrenergic receptors and of potassium channels. They found that LQT2&#x02013;iPSC-CM exhibited prolonged APD and increased sensitivity to early after depolarizations (EADs) with isoprenaline treatment, compared to control iPSC-CM, and such events were rescued by &#x003b2;-blockers. In addition, \u003Cem>I\u003C/em>\u003Csub>Kr\u003C/sub> channel blocker (E4031) caused EADs in 30% of the LQT2&#x02013;iPSC-CM while the potassium channel enhancers (nicorandil and PD-118057) shortened APD by more than 17%, demonstrating the efficacy of these drugs in normalizing the prolonged repolarization of CM with mutation in KCNH2 gene (\u003Ca href=\"#B52\">Matsa et al., 2011\u003C/a>). In another study, the &#x00160;aric group examined the utility of iPSC-CMs, derived from patients having RYR2 mutation (\u003Ca href=\"#B14\">Fatima et al., 2011\u003C/a>). They reported that iPSC-CMs derived from dermal fibroblasts of patient with inherited CPVT1 (caused by mutation in the RYR2 p.F2483I), exhibited arrhythmias and delayed afterdepolarizations (DADs) after catecholaminergic stimulation. Compared to control iPSC-CMs, CPVT1-iPSC-CMs demonstrated higher amplitudes and longer durations of spontaneous Ca\u003Csup>2&#x0002b;\u003C/sup> release events at basal state and the CICR events continued after repolarization, and such phenomena were eliminated with cytosolic cAMP levels with forskolin (\u003Ca href=\"#B14\">Fatima et al., 2011\u003C/a>). These foundational studies highlight the ability of patient-derived iPSC-CMs in modeling variant-induced arrhythmogenesis \u003Cem>in vitro\u003C/em>.\u003C/p>\u003Ca id=\"h3-3\" name=\"h3-3\">\u003C/a>\u003Ch3 class=\"pt0\">2.3 The growth of iPSC-CM modeling for multiple variants\u003C/h3>\u003Cp class=\"mb0\">Since aforementioned pioneering studies, numerous other studies have shown the ability of patient-derived iPSC-CMs in capturing specific variant-induced arrhythmias, such as LQTS, SQTS, CPVT, Timothy syndrome, and BrS, which are the results of genetic mutations in cardiac ion channels, transporters, or key cardiac proteins, such as KCNQ1 (LQTS1), KCNH2 (LQTS2), RYR2 (CPVT1), CASQ2 (CPVT2) (\u003Ca href=\"#B93\">van Mil et al., 2018\u003C/a>; \u003Ca href=\"#B69\">Pourrier and Fedida, 2020\u003C/a>). \u003Ca href=\"#B82\">Sun et al., 2023\u003C/a> reported that iPSC-CMs, derived from a SCN5A mutation-positive (D356Y) BrS family with severely affected proband, showed higher arrhythmias, slower depolarization and irregular calcium signaling when compared to controls. Furthermore, iPSC-CMs derived from asymptomatic mutation carriers were milder than that of proband iPSC-CMs, highlighting the ability of patient-specific iPSC-CMs in revealing phenotypic severity of BrS (\u003Ca href=\"#B82\">Sun et al., 2023\u003C/a>). Notably, CRISPR has provided an opportunity to rapidly expand the scope of iPSC-CMs in disease modeling and establish patient-independent human iPSC-CM-based models to uncover mechanistic pathways of genetic variants causing arrhythmias. For example, Chavali et al. introduced a CACNA1C-p.N639T variant in an unrelated but already established healthy human iPSC line using CRISPR/Cas9, differentiated them into iPSC-CMs and reported that the variant showed prolonged action potential and slowing of voltage-dependent inactivation of Ca\u003Csub>V\u003C/sub>1.2 currents (\u003Ca href=\"#B8\">Chavali et al., 2019\u003C/a>). Similarly, Shafaattalab et al. introduced a heterozygous I79N &#x000b1; TNNT2 variant into human iPSCs, differentiated them into iPSC-CMs and demonstrated that the variant iPSC-CMs exhibited- 1) lower intracellular Ca\u003Csup>2&#x0002b;\u003C/sup> transients, 2) clear pattern of alternans for both voltage (V\u003Csub>m\u003C/sub>) and Ca\u003Csup>2&#x0002b;\u003C/sup> transients when paced at frequencies &#x0003e;75&#x000a0;bpm, 3) significant upregulation of atrial natriuretic peptide, brain natriuretic peptide, ECM remodeling and Notch signaling components, when compared to the isogenic controls (\u003Ca href=\"#B76\">Shafaattalab et al., 2021\u003C/a>). In another study a homozygous Na\u003Csub>V\u003C/sub>1.5 KO iPSC line, established using CRISPR/Cas9 and differentiated into cardiomyocytes showed: 1) lower Na\u003Csup>&#x0002b;\u003C/sup> currents, 2) reduced action potential amplitudes, and 3) delayed propagation of Ca\u003Csup>2&#x0002b;\u003C/sup> waves, where such abnormal electrophysiological functions were rescued by WT Na\u003Csub>V\u003C/sub>1.5 channel expression in the KO iPSC-CMs (\u003Ca href=\"#B68\">Pierre et al., 2021\u003C/a>). Additional findings from foundational studies and current studies on human/patient-specific iPSC-CMs to understand the role of ion channel mutations and their functional modifications during channelopathies are provided in \u003Ca href=\"#SM1\">Supplementary Table 1\u003C/a>. In brief, iPSC-CMs recapitulate the \u003Cem>in vitro\u003C/em> electrophysiological characteristics of ionic currents, action potentials, calcium transients, proarrhythmogenic and arrhythmogenic events, and provide physiologically relevant disease models and drug screening platforms (\u003Ca href=\"#B93\">van Mil et al., 2018\u003C/a>; \u003Ca href=\"#B69\">Pourrier and Fedida, 2020\u003C/a>; \u003Ca href=\"#B55\">Micheu and Rosca, 2021\u003C/a>).\u003C/p>\u003Ca id=\"h3-4\" name=\"h3-4\">\u003C/a>\u003Ch3 class=\"pt0\">2.4 Pros and cons of human iPSC-CMs versus other models\u003C/h3>\u003Cp class=\"mb0\">Human/patient-specific iPSC-CMs carry human/patient-specific genome, reflect human cardiac electrophysiology, and provide an almost unlimited supply of cells for investigation. Thus, iPSC-CMs are preferred in disease modeling over heterologous cell cultures and animal models (\u003Ca href=\"#T1\">Table 1\u003C/a>). For example, \u003Ca href=\"#B75\">Selga et al. (2018)\u003C/a> compared the functional characteristics of sodium current in iPSC-CMs derived from a patient diagnosed with BrS and having a mutation in the SCN5A gene (c.1100G&#x0003e;A), with those from transfected tsA201 cells, carrying the same mutation. They reported that patient-derived iPSC-CMs showed: 1) a significant reduction (45%) in the peak \u003Cem>I\u003C/em>\u003Csub>Na\u003C/sub> density, 2) the I\u003Csub>Na\u003C/sub>-voltage activation curve was shifted by 7.42&#x000a0;mV and 3) the \u003Cem>I\u003C/em>\u003Csub>Na\u003C/sub>-voltage inactivation curve was negatively shifted by 8.5&#x000a0;mV compared to the control iPSC-CMs. Interestingly, transfected tsA201 cells also showed a significant drop in peak \u003Cem>I\u003C/em>\u003Csub>Na\u003C/sub> by &#x0223c; 50% when compared to wild type (WT) controls, but these cells did not show any voltage-dependent changes in kinetic properties of the sodium current that was observed in patient and control iPSC-CMs. Thus, the patient-specific genetic background, not just the specific gene variant, could affect overall expression of cardiac-specific proteins and thereby guide bio-functional characteristics of the ion channel currents (\u003Ca href=\"#B75\">Selga et al., 2018\u003C/a>).\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">Table 1\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg\" name=\"Table1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>Table 1\u003C/b>. A comparison on the advantages and disadvantages of animal models, heterologous cell culture models and iPSC-CMs in arrhythmias research.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cp class=\"mb0\">Nevertheless iPSC-CMs are hindered by their immature structural and ion channel characteristics when compared to native cardiomyocytes. To address such limitations, recent developments in cell reprogramming, differentiation and maturation strategies (\u003Ca href=\"#h6\">Section 5\u003C/a>) have positively impacted their scope in clinical studies for disease modeling and drug screening. As an example, a recent clinical study &#x0201c;Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells&#x0201d; (study location- France) was designed to generate patient-specific iPSCs and iPSC-CMs to study the molecular mechanisms of cardiomyopathies generated due to genetic defects [NCT03696628]. In the study, iPSCs were generated from peripheral blood mononuclear cells (PBMCs), using integration-free Sendai virus gene-delivery method, from three different Duchenne Muscular Dystrophy patients (&#x0003c;17&#x000a0;years, harboring deletions of exons 1, 52 and 55 in the dystrophin gene). The reprogrammed iPSCs showed normal karyotypes, pluripotency status and differentiated into iPSC-CMs using embryoid body formation (\u003Ca href=\"#B81\">Souidi et al., 2020\u003C/a>). Thus, although there is room for improvement, human/patient-specific iPSC-CMs provide an unlimited and instrumental platform in modeling arrhythmias due to multiple emerging variants and in understanding their mechanistic pathways.\u003C/p>\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>3 Roles of 3D culture, gene editing and all-optical platforms in arrhythmia research\u003C/h2>\u003Ca id=\"h4-1\" name=\"h4-1\">\u003C/a>\u003Ch3 class=\"pt0\">3.1 Tissue engineering platforms and beyond\u003C/h3>\u003Cp class=\"mb0\">The emergence of 3D models of iPSC-CMs, such as organoids, cell sheets and engineered heart tissues (EHT), have provided iPSC-CMs with additional methodologies to mimic \u003Cem>in vitro\u003C/em> cardiac events, such as tissue contractility, AP conduction velocity, origin, and propagation of re-entrant waves that are not attainable in traditional 2D cultures (\u003Ca href=\"#B79\">Simons et al., 2023\u003C/a>). Notably, the Lior Gepstein lab reported that iPSC-CMs, derived from dermal fibroblasts from a symptomatic SQTS patient having an N588K variant in the KCNH2 gene exhibited: 1) shortened APD, 2) increased \u003Cem>I\u003C/em>\u003Csub>Kr\u003C/sub> current density, and 3) increased channel protein expression compared to the healthy and isogenic controls at the cellular level (\u003Ca href=\"#B77\">Shinnawi et al., 2019\u003C/a>). Using optical mapping techniques, it was found that iPSC-CM-derived cardiac cell sheets exhibited shortened APD and increased susceptibility for sustained spiral waves at the tissue level, and such arrhythmogenic events were rescued with quinidine and disopyramide but not with sotalol. In another study, Goldfracht et al. examined the utility of EHT for modeling LQTS2 and CPVT2 (\u003Ca href=\"#B21\">Goldfracht et al., 2019\u003C/a>). They created EHTs by combining healthy or patient-specific iPSC-CMs with an ECM gel (derived from porcine cardiac tissues), allowed the cell-gel mixture to condense as rings within circular casting molds and they were transferred them into a passive stretching device for maturation. The optical recording data demonstrated significantly longer APD values measured in the LQTS2 derived EHT compared to their healthy control counterparts. Also, the CPVT2-ECM derived EHTs, but not their healthy counterparts, showed irregular calcium transients upon isoproterenol treatment (10&#x000a0;&#x000b5;m) and the occurrence and severity of such abnormal calcium activity was significantly lower when compared to the single-celled CPVT2-iPSC-CM counterparts, possibly due to higher electrotonic interactions in 3D. This implies 3D models are more clinically relevant in capturing \u003Cem>in vitro\u003C/em> electrophysiological features, when compared to 2D, as very frequent and very severe arrhythmogenic responses seen with single cells are often incompatible with life (\u003Ca href=\"#B21\">Goldfracht et al., 2019\u003C/a>).\u003C/p>\u003Ca id=\"h4-2\" name=\"h4-2\">\u003C/a>\u003Ch3 class=\"pt0\">3.2 Identification and validation of new variants with genetic testing\u003C/h3>\u003Cp class=\"mb0\">The incorporation of genetic testing as a clinical component for ICC patients has enabled the identification of hundreds of novel variants. However, this poses a significant challenge of identifying numerous emerging variants of uncertain significance (VUS) as normal or pathological, which is crucial for early risk stratification in clinical care (\u003Ca href=\"#B19\">Garg et al., 2018b\u003C/a>; \u003Ca href=\"#B30\">Hylind et al., 2018\u003C/a>). It has been reported that iPSC-CMs derived from a LQT2 patient having a novel missense variant (T983I) in the KCNH2 gene exhibited: 1) a significant prolongation in APD, 2) reduction of \u003Cem>I\u003C/em>\u003Csub>Kr\u003C/sub>, 3) reduction of hERG protein levels, and 4) higher pro-arrhythmogenic events compared to its healthy counterparts (\u003Ca href=\"#B19\">Garg et al., 2018b\u003C/a>). Notably, precise genomic correction of VUS iPSC-CM using CRISPR/Cas9 rescued the abnormal electrophysiological behavior while the introduction of the homozygous variant in the healthy cells elicited hallmarks of LQTS, implicating the pathogenic role of the KCNH2\u003Csup>T983I\u003C/sup> variant (\u003Ca href=\"#B19\">Garg et al., 2018b\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">Thus, CRISPR-based genome editing tools can greatly aid in the early identification of unknown arrhythmogenic variants. Moreover, novel CRISPR-based interference and activation system (CRISPRi/a) have emerged to overcome the concerns of double strand break-induced cellular toxicity and permanent gene-editing-induced phenotypic changes in iPSCs and iPSC-CMs (\u003Ca href=\"#B26\">Haapaniemi et al., 2018\u003C/a>; \u003Ca href=\"#B89\">Tian et al., 2019\u003C/a>). CRISPRi/a uses deactivated Cas9 (dCas9) enzyme linked to an effecter (an activator or a repressor) of gene transcription along with guide RNA (gRNA) provides reliable, reversible and spatiotemporal control of genetic modulation. In this regard, a recent study showed no significant effect of the CRISPRi components (DOX and dCas9-KRAB), on protein and mRNA levels of the ion channels of interest nor on the specific electrophysiological parameters in iPSC-CMs and clearly delineates that the observed physiological effects (such as APD80 prolongation and slowing of conduction velocity) were solely due to CRISPRi knockdown of KCNJ2 and GJA1 respectively in iPSC-CMs when gene edited using the DOX-inducible (Tet-on) dCas9-KRAB system (\u003Ca href=\"#B27\">Han and Entcheva, 2023\u003C/a>). Thus, novel CRISPR-based methods demonstrate a reliable gene editing platform to faithfully decipher gene-phenotype relations for arrhythmia research.\u003C/p>\u003Ca id=\"h4-3\" name=\"h4-3\">\u003C/a>\u003Ch3 class=\"pt0\">3.3 Novel use of all-optical platforms for iPSC-CM modeling\u003C/h3>\u003Cp class=\"mb0\">There is growing concern regarding the increasing cost, lengthy time, and the explosion in the number of candidate drugs to be tested for emerging arrhythmogenic variants. While classic patch-clamp electrophysiology requires physical contact and is a low throughput method, current automated systems significantly enhance the throughput, such as Multichannel Electrode Arrays (MEA), xCELLigence, and Fluorometric Imaging Plate Reader (FLIPR). Yest these systems cannot characterize tissue-level or multicellular effects, in 2D or 3D, respectively (\u003Ca href=\"#B39\">Klimas et al., 2016\u003C/a>). Fortunately, the birth of all-optical platforms, which is a merger of optogenetics and optical mapping methods, provides an opportunity for contactless actuation and readout of electrophysiological signals, offering tremendous potential for high-throughput functional readout for variant screenings and drug discovery (\u003Ca href=\"#B39\">Klimas et al., 2016\u003C/a>; \u003Ca href=\"#B4\">Baines et al., 2024\u003C/a>). Notably, the Emilia Entcheva lab has previously described an automated all-optical system (OptoDyCE) for capturing cardiac electrophysiology at the cellular/multicellular level (\u003Ca href=\"#B39\">Klimas et al., 2016\u003C/a>). This innovative system utilizes: 1) low-power LED light sources, 2) iPSC-CMs expressing light-gated cation channel Channelrhodopsin (iPSC-CMs-ChR2) where ChR2 acts as optogenetic actuator to enable optical pacing of the human iPSC-CMs, 3) optical sensors to record voltage (di-4-ANBDQBS) and intracellular calcium (Rhod-4a.m.) signals from the human iPSC-CMs, 4) multicellular samples in 96-wells, in 2D or 3D format, for HT capabilities, 5) a custom-built inverted microscope, high speed camera, and 6) custom-software for data analysis. As proof of concept, the system was able to perform dynamic drug-dose testing (using multi-beat pacing protocol) on 96-well format in less than 10&#x000a0;min, with the ability to record &#x0003e;30,000 cell readouts per 96-well plate, examine records at both global and cellular scale and foun pro-arrhythmic risks from voltage, calcium or contraction responses (\u003Ca href=\"#B39\">Klimas et al., 2016\u003C/a>). Recently the Entcheva lab has demonstrated another low-cost OptoDyCE-plate that can be used for the readout of cardiac function, providing data on change in APD and calcium transient duration (CTD) in human iPSC-CMs under spontaneous and paced, electrical or optogenetic (utilizing iPSC-CMs-ChR2 cells), conditions in standard 96 (or 3D electrospun PCL isotropic and anisotropic wells) and 384-well plate formats (\u003Ca href=\"#B28\">Heinson et al., 2023\u003C/a>). Using this system, investigators successfully tested the action of 4 drugs, dofetilide, cisapride, vanoxerine and nifedipine, on human iPSC-CMs and reported that:- 1) the first 3 drugs induced pacing frequency-dependent APD80 prolongation while the latter drug shortened APD80, 2) all 4 drugs showed pronounced APD effect at slower pacing rates while the effects were reduced at higher pacing rates, and 3) CTD80 changes under paced conditions were much smaller with the drugs (\u003Ca href=\"#B28\">Heinson et al., 2023\u003C/a>). These reports clearly depict that a synergy of iPSC-CMs, gene editing, high-throughput platform, and all-optical system would allow acquisition of massive amount of electrophysiological data, under static or dynamic conditions, in a non-invasive and real-time manner; thus offering a crucial platform to rapidly and efficiently capture electrophysiological features of multiple variants while simultaneously screening candidate drugs. Additional findings on such state-of-art iPSC-CM-based arrhythmia studies utilizing 3D models, CRISPR-Cas9 mediated gene editing, optogenetics, and optical platform are summarized in \u003Ca href=\"#T2\">Table 2\u003C/a>. In summary, by utilizing iPSC-CMs, 3D-culture models, CRISPR-based gene modulation, and all-optical platform, it is feasible to obtain real-time and high-throughput physiologically relevant electrophysiological data that offers unique potential in gaining mechanistic insights for emerging arrhythmia variants \u003Cem>in vitro\u003C/em> and will provide innovative platform for the discovery of novel therapies.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">Table 2\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg\" name=\"Table2\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t002.jpg\" alt=\"www.frontiersin.org\" id=\"T2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>Table 2\u003C/b>. State-of-art iPSC-CM-based arrhythmia studies utilizing 3D models, CRISPR-Cas9 mediated gene editing, Optogenetics and Optical mapping platform.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>4 Challenges of using iPSC-CMs in arrhythmia research and clinical care\u003C/h2>\u003Ca id=\"h5-1\" name=\"h5-1\">\u003C/a>\u003Ch3 class=\"pt0\">4.1 Variations in iPSCs\u003C/h3>\u003Cp class=\"mb0\">Clearly, human iPSC-CMs are invaluable tools for modeling arrhythmias and in understanding their mechanistic pathways; however, they exhibit some limitations in personalized screening and cardiotoxicity studies. One of the limitations of iPSC-CMs in personalized arrhythmia modeling and mechanistic studies stems from the variations in iPSCs themselves that may arise due to differences in: 1) tissue source and donor characteristics, 2) reprogramming methods, 3) culture conditions, and 4) clonal variations in iPSCs derived from the same donor and generated under the same reprogramming event, all which affects their pluripotency, differentiation potential and phenotypic characteristics (\u003Ca href=\"#B27\">Han and Entcheva, 2023\u003C/a>; \u003Ca href=\"#B59\">Nath et al., 2023\u003C/a>).\u003C/p>\u003Ca id=\"h5-2\" name=\"h5-2\">\u003C/a>\u003Ch3 class=\"pt0\">4.2 Biophysical characteristics of ion channels\u003C/h3>\u003Cp class=\"mb0\">In a recent study, Jonathan M Cordeiro and his group demonstrated that human iPSC-CMs and adult cardiomyocytes show a similar block of sodium current (\u003Cem>I\u003C/em>\u003Csub>Na\u003C/sub>) with lidocaine under voltage clamp but not under current clamp, suggesting a clear difference in the biophysical properties of \u003Cem>I\u003C/em>\u003Csub>Na\u003C/sub> (\u003Ca href=\"#B22\">Goodrow et al., 2018\u003C/a>). This may be due to the co-presence of fetal (exon 6 A) and adult (exon 6) isoforms of Na\u003Csub>v\u003C/sub>1.5 in iPSC-CMs or differences in the ratios of channel pore-forming &#x003b1; and accessory &#x003b2; subunits (the latter facilitates in the trafficking of Nav1.5 to the membrane) in the iPSC-CMs, compared to native cardiomyocytes (\u003Ca href=\"#B22\">Goodrow et al., 2018\u003C/a>). Another study reported no difference in \u003Cem>I\u003C/em>\u003Csub>Na\u003C/sub> and action potential upstroke velocity (V\u003Csub>max\u003C/sub>) in human iPSC-CM derived from 3 BrS patients who tested negative for coding region mutations in the known BrS-associated genes, when compared to iPSC-CM derived from healthy controls (\u003Ca href=\"#B94\">Veerman et al., 2016\u003C/a>). However, in another study (but under the same experimental system), loss of sodium channel function was detected, as reduced \u003Cem>I\u003C/em>\u003Csub>Na\u003C/sub> and \u003Cem>V\u003C/em>\u003Csub>max\u003C/sub>\u003Cem>,\u003C/em> in iPSC-CMs harboring a single sodium channel mutation SCN5A-1795insD (\u003Ca href=\"#B6\">Bezzina et al., 1999\u003C/a>). Such findings suggest: 1) ion channel dysfunction, mainly cardiac sodium channel, may not be the sole cause of arrhythmias in BrS (\u003Ca href=\"#B94\">Veerman et al., 2016\u003C/a>), 2) there may be possible involvement of other membrane proteins, cytoskeletal proteins or extracellular structural changes, such as fibrosis, in channelopathies, (\u003Ca href=\"#B63\">Paci et al., 2020\u003C/a>), and 3) the immature ion channel expression in iPSC-CM may fail to detect subtle differences in ionic currents and their biophysical characteristics in certain arrhythmic syndromes, inferring the need of more detailed analysis of iPSC-CM disease phenotypes, including proteomics and transcriptomics, to model arrhythmias \u003Cem>in vitro\u003C/em> (\u003Ca href=\"#B79\">Simons et al., 2023\u003C/a>). Hence, it is critical to conduct the study design and interpret the results on iPSC-CMs in arrhythmia research with care.\u003C/p>\u003Ca id=\"h5-3\" name=\"h5-3\">\u003C/a>\u003Ch3 class=\"pt0\">4.3 Structural, electrophysiological and metabolic immaturity\u003C/h3>\u003Cp class=\"mb0\">Another limitation of iPSC-CM in cardiac research stems from the challenge that iPSC-CMs are structurally, electro-physiologically, and metabolically more immature than native cardiomyocytes. iPSC-CMs: 1) lack definitive t-tubules, 2) lack or have rudimentary Ca\u003Csup>2&#x0002b;\u003C/sup> handling components such as RyR2, SERCA, calsequestrin, 3) exhibit slower upstroke velocity, shorter plateau phase or repolarization due to lower levels of Na\u003Csup>&#x0002b;\u003C/sup> and L-type Ca\u003Csup>2&#x0002b;\u003C/sup> channels, 4) possess automaticity due to lower current density of Kir\u003Csub>2.1\u003C/sub>-encoding \u003Cem>I\u003C/em>\u003Csub>K1\u003C/sub>, conferring them more proarrhythmic and depolarized at resting membrane potential than native cardiomyocytes (\u003Ca href=\"#B63\">Paci et al., 2020\u003C/a>; \u003Ca href=\"#B105\">Zhou et al., 2023\u003C/a>). A thorough comparison on the ultrastructural, contractile, electrophysiological, and metabolic characteristics of iPSC-CMs with those of the adult cardiomyocytes is presented in \u003Ca href=\"#SM1\">Supplementary Table 2\u003C/a>. In brief, human iPSC-CMs are limited by their structural and functional immaturity, such as lack of definitive t-tubules, poor Ca\u003Csup>2&#x0002b;\u003C/sup> handling machinery, unrestricted presence of gap junctions all over the cell membrane, depolarized resting membrane potential conferring differences in the activation of voltage-dependent ion channels, differences in the ion channel expression levels etc., which needs careful attention to boost the translational impact of iPSC-CM in disease modeling and regenerative medicine. Thus, it is crucial to implement strategies to address the limitations of iPSCs and post-differentiated iPSC-CMs for reliable arrhythmia research.\u003C/p>\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>5 Overcoming the challenges of iPSCs and iPSC-CMs in arrhythmia modeling\u003C/h2>\u003Cp class=\"mb15\">iPSCs derived from different donors may show phenotypic variations due to multiple genetic and epigenetic differences; hence, it is necessary to have isogenic controls for specific variants to correctly interpret the mechanistic findings (\u003Ca href=\"#B77\">Shinnawi et al., 2019\u003C/a>). Additionally, it is crucial to compare results of mutated/diseased iPSC-CMs with their corresponding isogenic controls, produced under same reprogramming and culture conditions (\u003Ca href=\"#B103\">Yoshida and Yamanaka, 2017\u003C/a>). Importantly, multiple strategies are being investigated to improve the maturity of iPSC-CMs and reduce their barriers in disease modeling, drug screening and regenerative medicine. Methods, such as long-term culture, electrical stimulation, mechanical stress, substrate stiffness, and biochemical stimulation (e.g., hormonal stimulation, paracrine signaling, metabolic modulation etc.) are being widely investigated to enhance structural and functional maturity in iPSC-CMs (\u003Ca href=\"#B90\">Tu et al., 2018\u003C/a>; \u003Ca href=\"#B100\">Wu et al., 2021\u003C/a>). We have illustrated some common and novel approaches for functional and structural modification of iPSC-CMs in \u003Ca href=\"#F3\">Figure 3\u003C/a>. We will briefly summarize some of the salient points and explore their scope in arrhythmia research and medicine in the following paragraphs.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">Figure 3\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg\" name=\"Figure3\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g003.jpg\" alt=\"www.frontiersin.org\" id=\"F3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>Figure 3\u003C/b>. A schematic representation to show common and novel approaches that are being investigated to modify the functional and structural properties of iPSC-CMs.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ca id=\"h6-1\" name=\"h6-1\">\u003C/a>\u003Ch3 class=\"pt0\">5.1 Culture duration\u003C/h3>\u003Cp class=\"mb0\">It has been hypothesized that prolonged cell culture times could promote maturation of iPSC-CMs originated from the fact that it takes almost a decade for native cardiomyocytes \u003Cem>in vitro\u003C/em> to acquire their adult structural phenotypes (\u003Ca href=\"#B67\">Peters et al., 1994\u003C/a>; \u003Ca href=\"#B95\">Vreeker et al., 2014\u003C/a>). In this aspect, Lundy et al. reported that iPSC-CMs with prolonged culture duration (80&#x02013;120&#x000a0;days) exhibit more mature structural and functional properties, such as increased cell size and anisotropy, a higher proportion of multinucleated cells, tight and orderly arrangement of myofibrils, a significant improvement in sarcomere contractile performance, and increase in calcium release and reuptake (\u003Ca href=\"#B48\">Lundy et al., 2013\u003C/a>). Similarly, other groups have reported the appearance of mature Z-bands, A-bands, H-bands, I-bands when culture duration of iPSC-CMs was increased to 180 days while M-band emerged lately when the culture was further prolonged to a year (\u003Ca href=\"#B35\">Kamakura et al., 2013\u003C/a>). Interestingly, it has recently been reported that late-stage iPSC-CM (aged &#x0003e;50&#x000a0;days) post-differentiation shows significantly larger \u003Cem>I\u003C/em>\u003Csub>Ca,L\u003C/sub> density, \u003Cem>I\u003C/em>\u003Csub>Ca,L\u003C/sub> evoked Ca\u003Csup>2&#x0002b;\u003C/sup> transients, and \u003Cem>I\u003C/em>\u003Csub>Na\u003C/sub> and \u003Cem>I\u003C/em>\u003Csub>K1\u003C/sub>, conferring them increased upstroke velocity and reduced APD (\u003Ca href=\"#B74\">Seibertz et al., 2023\u003C/a>).\u003C/p>\u003Ca id=\"h6-2\" name=\"h6-2\">\u003C/a>\u003Ch3 class=\"pt0\">5.2 Electrical stimulation\u003C/h3>\u003Cp class=\"mb0\">Since electrical signals play a fundamental role in the growth and development of the heart, electrical stimulation holds a potential to influence the maturity of iPSC-CM (\u003Ca href=\"#B100\">Wu et al., 2021\u003C/a>). Tan et al. reported that an endogenous electrical microenvironment provides structural and functional improvements to iPSC-CM, such as increased expression of cardiac troponin I and synchronized beating of the cardiomyocytes, which they achieved by incorporating trace amount of electrically conductive silicon nanowires (&#x0223c;0.004% w/v) in otherwise scaffold-free 3D iPSC-CM spheroids (\u003Ca href=\"#B87\">Tan et al., 2015\u003C/a>). They further reported that such nano-wired iPSC-CMs synergize with exogenous electrical stimulation as demonstrated by higher 1) cell-cell junction (Cx43, N-cadherin), 2) contractile machinery, 3) Ca\u003Csup>2&#x0002b;\u003C/sup> handling protein RyR2 expression, 4) Ca\u003Csup>2&#x0002b;\u003C/sup> release, but a significant reduction in the spontaneous beating of iPSC cardiac spheroids, addressing a major issue of automaticity with the iPSC-CMs (\u003Ca href=\"#B71\">Richards et al., 2016\u003C/a>). Further, Ma et al. reported the scope of cardiac-mimetic exogenous electrical pulses in enhancing the differentiation and functional maturation of iPSC-CMs, which was confirmed by a notable increase in intracellular Ca\u003Csup>2&#x0002b;\u003C/sup> levels and RYR2 expressions via Ca\u003Csup>2&#x0002b;/\u003C/sup>PKC/ERK signaling pathway (\u003Ca href=\"#B49\">Ma et al., 2018\u003C/a>). Similarly, Yoshida et al. demonstrated that a week regimen of electrical stimulation (2&#x000a0;Hz), using electrically conductive PVA-based permeable microchamber and carbon-based cyto-compatible electrodes, promotes expressions of myocardial structural proteins, such as cardiac troponin T and sarcomere-like structures in iPSC-CMs (\u003Ca href=\"#B102\">Yoshida et al., 2019\u003C/a>).\u003C/p>\u003Ca id=\"h6-3\" name=\"h6-3\">\u003C/a>\u003Ch3 class=\"pt0\">5.3 Mechanical stimulation\u003C/h3>\u003Cp class=\"mb0\">Given the heart&#x02019;s intrinsic role as a pump, mechanical stress also holds the potential to significantly influence CM maturity. Leonard et al. reported that progressive incremental mechanical stimulation in the form of applied afterload increases the sarcomere length, cardiomyocyte area and elongation, and calcium handling of iPSC-CMs in EHT, where such benefits plateaus at moderate afterload conditions (0.45&#x000a0;&#x003bc;N/&#x003bc;m) and is pathological at high afterload condition (9.2&#x000a0;&#x003bc;N/&#x003bc;m) (\u003Ca href=\"#B42\">Leonard et al., 2018\u003C/a>). Similarly, \u003Ca href=\"#B1\">Abilez et al. (2018)\u003C/a> demonstrated that passive stretch, guided by computational modeling, modulates the alignment and calcium dynamics of iPSC-CMs within an engineered heart muscle (EHM). Interestingly, they reported that passive stretch, along with fibroblast co-culture, in 3D EHM and culture duration enhanced the maturity of iPSC-CMs, as elicited by increased gene expression of troponin-T (\u003Cem>TNNT2\u003C/em>), calveolin-3 (\u003Cem>CAV3\u003C/em>), &#x003b2;-adrenergic receptors (\u003Cem>ADRB1\u003C/em>), and potassium (\u003Cem>KCNJ2\u003C/em>) and calcium (\u003Cem>CACNA1C\u003C/em>) ion channels (\u003Ca href=\"#B1\">Abilez et al., 2018\u003C/a>).\u003C/p>\u003Ca id=\"h6-4\" name=\"h6-4\">\u003C/a>\u003Ch3 class=\"pt0\">5.4 Biochemical signaling and cellular interactions\u003C/h3>\u003Cp class=\"mb0\">Postnatal hormones are known to significantly influence cardiomyocyte maturity (\u003Ca href=\"#B106\">Scuderi and Butcher, 2017\u003C/a>). Specifically, the incorporation of thyroid hormones and glucocorticoids have been pivotal in heart maturation during development (\u003Ca href=\"#B107\">Li et al., 2014\u003C/a>) (\u003Ca href=\"#B108\">Rog-Zielinska et al., 2015\u003C/a>). Triiodothyronine (T3)-treated iPSC-CMs developed elongated morphology, longer sarcomeres, increased mitochondrial activity, and improved calcium handling (\u003Ca href=\"#B3\">Ahmed et al., 2020\u003C/a>). Notably, Parikh et al. reported that enriching the iPSC-CM medium with Triiodothyronine (T3) and Dexamethasone (Dex) during days 16&#x02013;30, followed by single-cell culture on Matrigel mattress for next 5&#x000a0;days, provided 1) development of extensive T-tubule network, 2) promoted RyR2 structural organization, 3) enhanced and uniform calcium release characteristic of E-C coupling in ventricle, and 4) enhanced functional coupling between L-type Ca channels and RyR2 (\u003Ca href=\"#B64\">Parikh et al., 2017\u003C/a>). Apart from biochemical signaling, direct cellular interactions or indirect paracrine signaling in a native cardiac tissue are also known to influence cardiomyocyte maturity (\u003Ca href=\"#B86\">Talman and Kivel&#x000e4;, 2018\u003C/a>). Thus, iPSC-CM maturation strategies have also utilized methods to mimic those cellular interactions \u003Cem>in vitro\u003C/em>, such as by co-culturing iPSC-CM with endothelial cells, cardiac fibroblasts, epicardial cells, and smooth muscle cells (\u003Ca href=\"#B101\">Yang et al., 2023\u003C/a>). Interestingly, Kowalski et al. recently reported that co-culturing immature human iPSC-CMs with mouse sympathetic ganglion neurons (SN) promotes gene expression of mature cardiac structures (e.g., TNNT2, MYL2), ion channels (KCNH2, KCNQ1, KCNJ2, SCN5A), Na\u003Csup>&#x0002b;\u003C/sup>-Ca\u003Csup>2&#x0002b;\u003C/sup> exchanger (SLC8A1), calcium handling machinery (ATP2A2, RYR2, PLN) whereas culture of cardiomyocytes with isoproterenol alone did not cause changes in gene expression, inferring the vital role of direct cell-cell interactions in cardiomyocyte maturation (\u003Ca href=\"#B40\">Kowalski et al., 2022\u003C/a>). Further, they reported that such iPSC-CM, co-cultured with SN, elicited higher connexin-43 gap junction expression, sarcomere organization, and higher amplitudes of calcium transients but slower calcium relaxation compared to monoculture controls (\u003Ca href=\"#B40\">Kowalski et al., 2022\u003C/a>).\u003C/p>\u003Ca id=\"h6-5\" name=\"h6-5\">\u003C/a>\u003Ch3 class=\"pt0\">5.5 Gene editing\u003C/h3>\u003Cp class=\"mb0\">Gene editing provides an opportunity to directly probe the genomic characteristics and thereby influence the expression and function of the ion channels, dyad membrane proteins or other structural proteins, and tailor electrophysiological, structural and metabolic changes in iPSC-CMs. For example, \u003Ca href=\"#B105\">Zhou et al. (2023)\u003C/a> reported that iPSC-CMs, when overexpressed with KCNJ2 via lentiviral transduction method, showed significant protein expression of K\u003Csub>ir\u003C/sub>2.1 and current density of K\u003Csub>ir\u003C/sub>2.1-encoding I\u003Csub>K1\u003C/sub>. They also showed that such K\u003Csub>ir\u003C/sub>2.1-over expressed iPSC-CMs acquired quiescent phenotypes, which required pacing to elicit action potentials and the induced action potentials were abrogated by I\u003Csub>K1\u003C/sub> blocker BaCl\u003Csub>2\u003C/sub>, clearly showing the precise functional effect of the K\u003Csub>ir\u003C/sub>2.1 gene overexpression on iPSC-CMs (\u003Ca href=\"#B105\">Zhou et al., 2023\u003C/a>). They also reported that KCNJ2 overexpression significantly hyperpolarized the diastolic potential, shortened APD, increased maximal upstroke velocity, improved Ca\u003Csup>2&#x0002b;\u003C/sup> signaling, and mitochondrial energy metabolism of the iPSC-CMs (\u003Ca href=\"#B105\">Zhou et al., 2023\u003C/a>). In this aspect, \u003Ca href=\"#B54\">Meijer van Putten et al., 2015\u003C/a>, reported the role of I\u003Csub>\u003Cem>K1\u003C/em>\u003C/sub> in improving maturity of iPSC-CMs by injecting \u003Cem>in silico\u003C/em> I\u003Csub>k1\u003C/sub>, with a peak outward density of 4&#x02013;6&#x000a0;pA/pF, to the spontaneously beating iPSC-CMs and showed that the cells exhibited 1) ventricle-like action potential morphology, 2) improved resting membrane potential towards the physiological range (&#x02212;80&#x000a0;mV), 3) increased maximum upstroke velocity (&#x0003e;150&#x000a0;V/s), and 4) proarrhythmic action potential changes, upon injection of both loss-of-function and gain-of-function I\u003Csub>K1\u003C/sub>, associated with short QT syndrome and Andersen-Tawil syndrome (\u003Ca href=\"#B54\">Meijer van Putten et al., 2015\u003C/a>). Interestingly, Vaidyanathan et al. demonstrated that iPSC-CMs, with adenoviral-mediated I\u003Csub>K1\u003C/sub>-enhancement, showed 1) absence of spontaneous beating, 2) stable resting membrane potentials at around &#x02212;80&#x000a0;mV, and 3) twofold increase in cell size and membrane capacitance. Notably, such I\u003Csub>K1\u003C/sub>-enhanced iPSC-CMs, harboring F97C-CAV3 long QT9 mutation, showed increase in APD and late sodium current, representing a more mature arrhythmia model with I\u003Csub>K1\u003C/sub> enhancement (\u003Ca href=\"#B91\">Vaidyanathan et al., 2016\u003C/a>). In another study, using transcription activator-like effector nuclease (TALENs)-based gene editing platform, Wheelwright et al. induces expression of adult cardiac troponin I isoform in iPSC-CM and showed that iPSC-CMs depicted adult-like cardiac contractile features, such as faster relaxation kinetics under baseline and &#x003b2;-adrenergic stimulation, when compared to unedited iPSC-CMs (\u003Ca href=\"#B97\">Wheelwright et al., 2020\u003C/a>). These studies suggest that gene editing can tailor the expression and characteristics of ion channels and of other cardiac proteins to confer maturity to iPSC-CM for reliable arrhythmia modeling and regenerative medicine.\u003C/p>\u003Ca id=\"h6-6\" name=\"h6-6\">\u003C/a>\u003Ch3 class=\"pt0\">5.6 Optogenetics\u003C/h3>\u003Cp class=\"mb0\">An early study by Professor Yue and his team in 2014 demonstrated the ability to optically manipulate and map action potentials of neonatal rat ventricular cardiomyocytes (NRVM) by using excitatory/ inhibitory optogenetic actuators and all-optical system (\u003Ca href=\"#B65\">Park et al., 2014\u003C/a>). In brief, using blue light pulses (447&#x000a0;nm, 7.2&#x000a0;mW/mm\u003Csup>2\u003C/sup>, 51&#x000a0;ms), they elicited action potentials on electrically unstimulated NRVM, expressing light-gated cation channel (ChR2), and simultaneously mapped their voltage signals via optical activation (655&#x000a0;nm) of red-shifted voltage dye (PGH1). They also demonstrated that electrically stimulated action potentials in NRVM, expressing eNpHR3.0 (an improved version of light-driven chloride pump halorhodopsin), were silenced with green light pulses (1.4&#x02013;0.67&#x000a0;mW/mm\u003Csup>2\u003C/sup>, 530&#x000a0;nm) (\u003Ca href=\"#B65\">Park et al., 2014\u003C/a>). Interestingly, they also reported that electrically paced ChR2-expressing cardiomyocytes showed APD prolongation when illuminated with blue light (447&#x000a0;nm) during the repolarization phase (\u003Ca href=\"#B65\">Park et al., 2014\u003C/a>). Furthermore, Professor Spundich and his team reported that NRVM cardiomyocytes expressing anion channelrhodopsin from Guillardia theta (GtACRs), showed shortening in APDs when illuminated with green light pulses (510&#x000a0;nm) during the repolarization phase, where the extent of APD shortening was directly proportional to the light intensity (0&#x02013;230&#x000a0;&#x000b5;W/ mm\u003Csup>2\u003C/sup>) (\u003Ca href=\"#B23\">Govorunova et al., 2016\u003C/a>). Although these pioneering studies were done on NRVM, these studies clearly depict: 1) how electrophysiological characteristics of iPSC-CMs can be probed via light-activated opsins, which induces light-dependent reversible, unipolar depolarizing (via ChR2 activation) or hyperpolarizing (via GtACRs activation) currents, 2) the implications of such optogenetic tools in basic cardiac research and disease modeling (such as LQTS and SQTS), and 3) the scope of all-optical system in capturing real-time and non-invasive cellular electrophysiology.\u003C/p>\u003Cp class=\"mb0\">We recently reported optogenetic-based interrogation of action potential and calcium transients of iPSC-CM in a rapid, reversible and targeted manner (\u003Ca href=\"#B33\">Joshi et al., 2022\u003C/a>). Using CRISPR/Cas 9 genome editing tool, human iPSC-CMs were expressed with algal-derived transmembrane protein, ChR2 (iPSC-CMs-ChR2), that acts as light-gated cation channel (\u003Ca href=\"#B33\">Joshi et al., 2022\u003C/a>). Also, both control and iPSC-CMs-ChR2 were co-expressed with CCND2 and luciferin. The iPSC-CMs-ChR2 were- 1) labelled with calcium (Rhod-2 AM) or voltage-specific (RH237) dyes, 2) illuminated with blue light (460&#x000a0;nM, 1.6&#x000a0;mW/ mm\u003Csup>2\u003C/sup>), 3) and their calcium transients and membrane voltage were optically mapped using MiCAM03 N256 Single Camera System (Scimedia Ltd., United States), and 4) data was analyzed using BV Workbench (Version 2.7.2, Scimedia, United States). We found that functional characteristics of calcium repolarization and excitability of action potential in iPSC-CMs can be successfully modulated non-invasively, reversibly and instantaneously by activating light-gated ChR2 ion channel expressed in the iPSC-CMs (\u003Ca href=\"#B33\">Joshi et al., 2022\u003C/a>). In brief, blue light activation on control iPSC-CMs (not expressing ChR2) did not show any impact on the Ca\u003Csup>2&#x0002b;\u003C/sup> transient repolarization time, but the iPSC-CMs-ChR2 showed prolonged Ca\u003Csup>2&#x0002b;\u003C/sup> transient repolarization time and a delay in the initiation of new action potential with blue light (\u003Ca href=\"#F4\">Figure 4\u003C/a>). In the same study, we also demonstrated that blue light was able to interrogate, in real-time, myocardial functions, such as pressure, volume and ECG, of the infarcted SCID mice receiving iPSC-CMs-ChR2, but not in the mice receiving the control iPSC-CMs (\u003Ca href=\"#F5\">Figure 5\u003C/a>), which underscores the translational impact of optogenetics in probing the electrophysiological characteristics at both cellular and organ-level (\u003Ca href=\"#B33\">Joshi et al., 2022\u003C/a>).\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">Figure 4\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg\" name=\"Figure4\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g004.jpg\" alt=\"www.frontiersin.org\" id=\"F4\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>Figure 4\u003C/b>. Functional effect of blue light (460&#x000a0;nm) on the human iPSC-CMs-ChR2. The light activation on control iPSC-CMs (not expressing ChR2) did not show any impact on the Ca\u003Csup>2&#x0002b;\u003C/sup> transient repolarization time \u003Cb>(A)\u003C/b>, top panel. The iPSC-CMs-ChR2 showed prolonged Ca\u003Csup>2&#x0002b;\u003C/sup> transient repolarization time \u003Cb>(A)\u003C/b>, lower panel and a pause in the initiation of new action potential \u003Cb>(B)\u003C/b> when activated with blue light (\u003Ca href=\"#B33\">Joshi et al., 2022\u003C/a>).\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">Figure 5\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg\" name=\"Figure5\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g005.jpg\" alt=\"www.frontiersin.org\" id=\"F5\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>Figure 5\u003C/b>. Functional changes in the myocardial functions using Optogenetics. A schematic illustration of the Optogenetic system utilized in the study \u003Cb>(A)\u003C/b>. Left ventricular pressure (red), volume (blue), and ECG (green) were simultaneously recorded, using P-V loop, from anesthetized, open-chest SCID mice 6&#x000a0;months after infarction and intracardiac injection of control (upper panel) or iPSC-CMs-ChR2 (middle and lower panels) before, during, and after blue light illumination. Left panels show tracings from the same animals at expanded time scales (LabChart Scales 500:1 and 20:1). The blue horizontal lines indicate the duration of light pulses \u003Cb>(B)\u003C/b>. At the onset of PVC, a significant reduction in systolic ventricular pressure (P\u003Csub>max\u003C/sub>) was recorded with light activation in mice receiving ChR2 \u003Cb>(C)\u003C/b> (\u003Ca href=\"#B33\">Joshi et al., 2022\u003C/a>).\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cp class=\"mb0\">Apart from ChR2, other diverse group of transmembrane opsins, such as light-activated outwardly directed sodium pumps, yellow-light activated inwardly directed chloride pump (NpHR), calcium translocating channelrhodopsin variant (CaTCh) etc., have evolved over the past decade in cardiac research and medicine (\u003Ca href=\"#B15\">Ferenczi et al., 2019\u003C/a>; \u003Ca href=\"#B32\">Joshi et al., 2019\u003C/a>). In a recent study, Quach et al. demonstrated the scope of optogenetic-based dynamic current clamp platform to non-invasively tune the action potential of iPSC-CMs to a more mature phenotype (\u003Ca href=\"#B70\">Quach et al., 2018\u003C/a>). In brief, they introduced Archaerhodopsin TP009 (ArchT) opsin in iPSC-CMs to optically induce outward-current mimicking I\u003Csub>K1\u003C/sub>, which is otherwise insufficient in the iPSC-CMs, and showed that 1) optically clamped iPSC-CMs showed more adult-like action potential morphology, similar to those when injected with I\u003Csub>K1\u003C/sub> by traditional patch clamp, and 2) the effects of I\u003Csub>Kr\u003C/sub> inhibition on iPSC-CMs were similar, when clamped optically or via means of standard electrodes, clearly depicting the scope of non-invasive and scalable optical dynamic clamping in drug screening and disease modeling (\u003Ca href=\"#B70\">Quach et al., 2018\u003C/a>). Notably, optogenetic tools have shown the ability not only in modulating the direction and flow of specific ion channel currents, but novel optogenetic tools can also successfully control intracellular signal pathways, such as Gs signaling, Wnt signaling and TGF-&#x003b2; signaling, with spatiotemporal precision (\u003Ca href=\"#B32\">Joshi et al., 2019\u003C/a>; \u003Ca href=\"#B99\">Wu et al., 2023\u003C/a>). Thus, optogenetics offers unique capabilities in probing functional and biological characteristics of iPSC-CMs; hence, it can exert an influential role in the forefront of arrhythmia research and therapeutic medicine.\u003C/p>\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>6 The scope of iPSC-CMs beyond disease modeling\u003C/h2>\u003Ca id=\"h7-1\" name=\"h7-1\">\u003C/a>\u003Ch3 class=\"pt0\">6.1 Personalized cardiotoxicity screening\u003C/h3>\u003Cp class=\"mb0\">The overall goal of this review paper is to examine the scope and challenges of using iPSC-CMs in arrhythmia modeling from basic science research and translational perspective. However, it should not be forgotten that human/patient-derived iPSC-CMs also hold significant potential on personalized cardiotoxicity screening and regenerative medicine. A clinical study on &#x0201c;Generation of Induced Pluripotent Stem Cell Derived Cardiomyocytes From Patients Exposed to Trastuzumab Therapy for Breast Cancer&#x0201d; (study location- Memorial Sloan Kettering Cancer Center, NY) uses skin biopsy of the patients, transform them into cardiomyocytes and aims to understand cardiotoxicity mechanisms in breast cancer patients, treated with anti-cancer drugs such as- Doxorubicin and Herceptin [NCT02772367]. Another study by Professor Joseph Wu and his team have also utilized human iPSC-CMs to understand the cellular mechanisms of trastuzumab-induced cardiac dysfunction (\u003Ca href=\"#B38\">Kitani et al., 2019\u003C/a>). They utilized 1) control iPSC-CMs which were derived from Stanford Cardiovascular Institute iPSC Biobank and 2) patient-specific iPSC-CMs which were derived from PBMCs of breast cancer patients, previously treated with trastuzumab and with or without drug-induced cardiac dysfunctions. They reported that clinically relevant doses of trastuzumab significantly impacted- 1) the contractile and Ca\u003Csup>2&#x0002b;\u003C/sup> handling characteristics and 2) mitochondrial function and cardiac energy metabolism of control iPSC-CMs. Interestingly, they demonstrated that iPSC-CMs generated from patients, who experienced severe cardiac dysfunctions with trastuzumab, were more vulnerable to trastuzumab treatment than the iPSC-CMs derived from patients, who did not exhibit cardiac dysfunction with trastuzumab therapy (\u003Ca href=\"#B38\">Kitani et al., 2019\u003C/a>). These studies underscore the translational impact of patient-specific iPSC-CMs in personalized drug-induced cardiotoxicity screening.\u003C/p>\u003Ca id=\"h7-2\" name=\"h7-2\">\u003C/a>\u003Ch3 class=\"pt0\">6.2 Cardiac regenerative medicine\u003C/h3>\u003Cp class=\"mb0\">Human/-patient-specific iPSC-CMs are also being utilized globally in multiple clinical studies to improve cardiac function and tissue regeneration. In clinical studies, autologous or allogeneic, iPSC-CMs are delivered either as single cells, spheroids, sheets, or patches to treat patients with heart failures or congenital heart defects [NCT05566600, NCT04696328, NCT04945018, NCT04982081, and NCT05647213]. A recent clinical trial by Professor Shigeru Miyagawa and his team (Osaka University, Japan) aimed to confirm the safety profile of allogenic iPSC-CMs transplantation in heart failure patients (\u003Ca href=\"#B37\">Kawamura et al., 2023\u003C/a>). In their study, they transplanted iPSC-CMs-based cardiac patches on the patients having 1) ischemic cardiomyopathy, 2) left ventricular ejection fraction of 35% or less and 3) heart failure symptoms of New York Heart Association class III or greater, despite existing therapies such as revascularization. Surgically, three iPSC-CM-based circular patches (each containing 3.3&#x0002a;10\u003Csup>7\u003C/sup> cells and diameter of 3.5&#x000a0;cm) were transplanted on the left ventricular anterior and the lateral wall and fixed. The patients were given immunosuppressants for 3 months after the surgery and were observed for up to a year. In the first 3 cases of the trial, they observed 1) improvement in heart failure symptoms, 2) no transplant-related adverse outcomes, such as tumor formation, during the observation period, and 3) 2 of the 3 patients showed improvements in left ventricular contractility and myocardial blood flow, demonstrating the feasibility and safety of utilizing allogenic human iPSC-CMs for treating heart diseases (\u003Ca href=\"#B37\">Kawamura et al., 2023\u003C/a>). Since the n-values of this study is low, it is hard to draw a definitive conclusion on the therapeutic efficacy and possible concerns of immune rejections on using such allogenic transplants. Nevertheless, novel developments on hypoimmunogenic and universal iPSC lines, using CRISPR/Cas9 (\u003Ca href=\"#B104\">Zhao et al., 2020\u003C/a>), can greatly circumvent concerns of immune rejection with allogenic iPSC-CMs and help to establish off-the-shelf iPSC-CMs-based allogenic patches, which can reduce the time and cost needed to generate autologous grafts and could lower dependency on the donor organs.\u003C/p>\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>7 Summary and Future directions\u003C/h2>\u003Cp class=\"mb15\">Limited availability of human cardiac tissues necessitates the need of an accessible and scalable human-derived cell/tissue system that carries patient genetic information and expresses native cardiomyocyte-like structural and functional properties. Patient-derived iPSCs provide an inexhaustible source to obtain differentiated cells of all three germ layers in a reproducible manner. Specifically, current reprogramming and differentiation protocols have made it feasible to reliably obtain human iPSC-CMs that retain the genomic traits of the donor and exhibit the cellular and electrophysiological characteristics of the native cardiomyocytes. Thus, iPSC-CMs, derived from symptomatic or asymptomatic patients, are invaluable, accessible and scalable tools to understand the cellular and molecular mechanisms of channelopathies. Thus, in this review, we summarized several foundational and recent studies to provide in-depth knowledge on how patient-specific iPSC-CMs are utilized to model patient-specific arrhythmias that originated due to mutations on specific ion channel or dyad protein. We also highlighted recent advancements in CRISPR/Cas9 that have enabled us to establish patient-independent, variant-induced iPSC-CMs-based arrhythmia models. Next, we also examined developments on 3D models, such as iPSC-CMs-based cell sheets and patches, that capture \u003Cem>in vitro\u003C/em> electrophysiological characteristics in a more physiologically relevant manner, compared to 2D models. Notably, we also examined that such iPSC-CMs-based 3D patches have been transplanted in patients with ischemic cardiomyopathy to induce their myocardial tissue regeneration and improve myocardial functions. We further examined that a synergy of iPSC-CMs, gene editing, 3D models, all-optical, and high-throughput platform allow rapid acquisition of electrophysiological data in non-invasive and real-time manner, offering a platform to screen large number of emerging variants and investigate potential drugs/ therapies. Furthermore, we examined potential pitfalls of using iPSC-CM-based disease models that may arise due to differences in the expression level of ion channels or in their biophysical properties, highlighting the need to conduct iPSC-CM-based study and interpret the results with proper care. For example, iPSC-CMs are proarrhythmic when compared to their native counterparts; hence, such effects that arise due to the electrophysiological immaturity of iPSC-CMs should not be confused with the drug toxicity. This underscores the need to keep adequate experimental controls and isogenic controls of iPSC-CM for arrhythmia research. Importantly, we also examined that gene editing and optogenetics provide unique opportunity to tailor the functional characteristics of the ion channels or signaling components in the iPSC-CMs, allowing us to better understand the role of specific ion channel and signaling pathways in healthy or diseased conditions.\u003C/p>\u003Cp class=\"mb15\">Our studies and genome-wide association studies have shown that arrhythmias arise not only due to mutations in ion channels but also due to mutations in genes encoding cytoskeletal proteins (&#x003b2;2 spectrin), adapter proteins (Ankyrin 2), ECM, fibrosis, cardio-genesis, and cell-cell coupling. Thus, it is crucial that \u003Cem>in vitro\u003C/em> arrhythmia modeling should address the complex disease phenotype thath can partly be achieved by differentiating iPSCs into different cardiac cells, culturing them in 3D (as organoids or patches) and providing them with appropriate biomechanical and electrical stimulus. Such biomimetic 3D model would allow to comprehend the specific role of cellular or signaling components in eliciting arrhythmias. In addition, integration of such 3D culture models with high-throughput screening platform would allow rapid characterization of the variants and their targets in a physiologically relevant manner. More importantly, such high-throughput-based \u003Cem>in vitro\u003C/em> iPSC-CM arrhythmia models, in conjunction with reliable gene editing technology and all-optical technology, would provide reliable disease templates to rapidly and reliably screen large number of emerging arrhythmogenic variants and test novel therapies, while simultaneously reducing the time and cost of pre-clinical research.\u003C/p>\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Author contributions\u003C/h2>\u003Cp class=\"mb0\">JJ: Funding acquisition, Formal Analysis, Visualization, Methodology, Investigation, Data curation, Writing&#x02013;review and editing, Writing&#x02013;original draft, Conceptualization. CA: Writing&#x02013;original draft, Visualization, Formal Analysis, Data curation. NS: Writing&#x02013;original draft, Visualization, Formal Analysis, Data curation. SG: Writing&#x02013;original draft, Formal Analysis, Data curation. SS: Writing&#x02013;review and editing, Supervision, Resources, Methodology, Funding acquisition, Formal Analysis, Conceptualization.\u003C/p>\u003Ca id=\"h10\" name=\"h10\">\u003C/a>\u003Ch2>Funding\u003C/h2>\u003Cp class=\"mb0\">The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Institutes of Health T32 Postdoctoral Fellowship Award T32HL149637 (JJ), NIH R01 HL160590, Frick Fund (GF483501, SAS is Bob Frick Research Chair in Heart Failure and Arrhythmia), and DOIM Pilot Award (GR120502, SAS).\u003C/p>\u003Ca id=\"h11\" name=\"h11\">\u003C/a>\u003Ch2>Acknowledgments\u003C/h2>\u003Cp class=\"mb03\">The authors would like to thank Professors Loren E Wold, Isabelle Deschenes, Hua Zhu, and Thomas Hund for their continual support and guidance. The authors also would like to thank Bob and Corrine Frick (SAS: Bob Frick Research Chair in Heart Failure and Arrhythmia).\u003C/p>\u003Ca id=\"h12\" name=\"h12\">\u003C/a>\u003Ch2>Conflict of interest\u003C/h2>\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\u003Ca id=\"h13\" name=\"h13\">\u003C/a>\u003Ch2>Publisher&#x02019;s note\u003C/h2>\u003Cp class=\"mb15\">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C/p>\u003Ca id=\"h14\" name=\"h14\">\u003C/a>\u003Ch2>Supplementary material\u003C/h2>\u003Cp class=\"mb15\" id=\"SM1\">The Supplementary Material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fphys.2024.1475152/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fphys.2024.1475152/full&#x00023;supplementary-material\u003C/a>\u003C/p>\u003Ca id=\"h15\" name=\"h15\">\u003C/a>\u003Ch2>References\u003C/h2>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a>Abilez O. J., Tzatzalos E., Yang H., Zhao M.-T., Jung G., Z&#x000f6;llner A. M., et al. (2018). Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling. \u003Cem>Stem Cells\u003C/em> 36, 265&#x02013;277. doi:10.1002/stem.2732\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29086457/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/stem.2732\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Passive+stretch+induces+structural+and+functional+maturation+of+engineered+heart+muscle+as+predicted+by+computational+modeling&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a>Adegunsoye A., Gonzales N. M., Gilad Y. (2023). Induced pluripotent stem cells in disease biology and the evidence for their \u003Cem>in vitro\u003C/em> utility. \u003Cem>Annu. Rev. Genet.\u003C/em> 57, 341&#x02013;360. doi:10.1146/annurev-genet-022123-090319\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37708421/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1146/annurev-genet-022123-090319\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Induced+pluripotent+stem+cells+in+disease+biology+and+the+evidence+for+their+in+vitro+utility&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a>Ahmed R. E., Anzai T., Chanthra N., Uosaki H. (2020). A brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes. \u003Cem>Front. Cell Dev. Biol.\u003C/em> 8, 178. doi:10.3389/fcell.2020.00178\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32266260/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fcell.2020.00178\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+brief+review+of+current+maturation+methods+for+human+induced+pluripotent+stem+cells-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a>Baines O., Sha R., Kalla M., Holmes A. P., Efimov I. R., Pavlovic D., et al. (2024). Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review. \u003Cem>Europace\u003C/em> 26, euae017. doi:10.1093/europace/euae017\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38227822/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1093/europace/euae017\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optical+mapping+and+optogenetics+in+cardiac+electrophysiology+research+and+therapy:+a+state-of-the-art+review&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a>Barbuti A., Benzoni P., Campostrini G., Dell&#x02019;Era P. (2016). Human derived cardiomyocytes: a decade of knowledge after the discovery of induced pluripotent stem cells. \u003Cem>Dev. Dyn.\u003C/em> 245, 1145&#x02013;1158. doi:10.1002/dvdy.24455\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27599668/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/dvdy.24455\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+derived+cardiomyocytes:+a+decade+of+knowledge+after+the+discovery+of+induced+pluripotent+stem+cells&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a>Bezzina C., Veldkamp M. W., van Den Berg M. P., Postma A. V., Rook M. B., Viersma J. W., et al. (1999). A single Na(&#x0002b;) channel mutation causing both long-QT and Brugada syndromes. \u003Cem>Circ. Res.\u003C/em> 85, 1206&#x02013;1213. doi:10.1161/01.res.85.12.1206\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/10590249/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/01.res.85.12.1206\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+single+Na(+)+channel+mutation+causing+both+long-QT+and+Brugada+syndromes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a>Burnett S. D., Blanchette A. D., Chiu W. A., Rusyn I. (2021). Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an \u003Cem>in vitro\u003C/em> model in toxicology: strengths and weaknesses for hazard identification and risk characterization. \u003Cem>Expert Opin. Drug Metab. Toxicol.\u003C/em> 17, 887&#x02013;902. doi:10.1080/17425255.2021.1894122\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33612039/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1080/17425255.2021.1894122\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+induced+pluripotent+stem+cell+(iPSC)-derived+cardiomyocytes+as+an+in+vitro+model+in+toxicology:+strengths+and+weaknesses+for+hazard+identification+and+risk+characterization&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a>Chavali N. V., Kryshtal D. O., Parikh S. S., Wang L., Glazer A. M., Blackwell D. J., et al. (2019). Patient-independent human induced pluripotent stem cell model: a new tool for rapid determination of genetic variant pathogenicity in long QT syndrome. \u003Cem>Heart rhythm.\u003C/em> 16, 1686&#x02013;1695. doi:10.1016/j.hrthm.2019.04.031\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31004778/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.hrthm.2019.04.031\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-independent+human+induced+pluripotent+stem+cell+model:+a+new+tool+for+rapid+determination+of+genetic+variant+pathogenicity+in+long+QT+syndrome&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a>Cheng M., Yang F., Liu J., Yang D., Zhang S., Yu Y., et al. (2021). Tyrosine Kinase inhibitors-induced arrhythmias: from molecular mechanisms, pharmacokinetics to therapeutic strategies. \u003Cem>Front. Cardiovasc Med.\u003C/em> 8, 758010. doi:10.3389/fcvm.2021.758010\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34869670/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fcvm.2021.758010\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Tyrosine+Kinase+inhibitors-induced+arrhythmias:+from+molecular+mechanisms,+pharmacokinetics+to+therapeutic+strategies&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a>Chockalingam P., Wilde A. (2012). The multifaceted cardiac sodium channel and its clinical implications. \u003Cem>Heart\u003C/em> 98, 1318&#x02013;1324. doi:10.1136/heartjnl-2012-301784\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22875823/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1136/heartjnl-2012-301784\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+multifaceted+cardiac+sodium+channel+and+its+clinical+implications&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a>Davis R. P., van den Berg C. W., Casini S., Braam S. R., Mummery C. L. (2011). Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. \u003Cem>Trends Mol. Med.\u003C/em> 17, 475&#x02013;484. doi:10.1016/j.molmed.2011.05.001\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21703926/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.molmed.2011.05.001\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Pluripotent+stem+cell+models+of+cardiac+disease+and+their+implication+for+drug+discovery+and+development&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a>Derbala M. H., Guo A. S., Mohler P. J., Smith S. A. (2018). The role of &#x003b2;II spectrin in cardiac health and disease. \u003Cem>Life Sci.\u003C/em> 192, 278&#x02013;285. doi:10.1016/j.lfs.2017.11.009\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29128512/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.lfs.2017.11.009\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+role+of+II+spectrin+in+cardiac+health+and+disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a>El Refaey M. M., Mohler P. J. (2017). Ankyrins and spectrins in cardiovascular biology and disease. \u003Cem>Front. Physiol.\u003C/em> 8, 852. doi:10.3389/fphys.2017.00852\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29163198/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fphys.2017.00852\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Ankyrins+and+spectrins+in+cardiovascular+biology+and+disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a>Fatima A., Xu G., Shao K., Papadopoulos S., Lehmann M., Arn&#x000e1;iz-Cot J. J., et al. (2011). \u003Cem>In vitro\u003C/em> modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. \u003Cem>Cell Physiol. Biochem.\u003C/em> 28, 579&#x02013;592. doi:10.1159/000335753\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22178870/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1159/000335753\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=In+vitro+modeling+of+ryanodine+receptor+2+dysfunction+using+human+induced+pluripotent+stem+cells&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a>Ferenczi E. A., Tan X., Huang C. L.-H. (2019). Principles of optogenetic methods and their application to cardiac experimental systems. \u003Cem>Front. Physiol.\u003C/em> 10, 1096. doi:10.3389/fphys.2019.01096\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31572204/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fphys.2019.01096\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Principles+of+optogenetic+methods+and+their+application+to+cardiac+experimental+systems&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a>Fern&#x000e1;ndez-Falgueras A., Sarquella-Brugada G., Brugada J., Brugada R., Campuzano O. (2017). Cardiac channelopathies and sudden death: recent clinical and genetic advances. \u003Cem>Biol. (Basel)\u003C/em> 6, 7. doi:10.3390/biology6010007\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.3390/biology6010007\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Cardiac+channelopathies+and+sudden+death:+recent+clinical+and+genetic+advances&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a>Ferrero-Miliani L., Holst A. G., Pehrson S., Morling N., Bundgaard H. (2010). Strategy for clinical evaluation and screening of sudden cardiac death relatives. \u003Cem>Fundam. Clin. Pharmacol.\u003C/em> 24, 619&#x02013;635. doi:10.1111/j.1472-8206.2010.00864.x\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20698891/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1111/j.1472-8206.2010.00864.x\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Strategy+for+clinical+evaluation+and+screening+of+sudden+cardiac+death+relatives&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a>Garg P., Garg V., Shrestha R., Sanguinetti M. C., Kamp T. J., Wu J. C. (2018a). Human induced pluripotent stem cell-derived cardiomyocytes as models for cardiac channelopathies: a primer for non-electrophysiologists. \u003Cem>Circ. Res.\u003C/em> 123, 224&#x02013;243. doi:10.1161/CIRCRESAHA.118.311209\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29976690/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCRESAHA.118.311209\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+induced+pluripotent+stem+cell-derived+cardiomyocytes+as+models+for+cardiac+channelopathies:+a+primer+for+non-electrophysiologists&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a>Garg P., Oikonomopoulos A., Chen H., Li Y., Lam C. K., Sallam K., et al. (2018b). Genome editing of induced pluripotent stem cells to decipher cardiac channelopathy variant. \u003Cem>J. Am. Coll. Cardiol.\u003C/em> 72, 62&#x02013;75. doi:10.1016/j.jacc.2018.04.041\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29957233/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.jacc.2018.04.041\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genome+editing+of+induced+pluripotent+stem+cells+to+decipher+cardiac+channelopathy+variant&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a>Giudicessi J. R., Ackerman M. J. (2013). Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. \u003Cem>Transl. Res.\u003C/em> 161, 1&#x02013;14. doi:10.1016/j.trsl.2012.08.005\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22995932/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.trsl.2012.08.005\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Determinants+of+incomplete+penetrance+and+variable+expressivity+in+heritable+cardiac+arrhythmia+syndromes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a>Goldfracht I., Efraim Y., Shinnawi R., Kovalev E., Huber I., Gepstein A., et al. (2019). Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications. \u003Cem>Acta Biomater.\u003C/em> 92, 145&#x02013;159. doi:10.1016/j.actbio.2019.05.016\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31075518/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.actbio.2019.05.016\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Engineered+heart+tissue+models+from+hiPSC-derived+cardiomyocytes+and+cardiac+ECM+for+disease+modeling+and+drug+testing+applications&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a>Goodrow R. J., Desai S., Treat J. A., Panama B. K., Desai M., Nesterenko V. V., et al. (2018). Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes. \u003Cem>J. Pharmacol. Toxicol. Methods\u003C/em> 90, 19&#x02013;30. doi:10.1016/j.vascn.2017.11.001\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29128504/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.vascn.2017.11.001\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Biophysical+comparison+of+sodium+currents+in+native+cardiac+myocytes+and+human+induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a>Govorunova E. G., Cunha S. R., Sineshchekov O. A., Spudich J. L. (2016). Anion channelrhodopsins for inhibitory cardiac optogenetics. \u003Cem>Sci. Rep.\u003C/em> 6, 33530. doi:10.1038/srep33530\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27628215/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/srep33530\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Anion+channelrhodopsins+for+inhibitory+cardiac+optogenetics&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a>Graham G. (2015). Disparities in cardiovascular disease risk in the United States. \u003Cem>Curr. Cardiol. Rev.\u003C/em> 11, 238&#x02013;245. doi:10.2174/1573403x11666141122220003\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25418513/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.2174/1573403x11666141122220003\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Disparities+in+cardiovascular+disease+risk+in+the+United+States&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a>Guerrier K., Kwiatkowski D., Czosek R. J., Spar D. S., Anderson J. B., Knilans T. K. (2015). Short QT interval prevalence and clinical outcomes in a pediatric population. \u003Cem>Circ. Arrhythm. Electrophysiol.\u003C/em> 8, 1460&#x02013;1464. doi:10.1161/CIRCEP.115.003256\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26386018/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCEP.115.003256\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Short+QT+interval+prevalence+and+clinical+outcomes+in+a+pediatric+population&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a>Haapaniemi E., Botla S., Persson J., Schmierer B., Taipale J. (2018). CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. \u003Cem>Nat. Med.\u003C/em> 24, 927&#x02013;930. doi:10.1038/s41591-018-0049-z\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29892067/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41591-018-0049-z\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=CRISPR-Cas9+genome+editing+induces+a+p53-mediated+DNA+damage+response&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a>Han J. L., Entcheva E. (2023). Gene modulation with CRISPR-based tools in human iPSC-cardiomyocytes. \u003Cem>Stem Cell Rev. Rep.\u003C/em> 19, 886&#x02013;905. doi:10.1007/s12015-023-10506-4\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36656467/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s12015-023-10506-4\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Gene+modulation+with+CRISPR-based+tools+in+human+iPSC-cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a>Heinson Y. W., Han J. L., Entcheva E. (2023). OptoDyCE-plate as an affordable high throughput imager for all optical cardiac electrophysiology. \u003Cem>bioRxiv\u003C/em> 29 (08). doi:10.1101/2023.08.29.555447\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1101/2023.08.29.555447\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=OptoDyCE-plate+as+an+affordable+high+throughput+imager+for+all+optical+cardiac+electrophysiology&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a>Huang J., Feng Q., Wang L., Zhou B. (2021). Human pluripotent stem cell-derived cardiac cells: application in disease modeling, cell therapy, and drug discovery. \u003Cem>Front. Cell Dev. Biol.\u003C/em> 9, 655161. doi:10.3389/fcell.2021.655161\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33869218/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fcell.2021.655161\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+pluripotent+stem+cell-derived+cardiac+cells:+application+in+disease+modeling,+cell+therapy,+and+drug+discovery&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a>Hylind R. J., Chandler S. F., Skinner J. R., Abrams D. J. (2018). Genetic testing for inherited cardiac arrhythmias: current state-of-the-art and future avenues. \u003Cem>J. Innov. Card. Rhythm Manag.\u003C/em> 9, 3406&#x02013;3416. doi:10.19102/icrm.2018.091102\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32494476/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.19102/icrm.2018.091102\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genetic+testing+for+inherited+cardiac+arrhythmias:+current+state-of-the-art+and+future+avenues&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a>Jim&#x000e9;nez-J&#x000e1;imez J., Peinado R., Grima E. Z., Segura F., Mori&#x000f1;a P., S&#x000e1;nchez Mu&#x000f1;oz J. J., et al. (2015). Diagnostic approach to unexplained cardiac arrest (from the FIVI-gen study). \u003Cem>Am. J. Cardiol.\u003C/em> 116, 894&#x02013;899. doi:10.1016/j.amjcard.2015.06.030\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26189708/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.amjcard.2015.06.030\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Diagnostic+approach+to+unexplained+cardiac+arrest+(from+the+FIVI-gen+study)&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B32\" id=\"B32\">\u003C/a>Joshi J., Rubart M., Zhu W. (2019). Optogenetics: background, methodological advances and potential applications for cardiovascular research and medicine. \u003Cem>Front. Bioeng. Biotechnol.\u003C/em> 7, 466. doi:10.3389/fbioe.2019.00466\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32064254/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fbioe.2019.00466\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optogenetics:+background,+methodological+advances+and+potential+applications+for+cardiovascular+research+and+medicine&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B33\" id=\"B33\">\u003C/a>Joshi J., Xu B., Rubart M., Chang Y., Bao X., Chaliki H. P., et al. (2022). Optogenetic control of engrafted human induced pluripotent stem cell-derived cardiomyocytes in live mice: a proof-of-concept study. \u003Cem>Cells\u003C/em> 11, 951. doi:10.3390/cells11060951\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35326403/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/cells11060951\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optogenetic+control+of+engrafted+human+induced+pluripotent+stem+cell-derived+cardiomyocytes+in+live+mice:+a+proof-of-concept+study&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B34\" id=\"B34\">\u003C/a>Joukar S. (2021). A comparative review on heart ion channels, action potentials and electrocardiogram in rodents and human: extrapolation of experimental insights to clinic. \u003Cem>Lab. Anim. Res.\u003C/em> 37, 25. doi:10.1186/s42826-021-00102-3\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34496976/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1186/s42826-021-00102-3\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+comparative+review+on+heart+ion+channels,+action+potentials+and+electrocardiogram+in+rodents+and+human:+extrapolation+of+experimental+insights+to+clinic&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B35\" id=\"B35\">\u003C/a>Kamakura T., Makiyama T., Sasaki K., Yoshida Y., Wuriyanghai Y., Chen J., et al. (2013). Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. \u003Cem>Circ. J.\u003C/em> 77, 1307&#x02013;1314. doi:10.1253/circj.cj-12-0987\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23400258/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1253/circj.cj-12-0987\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Ultrastructural+maturation+of+human-induced+pluripotent+stem+cell-derived+cardiomyocytes+in+a+long-term+culture&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B36\" id=\"B36\">\u003C/a>Kawaguchi N., Nakanishi T. (2023). Animal disease models and patient-iPS-cell-derived \u003Cem>in vitro\u003C/em> disease models for cardiovascular biology-how close to disease? \u003Cem>Biol. (Basel)\u003C/em> 12, 468. doi:10.3390/biology12030468\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.3390/biology12030468\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Animal+disease+models+and+patient-iPS-cell-derived+in+vitro+disease+models+for+cardiovascular+biology-how+close+to+disease?&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B37\" id=\"B37\">\u003C/a>Kawamura T., Ito Y., Ito E., Takeda M., Mikami T., Taguchi T., et al. (2023). Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports. \u003Cem>Front. Cardiovasc Med.\u003C/em> 10, 1182209. doi:10.3389/fcvm.2023.1182209\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37781295/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fcvm.2023.1182209\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Safety+confirmation+of+induced+pluripotent+stem+cell-derived+cardiomyocyte+patch+transplantation+for+ischemic+cardiomyopathy:+first+three+case+reports&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B38\" id=\"B38\">\u003C/a>Kitani T., Ong S.-G., Lam C. K., Rhee J.-W., Zhang J. Z., Oikonomopoulos A., et al. (2019). Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer. \u003Cem>Circulation\u003C/em> 139, 2451&#x02013;2465. doi:10.1161/CIRCULATIONAHA.118.037357\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30866650/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCULATIONAHA.118.037357\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human-induced+pluripotent+stem+cell+model+of+trastuzumab-induced+cardiac+dysfunction+in+patients+with+breast+cancer&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B39\" id=\"B39\">\u003C/a>Klimas A., Ambrosi C. M., Yu J., Williams J. C., Bien H., Entcheva E. (2016). OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology. \u003Cem>Nat. Commun.\u003C/em> 7, 11542. doi:10.1038/ncomms11542\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27161419/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/ncomms11542\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=OptoDyCE+as+an+automated+system+for+high-throughput+all-optical+dynamic+cardiac+electrophysiology&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B40\" id=\"B40\">\u003C/a>Kowalski W. J., Garcia-Pak I. H., Li W., Uosaki H., Tampakakis E., Zou J., et al. (2022). Sympathetic neurons regulate cardiomyocyte maturation in culture. \u003Cem>Front. Cell Dev. Biol.\u003C/em> 10, 850645. doi:10.3389/fcell.2022.850645\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35359438/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fcell.2022.850645\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Sympathetic+neurons+regulate+cardiomyocyte+maturation+in+culture&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B41\" id=\"B41\">\u003C/a>Lahrouchi N., Raju H., Lodder E. M., Papatheodorou E., Ware J. S., Papadakis M., et al. (2017). Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome. \u003Cem>J. Am. Coll. Cardiol.\u003C/em> 69, 2134&#x02013;2145. doi:10.1016/j.jacc.2017.02.046\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28449774/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.jacc.2017.02.046\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Utility+of+post-mortem+genetic+testing+in+cases+of+sudden+arrhythmic+death+syndrome&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B42\" id=\"B42\">\u003C/a>Leonard A., Bertero A., Powers J. D., Beussman K. M., Bhandari S., Regnier M., et al. (2018). Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues. \u003Cem>J. Mol. Cell Cardiol.\u003C/em> 118, 147&#x02013;158. doi:10.1016/j.yjmcc.2018.03.016\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29604261/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.yjmcc.2018.03.016\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Afterload+promotes+maturation+of+human+induced+pluripotent+stem+cell+derived+cardiomyocytes+in+engineered+heart+tissues&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B107\" id=\"B107\">\u003C/a>Li M., Iismaa S. E., Naqvi N., Nicks A., Husain A., Graham R. M. (2014). Thyroid hormone action in postnatal heart development. \u003Cem>Stem Cell Res.\u003C/em> 13 (3 Pt B), 582&#x02013;591. doi:10.1016/j.scr.2014.07.001\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25087894/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.scr.2014.07.001\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Thyroid+hormone+action+in+postnatal+heart+development&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B43\" id=\"B43\">\u003C/a>Liang P., Sallam K., Wu H., Li Y., Itzhaki I., Garg P., et al. (2016). Patient-specific and genome-edited induced pluripotent stem cell-derived cardiomyocytes elucidate single-cell phenotype of Brugada syndrome. \u003Cem>J. Am. Coll. Cardiol.\u003C/em> 68, 2086&#x02013;2096. doi:10.1016/j.jacc.2016.07.779\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27810048/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.jacc.2016.07.779\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-specific+and+genome-edited+induced+pluripotent+stem+cell-derived+cardiomyocytes+elucidate+single-cell+phenotype+of+Brugada+syndrome&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B44\" id=\"B44\">\u003C/a>Lippi M., Stadiotti I., Pompilio G., Sommariva E. (2020). Human cell modeling for cardiovascular diseases. \u003Cem>Int. J. Mol. Sci.\u003C/em> 21, 6388. doi:10.3390/ijms21176388\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32887493/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/ijms21176388\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Human+cell+modeling+for+cardiovascular+diseases&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B45\" id=\"B45\">\u003C/a>Liu G., David B. T., Trawczynski M., Fessler R. G. (2020). Advances in pluripotent stem cells: history, mechanisms, technologies, and applications. \u003Cem>Stem Cell Rev. Rep.\u003C/em> 16, 3&#x02013;32. doi:10.1007/s12015-019-09935-x\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31760627/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s12015-019-09935-x\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Advances+in+pluripotent+stem+cells:+history,+mechanisms,+technologies,+and+applications&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B46\" id=\"B46\">\u003C/a>Lozano-Velasco E., Franco D., Aranega A., Daimi H. (2020). Genetics and epigenetics of atrial fibrillation. \u003Cem>Int. J. Mol. Sci.\u003C/em> 21, 5717. doi:10.3390/ijms21165717\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32784971/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/ijms21165717\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genetics+and+epigenetics+of+atrial+fibrillation&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B47\" id=\"B47\">\u003C/a>Lu F., Pu W. T. (2020). The architecture and function of cardiac dyads. \u003Cem>Biophys. Rev.\u003C/em> 12, 1007&#x02013;1017. doi:10.1007/s12551-020-00729-x\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32661902/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s12551-020-00729-x\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+architecture+and+function+of+cardiac+dyads&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B48\" id=\"B48\">\u003C/a>Lundy S. D., Zhu W.-Z., Regnier M., Laflamme M. A. (2013). Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. \u003Cem>Stem Cells Dev.\u003C/em> 22, 1991&#x02013;2002. doi:10.1089/scd.2012.0490\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23461462/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1089/scd.2012.0490\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Structural+and+functional+maturation+of+cardiomyocytes+derived+from+human+pluripotent+stem+cells&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B49\" id=\"B49\">\u003C/a>Ma R., Liang J., Huang W., Guo L., Cai W., Wang L., et al. (2018). Electrical stimulation enhances cardiac differentiation of human induced pluripotent stem cells for myocardial infarction therapy. \u003Cem>Antioxid. Redox Signal\u003C/em> 28, 371&#x02013;384. doi:10.1089/ars.2016.6766\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27903111/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1089/ars.2016.6766\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Electrical+stimulation+enhances+cardiac+differentiation+of+human+induced+pluripotent+stem+cells+for+myocardial+infarction+therapy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B50\" id=\"B50\">\u003C/a>Manfra O., Frisk M., Louch W. E. (2017). Regulation of cardiomyocyte T-tubular structure: opportunities for therapy. \u003Cem>Curr. Heart Fail Rep.\u003C/em> 14, 167&#x02013;178. doi:10.1007/s11897-017-0329-9\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28447290/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s11897-017-0329-9\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Regulation+of+cardiomyocyte+T-tubular+structure:+opportunities+for+therapy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B51\" id=\"B51\">\u003C/a>Mariani M. V., Pierucci N., Fanisio F., Laviola D., Silvetti G., Piro A., et al. (2024). Inherited arrhythmias in the pediatric population: an updated overview. \u003Cem>Med. Kaunas.\u003C/em> 60, 94. doi:10.3390/medicina60010094\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.3390/medicina60010094\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Inherited+arrhythmias+in+the+pediatric+population:+an+updated+overview&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B52\" id=\"B52\">\u003C/a>Matsa E., Rajamohan D., Dick E., Young L., Mellor I., Staniforth A., et al. (2011). Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. \u003Cem>Eur. Heart J.\u003C/em> 32, 952&#x02013;962. doi:10.1093/eurheartj/ehr073\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21367833/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1093/eurheartj/ehr073\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Drug+evaluation+in+cardiomyocytes+derived+from+human+induced+pluripotent+stem+cells+carrying+a+long+QT+syndrome+type+2+mutation&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B53\" id=\"B53\">\u003C/a>Maurissen T. L., Kawatou M., L&#x000f3;pez-D&#x000e1;vila V., Minatoya K., Yamashita J. K., Woltjen K. (2024). Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues. \u003Cem>Sci. Rep.\u003C/em> 14, 2586. doi:10.1038/s41598-024-52871-1\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38297132/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41598-024-52871-1\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modeling+mutation-specific+arrhythmogenic+phenotypes+in+isogenic+human+iPSC-derived+cardiac+tissues&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B54\" id=\"B54\">\u003C/a>Meijer van Putten R. M. E., Mengarelli I., Guan K., Zegers J. G., van Ginneken A. C. G., Verkerk A. O., et al. (2015). Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual Ik1. \u003Cem>Front. Physiol.\u003C/em> 6, 7. doi:10.3389/fphys.2015.00007\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25691870/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fphys.2015.00007\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Ion+channelopathies+in+human+induced+pluripotent+stem+cell+derived+cardiomyocytes:+a+dynamic+clamp+study+with+virtual+Ik1&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B55\" id=\"B55\">\u003C/a>Micheu M. M., Rosca A.-M. (2021). Patient-specific induced pluripotent stem cells as &#x0201c;disease-in-a-dish&#x0201d; models for inherited cardiomyopathies and channelopathies - 15 years of research. \u003Cem>World J. Stem Cells\u003C/em> 13, 281&#x02013;303. doi:10.4252/wjsc.v13.i4.281\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33959219/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.4252/wjsc.v13.i4.281\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-specific+induced+pluripotent+stem+cells+as+disease-in-a-dish+models+for+inherited+cardiomyopathies+and+channelopathies+-+15+years+of+research&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B56\" id=\"B56\">\u003C/a>Moretti A., Bellin M., Welling A., Jung C. B., Lam J. T., Bott-Fl&#x000fc;gel L., et al. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. \u003Cem>N. Engl. J. Med.\u003C/em> 363, 1397&#x02013;1409. doi:10.1056/NEJMoa0908679\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20660394/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1056/NEJMoa0908679\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-specific+induced+pluripotent+stem-cell+models+for+long-QT+syndrome&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B57\" id=\"B57\">\u003C/a>Musa H., Murphy N. P., Curran J., Higgins J. D., Webb T. R., Makara M. A., et al. (2016). Common human ANK2 variant confers \u003Cem>in vivo\u003C/em> arrhythmia phenotypes. \u003Cem>Heart rhythm.\u003C/em> 13, 1932&#x02013;1940. doi:10.1016/j.hrthm.2016.06.012\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27298202/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.hrthm.2016.06.012\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Common+human+ANK2+variant+confers+in+vivo+arrhythmia+phenotypes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B58\" id=\"B58\">\u003C/a>Napolitano C., Bloise R., Monteforte N., Priori S. G. (2012). Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. \u003Cem>Circulation\u003C/em> 125, 2027&#x02013;2034. doi:10.1161/CIRCULATIONAHA.111.055947\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22529064/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCULATIONAHA.111.055947\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Sudden+cardiac+death+and+genetic+ion+channelopathies:+long+QT,+Brugada,+short+QT,+catecholaminergic+polymorphic+ventricular+tachycardia,+and+idiopathic+ventricular+fibrillation&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B59\" id=\"B59\">\u003C/a>Nath S. C., Menendez L., Friedrich Ben-Nun I. (2023). Overcoming the variability of iPSCs in the manufacturing of cell-based therapies. \u003Cem>Int. J. Mol. Sci.\u003C/em> 24, 16929. doi:10.3390/ijms242316929\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38069252/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/ijms242316929\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Overcoming+the+variability+of+iPSCs+in+the+manufacturing+of+cell-based+therapies&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B60\" id=\"B60\">\u003C/a>Nijak A., Saenen J., Labro A. J., Schepers D., Loeys B. L., Alaerts M. (2021). iPSC-cardiomyocyte models of Brugada syndrome-achievements, challenges and future perspectives. \u003Cem>Int. J. Mol. Sci.\u003C/em> 22, 2825. doi:10.3390/ijms22062825\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33802229/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/ijms22062825\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=iPSC-cardiomyocyte+models+of+Brugada+syndrome-achievements,+challenges+and+future+perspectives&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B61\" id=\"B61\">\u003C/a>Ntusi N. A. B., Sliwa K. (2021). Impact of racial and ethnic disparities on patients with dilated cardiomyopathy: JACC focus seminar 7/9. \u003Cem>J. Am. Coll. Cardiol.\u003C/em> 78, 2580&#x02013;2588. doi:10.1016/j.jacc.2021.10.021\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34887144/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.jacc.2021.10.021\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Impact+of+racial+and+ethnic+disparities+on+patients+with+dilated+cardiomyopathy:+JACC+focus+seminar+7/9&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B62\" id=\"B62\">\u003C/a>Ozturk N., Uslu S., Ozdemir S. (2021). Diabetes-induced changes in cardiac voltage-gated ion channels. \u003Cem>World J. Diabetes\u003C/em> 12, 1&#x02013;18. doi:10.4239/wjd.v12.i1.1\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33520105/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.4239/wjd.v12.i1.1\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Diabetes-induced+changes+in+cardiac+voltage-gated+ion+channels&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B63\" id=\"B63\">\u003C/a>Paci M., Penttinen K., Pekkanen-Mattila M., Koivum&#x000e4;ki J. T. (2020). Arrhythmia mechanisms in human induced pluripotent stem cell-derived cardiomyocytes. \u003Cem>J. Cardiovasc Pharmacol.\u003C/em> 77, 300&#x02013;316. doi:10.1097/FJC.0000000000000972\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33323698/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1097/FJC.0000000000000972\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Arrhythmia+mechanisms+in+human+induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B64\" id=\"B64\">\u003C/a>Parikh S. S., Blackwell D. J., Gomez-Hurtado N., Frisk M., Wang L., Kim K., et al. (2017). Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes. \u003Cem>Circ. Res.\u003C/em> 121, 1323&#x02013;1330. doi:10.1161/CIRCRESAHA.117.311920\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28974554/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCRESAHA.117.311920\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Thyroid+and+glucocorticoid+hormones+promote+functional+T-tubule+development+in+human-induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B65\" id=\"B65\">\u003C/a>Park S. A., Lee S.-R., Tung L., Yue D. T. (2014). Optical mapping of optogenetically shaped cardiac action potentials. \u003Cem>Sci. Rep.\u003C/em> 4, 6125. doi:10.1038/srep06125\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25135113/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/srep06125\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optical+mapping+of+optogenetically+shaped+cardiac+action+potentials&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B66\" id=\"B66\">\u003C/a>Park S.-J., Zhang D., Qi Y., Li Y., Lee K. Y., Bezzerides V. J., et al. (2019). Insights into the pathogenesis of catecholaminergic polymorphic ventricular tachycardia from engineered human heart tissue. \u003Cem>Circulation\u003C/em> 140, 390&#x02013;404. doi:10.1161/CIRCULATIONAHA.119.039711\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31311300/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCULATIONAHA.119.039711\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Insights+into+the+pathogenesis+of+catecholaminergic+polymorphic+ventricular+tachycardia+from+engineered+human+heart+tissue&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B67\" id=\"B67\">\u003C/a>Peters N. S., Severs N. J., Rothery S. M., Lincoln C., Yacoub M. H., Green C. R. (1994). Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. \u003Cem>Circulation\u003C/em> 90, 713&#x02013;725. doi:10.1161/01.cir.90.2.713\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/8044940/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/01.cir.90.2.713\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Spatiotemporal+relation+between+gap+junctions+and+fascia+adherens+junctions+during+postnatal+development+of+human+ventricular+myocardium&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B68\" id=\"B68\">\u003C/a>Pierre M., Djemai M., Poulin H., Chahine M. (2021). NaV1.5 knockout in iPSCs: a novel approach to study NaV1.5 variants in a human cardiomyocyte environment. \u003Cem>Sci. Rep.\u003C/em> 11, 17168. doi:10.1038/s41598-021-96474-6\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34433864/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41598-021-96474-6\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=NaV1.5+knockout+in+iPSCs:+a+novel+approach+to+study+NaV1.5+variants+in+a+human+cardiomyocyte+environment&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B69\" id=\"B69\">\u003C/a>Pourrier M., Fedida D. (2020). The emergence of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as a platform to model arrhythmogenic diseases. \u003Cem>Int. J. Mol. Sci.\u003C/em> 21, 657. doi:10.3390/ijms21020657\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31963859/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/ijms21020657\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+emergence+of+human+induced+pluripotent+stem+cell-derived+cardiomyocytes+(hiPSC-CMs)+as+a+platform+to+model+arrhythmogenic+diseases&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B70\" id=\"B70\">\u003C/a>Quach B., Krogh-Madsen T., Entcheva E., Christini D. J. (2018). Light-activated dynamic clamp using iPSC-derived cardiomyocytes. \u003Cem>Biophys. J.\u003C/em> 115, 2206&#x02013;2217. doi:10.1016/j.bpj.2018.10.018\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30447994/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.bpj.2018.10.018\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Light-activated+dynamic+clamp+using+iPSC-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B71\" id=\"B71\">\u003C/a>Richards D. J., Tan Y., Coyle R., Li Y., Xu R., Yeung N., et al. (2016). Nanowires and electrical stimulation synergistically improve functions of hiPSC cardiac spheroids. \u003Cem>Nano Lett.\u003C/em> 16, 4670&#x02013;4678. doi:10.1021/acs.nanolett.6b02093\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27328393/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1021/acs.nanolett.6b02093\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Nanowires+and+electrical+stimulation+synergistically+improve+functions+of+hiPSC+cardiac+spheroids&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B108\" id=\"B108\">\u003C/a>Rog-Zielinska E. A., Craig M. A., Manning J. R., Richardson R. V., Gowans G. J., Dunbar D. R., et al. (2015). Glucocorticoids promote structural and functional maturation of foetal cardiomyocytes: a role for PGC-1&#x003b1;. \u003Cem>Cell Death Differ.\u003C/em> 22 (7), 1106&#x02013;1116. doi:10.1038/cdd.2014.181\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25361084/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/cdd.2014.181\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Glucocorticoids+promote+structural+and+functional+maturation+of+foetal+cardiomyocytes:+a+role+for+PGC-1&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B72\" id=\"B72\">\u003C/a>Romito A., Cobellis G. (2016). Pluripotent stem cells: current understanding and future directions. \u003Cem>Stem Cells Int.\u003C/em> 2016, 9451492. doi:10.1155/2016/9451492\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26798367/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1155/2016/9451492\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Pluripotent+stem+cells:+current+understanding+and+future+directions&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B73\" id=\"B73\">\u003C/a>Scoote M., Poole-Wilson P. A., Williams A. J. (2003). The therapeutic potential of new insights into myocardial excitation-contraction coupling. \u003Cem>Heart\u003C/em> 89, 371&#x02013;376. doi:10.1136/heart.89.4.371\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12639859/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1136/heart.89.4.371\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+therapeutic+potential+of+new+insights+into+myocardial+excitation-contraction+coupling&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B106\" id=\"B106\">\u003C/a>Scuderi G. J., Butcher J. (2017). Naturally engineered maturation of cardiomyocytes. \u003Cem>Front. Cell. Dev. Biol.\u003C/em>, 5&#x02013;50. doi:10.3389/fcell.2017.00050\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.3389/fcell.2017.00050\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Naturally+engineered+maturation+of+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B74\" id=\"B74\">\u003C/a>Seibertz F., Sutanto H., D&#x000fc;lk R., Pronto J. R. D., Springer R., Rapedius M., et al. (2023). Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes. \u003Cem>Basic Res. Cardiol.\u003C/em> 118, 14. doi:10.1007/s00395-022-00973-0\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37020075/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s00395-022-00973-0\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Electrophysiological+and+calcium-handling+development+during+long-term+culture+of+human-induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B75\" id=\"B75\">\u003C/a>Selga E., Sendfeld F., Martinez-Moreno R., Medine C. N., Tura-Ceide O., Wilmut S. I., et al. (2018). Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient. \u003Cem>J. Mol. Cell Cardiol.\u003C/em> 114, 10&#x02013;19. doi:10.1016/j.yjmcc.2017.10.002\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29024690/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.yjmcc.2017.10.002\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Sodium+channel+current+loss+of+function+in+induced+pluripotent+stem+cell-derived+cardiomyocytes+from+a+Brugada+syndrome+patient&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B76\" id=\"B76\">\u003C/a>Shafaattalab S., Li A. Y., Gunawan M. G., Kim B., Jayousi F., Maaref Y., et al. (2021). Mechanisms of arrhythmogenicity of hypertrophic cardiomyopathy-associated troponin T (TNNT2) variant I79N. \u003Cem>Front. Cell Dev. Biol.\u003C/em> 9, 787581. doi:10.3389/fcell.2021.787581\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34977031/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fcell.2021.787581\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Mechanisms+of+arrhythmogenicity+of+hypertrophic+cardiomyopathy-associated+troponin+T+(TNNT2)+variant+I79N&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B77\" id=\"B77\">\u003C/a>Shinnawi R., Shaheen N., Huber I., Shiti A., Arbel G., Gepstein A., et al. (2019). Modeling reentry in the short QT syndrome with human-induced pluripotent stem cell-derived cardiac cell sheets. \u003Cem>J. Am. Coll. Cardiol.\u003C/em> 73, 2310&#x02013;2324. doi:10.1016/j.jacc.2019.02.055\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31072576/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.jacc.2019.02.055\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modeling+reentry+in+the+short+QT+syndrome+with+human-induced+pluripotent+stem+cell-derived+cardiac+cell+sheets&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B78\" id=\"B78\">\u003C/a>Shiti A., Arbil G., Shaheen N., Huber I., Setter N., Gepstein L. (2023). Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome. \u003Cem>J. Mol. Cell Cardiol.\u003C/em> 183, 42&#x02013;53. doi:10.1016/j.yjmcc.2023.08.003\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37579942/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.yjmcc.2023.08.003\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Utilizing+human+induced+pluripotent+stem+cells+to+study+atrial+arrhythmias+in+the+short+QT+syndrome&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B79\" id=\"B79\">\u003C/a>Simons E., Loeys B., Alaerts M. (2023). iPSC-derived cardiomyocytes in inherited cardiac arrhythmias: pathomechanistic discovery and drug development. \u003Cem>Biomedicines\u003C/em> 11, 334. doi:10.3390/biomedicines11020334\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36830871/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/biomedicines11020334\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=iPSC-derived+cardiomyocytes+in+inherited+cardiac+arrhythmias:+pathomechanistic+discovery+and+drug+development&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B80\" id=\"B80\">\u003C/a>Smith S. A., Sturm A. C., Curran J., Kline C. F., Little S. C., Bonilla I. M., et al. (2015). Dysfunction in the &#x003b2;II spectrin-dependent cytoskeleton underlies human arrhythmia. \u003Cem>Circulation\u003C/em> 131, 695&#x02013;708. doi:10.1161/CIRCULATIONAHA.114.013708\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25632041/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCULATIONAHA.114.013708\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Dysfunction+in+the+II+spectrin-dependent+cytoskeleton+underlies+human+arrhythmia&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B81\" id=\"B81\">\u003C/a>Souidi M., Am&#x000e9;dro P., Meyer P., Desprat R., Lema&#x000ee;tre J.-M., Rivier F., et al. (2020). Generation of three Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). \u003Cem>Stem Cell Res.\u003C/em> 49, 102094. doi:10.1016/j.scr.2020.102094\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33246213/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.scr.2020.102094\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Generation+of+three+Duchenne+muscular+dystrophy+patient-specific+induced+pluripotent+stem+cell+lines+DMD_YoTaz_PhyMedEXp,+DMD_RaPer_PhyMedEXp,+DMD_OuMen_PhyMedEXp+(INSRMi008-A,+INSRMi009-A+and+INSRMi010-A)&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B82\" id=\"B82\">\u003C/a>Sun Y., Su J., Wang X., Wang J., Guo F., Qiu H., et al. (2023). Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome. \u003Cem>EBioMedicine\u003C/em> 95, 104741. doi:10.1016/j.ebiom.2023.104741\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37544203/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.ebiom.2023.104741\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Patient-specific+iPSC-derived+cardiomyocytes+reveal+variable+phenotypic+severity+of+Brugada+syndrome&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B83\" id=\"B83\">\u003C/a>Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. \u003Cem>Cell\u003C/em> 131, 861&#x02013;872. doi:10.1016/j.cell.2007.11.019\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18035408/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.cell.2007.11.019\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Induction+of+pluripotent+stem+cells+from+adult+human+fibroblasts+by+defined+factors&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B84\" id=\"B84\">\u003C/a>Takahashi K., Yamanaka S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. \u003Cem>Cell\u003C/em> 126, 663&#x02013;676. doi:10.1016/j.cell.2006.07.024\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16904174/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.cell.2006.07.024\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Induction+of+pluripotent+stem+cells+from+mouse+embryonic+and+adult+fibroblast+cultures+by+defined+factors&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B85\" id=\"B85\">\u003C/a>Takaki T., Inagaki A., Chonabayashi K., Inoue K., Miki K., Ohno S., et al. (2019). Optical recording of action potentials in human induced pluripotent stem cell-derived cardiac single cells and monolayers generated from long QT syndrome type 1 patients. \u003Cem>Stem Cells Int.\u003C/em> 2019, 7532657. doi:10.1155/2019/7532657\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30956674/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1155/2019/7532657\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Optical+recording+of+action+potentials+in+human+induced+pluripotent+stem+cell-derived+cardiac+single+cells+and+monolayers+generated+from+long+QT+syndrome+type+1+patients&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B86\" id=\"B86\">\u003C/a>Talman V., Kivel&#x000e4; R. (2018). Cardiomyocyte-endothelial cell interactions in cardiac remodeling and regeneration. \u003Cem>Front. Cardiovasc Med.\u003C/em> 5, 101. doi:10.3389/fcvm.2018.00101\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30175102/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fcvm.2018.00101\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Cardiomyocyte-endothelial+cell+interactions+in+cardiac+remodeling+and+regeneration&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B87\" id=\"B87\">\u003C/a>Tan Y., Richards D., Xu R., Stewart-Clark S., Mani S. K., Borg T. K., et al. (2015). Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells. \u003Cem>Nano Lett.\u003C/em> 15, 2765&#x02013;2772. doi:10.1021/nl502227a\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25826336/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1021/nl502227a\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Silicon+nanowire-induced+maturation+of+cardiomyocytes+derived+from+human+induced+pluripotent+stem+cells&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B88\" id=\"B88\">\u003C/a>Tester D. J., Medeiros-Domingo A., Will M. L., Haglund C. M., Ackerman M. J. (2012). Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. \u003Cem>Mayo Clin. Proc.\u003C/em> 87, 524&#x02013;539. doi:10.1016/j.mayocp.2012.02.017\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22677073/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.mayocp.2012.02.017\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Cardiac+channel+molecular+autopsy:+insights+from+173+consecutive+cases+of+autopsy-negative+sudden+unexplained+death+referred+for+postmortem+genetic+testing&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B89\" id=\"B89\">\u003C/a>Tian R., Gachechiladze M. A., Ludwig C. H., Laurie M. T., Hong J. Y., Nathaniel D., et al. (2019). CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. \u003Cem>Neuron\u003C/em> 104, 239&#x02013;255. doi:10.1016/j.neuron.2019.07.014\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31422865/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.neuron.2019.07.014\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=CRISPR+interference-based+platform+for+multimodal+genetic+screens+in+human+iPSC-derived+neurons&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B90\" id=\"B90\">\u003C/a>Tu C., Chao B. S., Wu J. C. (2018). Strategies for improving the maturity of human induced pluripotent stem cell-derived cardiomyocytes. \u003Cem>Circ. Res.\u003C/em> 123, 512&#x02013;514. doi:10.1161/CIRCRESAHA.118.313472\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30355143/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCRESAHA.118.313472\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Strategies+for+improving+the+maturity+of+human+induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B91\" id=\"B91\">\u003C/a>Vaidyanathan R., Markandeya Y. S., Kamp T. J., Makielski J. C., January C. T., Eckhardt L. L. (2016). Ik1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes. \u003Cem>Am. J. Physiol. Heart Circ. Physiol.\u003C/em> 310, H1611&#x02013;H1621. doi:10.1152/ajpheart.00481.2015\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27059077/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1152/ajpheart.00481.2015\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Ik1-enhanced+human-induced+pluripotent+stem+cell-derived+cardiomyocytes:+an+improved+cardiomyocyte+model+to+investigate+inherited+arrhythmia+syndromes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B92\" id=\"B92\">\u003C/a>van den Brink L., Grandela C., Mummery C. L., Davis R. P. (2020). Inherited cardiac diseases, pluripotent stem cells, and genome editing combined-the past, present, and future. \u003Cem>Stem Cells\u003C/em> 38, 174&#x02013;186. doi:10.1002/stem.3110\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31664757/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/stem.3110\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Inherited+cardiac+diseases,+pluripotent+stem+cells,+and+genome+editing+combined-the+past,+present,+and+future&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B93\" id=\"B93\">\u003C/a>van Mil A., Balk G. M., Neef K., Buikema J. W., Asselbergs F. W., Wu S. M., et al. (2018). Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential. \u003Cem>Cardiovasc Res.\u003C/em> 114, 1828&#x02013;1842. doi:10.1093/cvr/cvy208\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30169602/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1093/cvr/cvy208\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modelling+inherited+cardiac+disease+using+human+induced+pluripotent+stem+cell-derived+cardiomyocytes:+progress,+pitfalls,+and+potential&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B94\" id=\"B94\">\u003C/a>Veerman C. C., Mengarelli I., Guan K., Stauske M., Barc J., Tan H. L., et al. (2016). hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities. \u003Cem>Sci. Rep.\u003C/em> 6, 30967. doi:10.1038/srep30967\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27485484/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/srep30967\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=hiPSC-derived+cardiomyocytes+from+Brugada+Syndrome+patients+without+identified+mutations+do+not+exhibit+clear+cellular+electrophysiological+abnormalities&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B95\" id=\"B95\">\u003C/a>Vreeker A., van Stuijvenberg L., Hund T. J., Mohler P. J., Nikkels P. G. J., van Veen T. A. B. (2014). Assembly of the cardiac intercalated disk during pre- and postnatal development of the human heart. \u003Cem>PLoS One\u003C/em> 9, e94722. doi:10.1371/journal.pone.0094722\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24733085/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1371/journal.pone.0094722\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Assembly+of+the+cardiac+intercalated+disk+during+pre-+and+postnatal+development+of+the+human+heart&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B96\" id=\"B96\">\u003C/a>Wang M., Tu X. (2022). The genetics and epigenetics of ventricular arrhythmias in patients without structural heart disease. \u003Cem>Front. Cardiovasc Med.\u003C/em> 9, 891399. doi:10.3389/fcvm.2022.891399\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35783865/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3389/fcvm.2022.891399\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+genetics+and+epigenetics+of+ventricular+arrhythmias+in+patients+without+structural+heart+disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B97\" id=\"B97\">\u003C/a>Wheelwright M., Mikkila J., Bedada F. B., Mandegar M. A., Thompson B. R., Metzger J. M. (2020). Advancing physiological maturation in human induced pluripotent stem cell-derived cardiac muscle by gene editing an inducible adult troponin isoform switch. \u003Cem>Stem Cells\u003C/em> 38, 1254&#x02013;1266. doi:10.1002/stem.3235\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32497296/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/stem.3235\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Advancing+physiological+maturation+in+human+induced+pluripotent+stem+cell-derived+cardiac+muscle+by+gene+editing+an+inducible+adult+troponin+isoform+switch&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B98\" id=\"B98\">\u003C/a>Wu J. C., Garg P., Yoshida Y., Yamanaka S., Gepstein L., Hulot J.-S., et al. (2019). Towards precision medicine with human iPSCs for cardiac channelopathies. \u003Cem>Circ. Res.\u003C/em> 125, 653&#x02013;658. doi:10.1161/CIRCRESAHA.119.315209\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31465267/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCRESAHA.119.315209\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Towards+precision+medicine+with+human+iPSCs+for+cardiac+channelopathies&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B99\" id=\"B99\">\u003C/a>Wu J. Y., Yeager K., Tavakol D. N., Morsink M., Wang B., Soni R. K., et al. (2023). Directed differentiation of human iPSCs into mesenchymal lineages by optogenetic control of TGF-&#x003b2; signaling. \u003Cem>Cell Rep.\u003C/em> 42, 112509. doi:10.1016/j.celrep.2023.112509\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37178118/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.celrep.2023.112509\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Directed+differentiation+of+human+iPSCs+into+mesenchymal+lineages+by+optogenetic+control+of+TGF-+signaling&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B100\" id=\"B100\">\u003C/a>Wu P., Deng G., Sai X., Guo H., Huang H., Zhu P. (2021). Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes. \u003Cem>Biosci. Rep.\u003C/em> 41, BSR20200833. doi:10.1042/BSR20200833\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33057659/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1042/BSR20200833\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Maturation+strategies+and+limitations+of+induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B101\" id=\"B101\">\u003C/a>Yang H., Yang Y., Kiskin F. N., Shen M., Zhang J. Z. (2023). Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes. \u003Cem>Stem Cell Res. Ther.\u003C/em> 14, 228. doi:10.1186/s13287-023-03470-w\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37649113/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1186/s13287-023-03470-w\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Recent+advances+in+regulating+the+proliferation+or+maturation+of+human-induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B102\" id=\"B102\">\u003C/a>Yoshida S., Sumomozawa K., Nagamine K., Nishizawa M. (2019). Hydrogel microchambers integrated with organic electrodes for efficient electrical stimulation of human iPSC-derived cardiomyocytes. \u003Cem>Macromol. Biosci.\u003C/em> 19, e1900060. doi:10.1002/mabi.201900060\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31038841/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/mabi.201900060\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Hydrogel+microchambers+integrated+with+organic+electrodes+for+efficient+electrical+stimulation+of+human+iPSC-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B103\" id=\"B103\">\u003C/a>Yoshida Y., Yamanaka S. (2017). Induced pluripotent stem cells 10 Years later: for cardiac applications. \u003Cem>Circ. Res.\u003C/em> 120, 1958&#x02013;1968. doi:10.1161/CIRCRESAHA.117.311080\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28596174/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCRESAHA.117.311080\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Induced+pluripotent+stem+cells+10+Years+later:+for+cardiac+applications&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B104\" id=\"B104\">\u003C/a>Zhao W., Lei A., Tian L., Wang X., Correia C., Weiskittel T., et al. (2020). Strategies for genetically engineering hypoimmunogenic universal pluripotent stem cells. \u003Cem>iScience\u003C/em> 23, 101162. doi:10.1016/j.isci.2020.101162\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32502965/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.isci.2020.101162\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Strategies+for+genetically+engineering+hypoimmunogenic+universal+pluripotent+stem+cells&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B105\" id=\"B105\">\u003C/a>Zhou J., Cui B., Wang X., Wang H., Zheng J., Guo F., et al. (2023). Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes. \u003Cem>Stem Cell Res. Ther.\u003C/em> 14, 92. doi:10.1186/s13287-023-03312-9\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37061738/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1186/s13287-023-03312-9\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Overexpression+of+KCNJ2+enhances+maturation+of+human-induced+pluripotent+stem+cell-derived+cardiomyocytes&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Ca id=\"h16\" name=\"h16\">\u003C/a>\u003Ch2>Glossary\u003C/h2>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg\" name=\"Table3\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-t003.jpg\" alt=\"www.frontiersin.org\" id=\"udT1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003C/div>\u003Cdiv class=\"thinLineM20\">\u003C/div>\u003Cdiv class=\"AbstractSummary\">\u003Cp>\u003Cspan>Keywords:\u003C/span> iPSCs, patient-specific iPSC-CMs, \u003Cem>in vitro\u003C/em> arrhythmia models, ion channels, personalized medicine, CRISPR, gene editing, optogenetics\u003C/p>\u003Cp>\u003Cspan>Citation:\u003C/span> Joshi J, Albers C, Smole N, Guo S and Smith SA (2024) Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions. \u003Cem>Front. Physiol.\u003C/em> 15:1475152. doi: 10.3389/fphys.2024.1475152\u003C/p>\u003Cp id=\"timestamps\">\u003Cspan>Received:\u003C/span> 02 August 2024; \u003Cspan>Accepted:\u003C/span> 28 August 2024;\u003Cbr>\u003Cspan>Published:\u003C/span> 12 September 2024.\u003C/p>\u003Cdiv>\u003Cp>Edited by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/22602/overview\">David R. Van Wagoner\u003C/a>, Case Western Reserve University, United States\u003C/div>\u003Cdiv>\u003Cp>Reviewed by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/1881221/overview\">Mena Abdelsayed\u003C/a>, Lankenau Institute for Medical Research, United States\u003Cbr>\u003Ca href=\"https://loop.frontiersin.org/people/2596873/overview\">Carlo Lavalle\u003C/a>, Sapienza University of Rome, Italy\u003C/div>\u003Cp>\u003Cspan>Copyright\u003C/span> &#x000a9; 2024 Joshi, Albers, Smole, Guo and Smith. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY).\u003C/a> The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\u003Cp>\u003Cspan>&#x0002a;Correspondence:\u003C/span> Sakima A. Smith, \u003Ca id=\"encmail\">c2FraW1hLnNtaXRoQG9zdW1jLmVkdQ==\u003C/a>\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\r\n","\u003Cul class=\"flyoutJournal\">\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h2\">1 Introduction\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h3\">2 Patient-specific/human iPSC-CMs and their applications in modeling arrhythmias\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h4\">3 Roles of 3D culture, gene editing and all-optical platforms in arrhythmia research\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h5\">4 Challenges of using iPSC-CMs in arrhythmia research and clinical care\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h6\">5 Overcoming the challenges of iPSCs and iPSC-CMs in arrhythmia modeling\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h7\">6 The scope of iPSC-CMs beyond disease modeling\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h8\">7 Summary and Future directions\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h9\">Author contributions\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h10\">Funding\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h11\">Acknowledgments\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h12\">Conflict of interest\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h13\">Publisher&#x02019;s note\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h14\">Supplementary material\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h15\">References\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h16\">Glossary\u003C/a>\u003C/li>\u003C/ul>",[698,704,710,713,719],{"name":699,"fileServerPackageEntryId":19,"fileServerId":700,"fileServerVersionNumber":701,"type":702},"EPUB.epub","1475152/epub",2,{"code":703,"name":703},"EPUB",{"name":705,"fileServerPackageEntryId":706,"fileServerId":707,"fileServerVersionNumber":701,"type":708},"fphys-15-1475152.pdf","fphys-15-1475152-r1/fphys-15-1475152.pdf","1475152/pubmed-zip",{"code":709,"name":709},"PDF",{"name":705,"fileServerPackageEntryId":19,"fileServerId":711,"fileServerVersionNumber":701,"type":712},"1475152/publishers-proof/pdf",{"code":709,"name":709},{"name":714,"fileServerPackageEntryId":715,"fileServerId":707,"fileServerVersionNumber":701,"type":716},"fphys-15-1475152.xml","fphys-15-1475152-r1/fphys-15-1475152.xml",{"code":717,"name":718},"NLM_XML","XML",{"name":720,"fileServerPackageEntryId":19,"fileServerId":721,"fileServerVersionNumber":442,"type":722},"Provisional PDF.pdf","1475152/provisional-pdf",{"code":709,"name":709},"v3",{"title":725,"link":726,"meta":730,"script":833},"Frontiers | Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions",[727],{"rel":728,"href":729},"canonical","https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/full",[731,734,737,739,742,746,749,753,756,759,762,764,766,768,770,772,775,778,780,783,785,787,790,793,796,799,802,806,810,813,815,818,820,823,825,828,830],{"hid":732,"property":732,"name":732,"content":733},"description","Ion channels and cytoskeletal proteins in the cardiac dyad play a critical role in maintaining excitation-contraction (E-C) coupling and in providing cardiac...",{"hid":735,"property":735,"name":736,"content":725},"og:title","title",{"hid":738,"property":738,"name":732,"content":733},"og:description",{"hid":740,"name":740,"content":741},"keywords","iPSCs,patient-specific iPSC-CMs,in vitro arrhythmia models,Ion Channels,personalized medicine,CRISPR,gene editing,optogenetics Font: Italic Formatted: Font: Italic Formatted: Normal",{"hid":743,"property":743,"name":744,"content":745},"og:site_name","site_name","Frontiers",{"hid":747,"property":747,"name":435,"content":748},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1475152/fphys-15-1475152-HTML-r1/image_m/fphys-15-1475152-g001.jpg",{"hid":750,"property":750,"name":751,"content":752},"og:type","type","article",{"hid":754,"property":754,"name":755,"content":729},"og:url","url",{"hid":757,"name":757,"content":758},"twitter:card","summary_large_image",{"hid":760,"name":760,"content":761},"citation_volume","15",{"hid":763,"name":763,"content":116},"citation_journal_title",{"hid":765,"name":765,"content":745},"citation_publisher",{"hid":767,"name":767,"content":679},"citation_journal_abbrev",{"hid":769,"name":769,"content":680},"citation_issn",{"hid":771,"name":771,"content":587},"citation_doi",{"hid":773,"name":773,"content":774},"citation_firstpage","1475152",{"hid":776,"name":776,"content":777},"citation_language","English",{"hid":779,"name":779,"content":588},"citation_title",{"hid":781,"name":781,"content":782},"citation_keywords","iPSCs; patient-specific iPSC-CMs; in vitro arrhythmia models; Ion Channels; personalized medicine; CRISPR; gene editing; optogenetics Font: Italic Formatted: Font: Italic Formatted: Normal",{"hid":784,"name":784,"content":593},"citation_abstract",{"hid":786,"name":786,"content":602},"citation_article_type",{"hid":788,"name":788,"content":789},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/pdf",{"hid":791,"name":791,"content":792},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1475152/xml",{"hid":794,"name":794,"content":795},"citation_fulltext_world_readable","yes",{"hid":797,"name":797,"content":798},"citation_online_date","2024/08/28",{"hid":800,"name":800,"content":801},"citation_publication_date","2024/09/12",{"hid":803,"name":804,"content":805},"citation_author_0","citation_author","Joshi, Jyotsna ",{"hid":807,"name":808,"content":809},"citation_author_institution_0","citation_author_institution","Department of Internal Medicine, United States",{"hid":811,"name":804,"content":812},"citation_author_1","Albers, Cora ",{"hid":814,"name":808,"content":809},"citation_author_institution_1",{"hid":816,"name":804,"content":817},"citation_author_2","Smole, Nathan ",{"hid":819,"name":808,"content":809},"citation_author_institution_2",{"hid":821,"name":804,"content":822},"citation_author_3","Guo, Shuliang ",{"hid":824,"name":808,"content":809},"citation_author_institution_3",{"hid":826,"name":804,"content":827},"citation_author_4","Smith, Sakima A. ",{"hid":829,"name":808,"content":809},"citation_author_institution_4",{"hid":831,"name":831,"content":832},"dc.identifier","doi:10.3389/fphys.2024.1475152",[834,837,839,841,843],{"src":835,"body":13,"type":836,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":838,"body":13,"type":836,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":840,"body":13,"type":836,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":842,"body":13,"type":836,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fphys.2024.1475152?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":844,"body":13,"type":836,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":846,"articleHubArticlesList":847,"canJournalHasArticleHub":395,"articleDoiList":848},{},[],[],{"title":19,"image":-1,"breadcrumbs":850,"linksCollection":851,"metricsCollection":853},[],{"total":439,"items":852},[],{"total":439,"items":854},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fphys.2024.1475152?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>